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ABSTRACT

Nicholas Stepenosky
DATA FUSION OF COMPLEMENTARY INFORMATION FROM PARIETAL AND
OCCIPITAL EVENT RELATED POTENTIALS FOR EARLY DIAGNOSIS OF
ALZHEIMER'S DISEASE
2005/06
Dr. Robi Polikar
Master of Science in Electrical Engineering

The number of the elderly population affected by Alzheimer's disease is rapidly
rising. The need to find an accurate, inexpensive, and non-intrusive procedure that can be
made available to community healthcare providers for the early diagnosis of Alzheimer's
disease is becoming an increasingly urgent public health concern. Several recent studies
have looked at analyzing electroencephalogram signals through the use of many signal
processing techniques. While their methods show great promise, the final outcome of
these studies has been largely inconclusive. The inherent difficulty of the problem may be

the cause of this outcome, but most likely it is due to the inefficient use of the available
information, as many of these studies have used only a single EEG source for the
analysis. In this contribution, data from the event related potentials of 19 available
electrodes of the EEG are analyzed. These signals are decomposed into different
frequency bands using multiresolution wavelet analysis. Two data fusion approaches are

then investigated: i.) concatenating features before presenting them to a classification

algorithm with the expectation of creating a more informative feature space, and ii.)
generating multiple classifiers each trained with a different combination of features
obtained from various stimuli, electrode, and frequency bands. The classifiers are then
combined through the weighted majority vote, product and sum rule combination
schemes. The results indicate that a correct diagnosis performance of over 80% can be
obtained by combining data primarily from parietal and occipital lobe electrodes. The
performance significantly exceeds that reported from community clinic physicians,
despite their access to the outcomes of longitudinal monitoring of the patients.
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CHAPTER 1
INTRODUCTION
The number of the elderly population affected by Alzheimer's disease (AD) is rising and
has become a major public health concern. Therefore, the need for an accurate,
inexpensive and non-intrusive procedure for the early diagnosis of the disease that can be
made available to local healthcare providers becomes increasingly urgent. Although once
considered rare and part of normal aging, Alzheimer's disease is now the most common
type of dementia, as it accounts for more than half of all dementia cases [1,2]. In general,

evidence of dementia cases from well-planned, representative epidemiological surveys is
scarce in many regions. According to [3], there are an estimated 24.3 million people
suffering from dementia, with 4.6 million new cases of dementia every year. This means
that there is approximately one new case of dementia every 7 seconds. According to data
based on the number of cases detected in the 2000 United States census, the Alzheimer's
Association and the National Institute on Aging in the United States estimate that
approximately 4.5 million people have AD. This number is expected to increase
substantially and reach approximately 16 million cases in the United States alone by the
year 2050 [1].
The only definitive means for diagnosis is via autopsy, but clinical evaluations are
the most common procedure for diagnosing AD. A study showed that local physicians
have a significantly lower overall correct diagnostic accuracy than that of a skilled
physician with access to longitudinal monitoring of patients [1,4]. Unfortunately, this

type of expertise, particularly that of neuropsychologists, is only available at major
research and university hospitals and can be prohibitively expensive. There is currently
no standard procedure or effective diagnostic tool available to community healthcare
providers who serve as the first line of intervention for the disease. To have a meaningful
impact on healthcare, an effective, accurate, inexpensive, and non-invasive procedure for
the diagnosis of AD must be made available to community-based physicians. The goal of
this study is to develop an automated diagnostic tool for the early diagnosis of AD that
can be made available to local health clinics that is comparable to the diagnostic abilities
of an expert.
The approach proposed in this study for creating such a diagnostic tool involves an
analysis of EEG signals using signal processing techniques and automated classification.
Several studies have been performed on EEG signals for the early diagnosis of AD using
signal processing methods in order to establish a biomarker for AD, but these attempts
have shown only varying degrees of success. The reason for using EEGs is practical and
quite simple. EEGs are a well established technique, inexpensive and non-intrusive to
acquire, and many local healthcare facilities already own or have access to the necessary
equipment.

1.1

ALZHEIMER'S DISEASE

Alzheimer's disease is a progressive neurological disorder associated with aging, nerve
degeneration, and neuron death. It gradually destroys a person's memory and their ability
to learn, reason, make judgments, communicate, and carry out daily activities. In the preclinical stages of AD, there are no reliable and valid symptoms that can be detected to
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allow a very early diagnosis before irreversible cognitive deficits manifest. In the mild
stage, an impairment of learning and memory is usually noticeable. The declarative
recent memory, or fact memory, which stores information from the "what," "who,"
"where," and "when" kinds of questions, is predominantly affected with early loss of
memory for everyday events. Semantic difficulties with word generation and a
deterioration of object naming are also prominent. In the moderate dementia stage,
language difficulties increase and become more obvious [5]. Deficits in other cognitive
abilities (abstract and logical reasoning, planning, organizing,etc.) appear during the
progression of the disease [6]. As the disease progresses, individuals may also experience
changes in personality and behavior, such as anxiety, suspiciousness or agitation, and
some may experience delusions or hallucinations [1].
The likelihood of developing AD almost doubles every five years after the age of
65. This is often referred to as late-onset Alzheimer's disease. At this age range,
approximately one out of ten individuals will develop the disease. By the age of 85, the
odds of developing AD increases to one out of every two [1].
An AD patient may live eight to twenty years beyond diagnosis, if the disease is
diagnosed and treated in its earliest stages. An early diagnosis allows an early start of a
treatment plan, which can not only improve the life expectancy of the patient
significantly, but also improve their quality of life. Therefore, the early diagnosis of
Alzheimer's disease is of utmost importance.
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1.1.1

BIOLOGICAL ASPECTS OF ALZHEIMER'S DISEASE

As previously mentioned, Alzheimer's disease is associated with nerve degeneration and
neuron death. Scientists and researchers believe that factors that trigger the disease begins
its damage to the brain years before any detectable symptoms appear. When symptoms
do finally appear, nerve cells that process, store, and retrieve information, have already
begun to degenerate and die. Typically, the damage of the nerve cells begins with those
involved with learning and memory functions. The disease then gradually spreads to cells
that control the abilities and aspects of thought, judgment, and behavior. The
neuropathology of AD is characterized by widespread neuronal cell loss due to two types
of unusual proteins: neurofibrillary tangles, and senile amyloid plaques in the
hippocampus, neocortex, and other brain regions [7].
Amyloid plaques are clumps of protein fragments that accumulate outside of the
brain's nerve cells. Beta amyloid, which is typically a harmless protein, is believed to
cause these deposits of plaque which form between neurons early in the disease process,
before neurons begin to die and any symptoms develop [8]. The role of amyloid deposits
is uncertain as a part of the pathology of the disease because a variant form of the disease
has no amyloid deposits present [2].
Neurofibrillary tangles, on the other hand, are clumps of altered proteins inside
cells, mainly tau protein. During the progression of AD, threads of tau protein undergo
alterations that cause them to become twisted forming "tangles". Some researchers
believe that this seriously damages the neurons by breaking down their internal cellular
structure and causes them to die [8]. Just like that of amyloid deposits, the role of tau in
AD has also been questioned since mutations in the tau gene have been linked to a variety

of neurodegenerative diseases other than AD [2].
Some research efforts have focused on identifying genetic causes of the disease,
while other scientists and researchers have focused on developing medications that slow
and prevent the accumulation of suspected proteins. Many others yet believe that the
cause of the disease is not necessarily as important as the fact that the course of the
disease remains the same regardless of its cause [9].

1.1.2

CLINICAL DIAGNOSIS

Just as AD has no known single cause, there in no standard procedure for diagnosis. The
only definitive means of diagnosis is via an autopsy. The disease is characterized by the
above mentioned unusual proteins, which can only be seen by studying brain tissue under
a microscope. Researchers have been working to discover early symptoms, a method for
diagnosis, and medications to prevent possible causes and progression before the disease
reaches its debilitating stages.
The current 'gold standard' for AD diagnosis is clinical evaluation, which has been
used with considerable success for AD diagnosis. The evaluation process involves a
series of clinical interviews between a neuropsychologist and the subject. Results from a
thorough medical history, physical examination, and memory assessment and nervous
system function tests are combined to determine if there are changes in the person's
cognitive status. All of these tests are necessary to assess if a person has symptoms of

AD. Overall, it is difficult to determine whether a person is actually suffering from AD,
or from other possible forms of dementia such as vascular dementia, or if the symptoms
are simply associated with normal aging [10].

Having access to the expertise of a skilled physician is usually not an option for
the majority of dementia patients. Since most patients are evaluated at local community
clinics and healthcare facilities. The expertise and accuracy of diagnosis at such facilities
remains uncertain. Our only metric for these health care providers is a 1999 study, where
a group of Health Maintenance Organization-based physicians reported a sensitivity of
83%, a specificity of 55%, and an overall accuracy of 75% [4]. This performance is the
metric against which the results of this effort are compared.

1.1.3

OTHER DIAGNOSTIC TOOLS

Other methods besides conventional clinical evaluations are being considered for
diagnostic tools. Spinal taps are used to extract cerebrospinal fluid (CSF), which contains
known biomarkers for AD, but this is a highly invasive technique. One study has shown
that concentrations of beta amyloid, total tau, and phosphorylated tau in CSF are strongly
associated with the future development of Alzheimer's disease in patients with mild
cognitive impairment [11]. Magnetic resonance imaging (MRI) scans can capture images
of the lesions in the brain, but they are very expensive and are not always available at
local health care facility.
Abnormalities in the brain are known to disrupt the brain's electrical signals and
can theoretically be detected through electroencephalogram (EEG) signals. EEGs can be
obtained in a non-invasive manner, and are a fairly inexpensive to acquire. Traditionally,
EEG analysis was not used for AD diagnosis due to it poor spatial resolution. There were
difficulties in EEG analysis in distinguishing changes attributed by AD and those by
normal aging, other medical illnesses, and other factors associated with physiology [12].
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Recently, there has been a revival of EEG analysis used for the diagnosis of AD
and many techniques seem more promising then had originally been anticipated [13].
One reason behind this revival is that AD is a cortical dementia in which EEG
abnormalities are more frequently shown. Subcortical dementias exhibit relatively normal
EEG patterns compared with other cortical dementias [14]. The EEG abnormalities in
AD directly reflect anatomical and functional deficits of the cerebral cortex after being
damaged by the disease. Thus, it is anticipated that the analysis of EEG dynamics will
provide useful and informative clues concerning the neuropathology of AD.
Again, an accurate, cost-effective, and non-intrusive diagnostic tool, that can be
made available to local clinics is of critical importance. As we move the diagnostic
process earlier within the natural history of the disease, it is very important to maintain
current levels of sensitivity and specificity of the AD diagnosis. [15]. An approach based
on EEG analysis can potentially satisfy all of the mentioned requirements, if its accuracy
can be established. The EEG itself is an established and dependable technology, easy and
cost-effective to operate, and hence ideally suited for a health clinic setting. Overall, a
reliable method for diagnosing the illness in its early stages is essential so that
medications may be administered in a timely fashion to reduce the progression of the
disease to its later devastating stages.

1.2

OBJECTIVES OF THIS STUDY AND ORGANIZATION OF THE THESIS

The goal of this study has been the design and development of an automated algorithm
for the early diagnosis of Alzheimer's disease. The specific research objectives were:
1. Develop an automated classification procedure for the early diagnosis of

Alzheimer's disease through the analysis of EEG signals that is comparable in
accuracy to a clinical diagnosis by an expert.
2. Compare the diagnostic performance of different frequency subbands from the
wavelet analysis of data from all available electrode recordings acquired during
both the target and novel stimuli.
3. Combine features from electrodes using data fusion techniques in an effort to
provide the most informed decision for classification and enhance the overall
generalization performance.
The organization of this thesis is as follows. Alzheimer's disease and difficulties
associated with its diagnosis were introduced in this chapter. Chapter 2 provides specific
background on EEG signals, event related potentials, and their acquisition. Chapter 3
describes previous approaches on using EEGs and ERPs for AD diagnosis. Chapter 4
includes the implementation of our approach as well as the data acquisition process, and
subject statistics. The theory behind the multiresolution wavelet analysis which is used as
the feature extraction technique is also covered in Chapter 4. Chapter 5 describes the
theory behind the classifier and ensemble based algorithms and techniques used
throughout the experiments of this research. Chapter 6 presents the results from all
experiments which include using single MLP neural networks, and different ensembles
and combination rules. Finally, Chapter 7 summarizes the accomplishments of this study,
discusses possible sources of error, and presents recommendations for future work as a
conclusion for this thesis.

CHAPTER 2
THE ELECTROENCEPHALOGRAM
AND
THE EVENT RELATED POETENTIAL
2.1

ELECTROENCEPHALOGRAM

Electroencephalogram (EEG) signals represent the electrical activity of the brain as
voltage (typically microvolts) over time. EEGs are recorded using a series of electrodes
placed on the scalp. These signals have traditionally been used to determine illnesses
associated with brain activity, such as schizophrenia [16], and epilepsy [17]. Changes in
the brain's electrical activity can reflect changes in cognitive status. Hence, the main goal
of this study is to determine whether our method of automated analysis can detect
changes in EEG signals that reflect the earliest changes caused by Alzheimer's disease.
Hans Berger, a neuropsychiatrist, is credited for the discovery of human EEG
signals [18]. Berger started studying humans in 1924 using various galvanometers. In the
following years, he identified different features within the brain's signals such as sleep
spindles, fluctuations of consciousness, the first evidence of alpha rhythms, as well as a
several disorders [19]. He was also the first to observe pathological EEG sequences in a
historically verified AD patient [18,20].
Thereafter, the EEG developed as a method for investigating mental processes and
was quickly adopted for use in clinical applications. The EEG became more popular with
the introduction of event-related potentials (ERPs), which are components of the EEG
that result from specific sensory and cognitive processes.

Many advances in EEG studies led to breakthroughs in neurophysiology. The idea
that different neurological disorders could be explored further through the use of EEGs
caused research to shift in that direction [19,21].

2.1.1

EEG RECORDINGS

EEG recordings are acquired using electrodes placed in different locations on the scalp.
EEGs can be recorded as bipolar recordings where electric potentials are recorded
between pairs of active electrodes, or as a monopolar recording where potentials are
recorded with respect to a single passive reference electrode. These measures are
primarily performed on the surface of the scalp (scalp EEG), but special electrodes can
also be placed on the surface of the brain during a surgical operation (intracranial EEG).
Better resolution can be achieved with the intracranial implanted electrodes, but a
surgical procedure is required for placement of the electrodes. Hence, intracranial
recordings are impractical for most human studies [21].
The standard system in use for the placement of scalp electrodes is the
International 10-20 system, which was developed to keep a consistent placement scheme
for comparison studies. The system is termed 10-20 because EEG electrodes are placed
on the scalp at 10 and 20 percent of a measured distance (the circumference of one's
head). The system involves a number of electrodes connected at key scalp locations. The
electrodes are usually referenced to two electrodes on the earlobes to obtain signals from
particular regions of the brain.
One problem with scalp electrode recordings is that artifacts alter the EEG signal.
Artifacts are easily created due to head and eye movements, muscle activity, etc. Since
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the EEG signals have such low amplitudes, artifacts from these added stimuli
contaminate recordings. These artifacts are typically removed as a preprocessing
procedure by the EEG technician. Synchronized and repeated signals are then averaged to
make the components within the signal more pronounced [21].
Figure 2.1 shows an expanded version of the International 10-20 system. It
displays the possible electrode names and their positions on the scalp. Note that these
extra electrodes are added in between the usual electrodes for a more thorough analysis
and higher resolution. The notation in Figure 2.1 is as follows: F = frontal, C = central
(cortex), P = parietal, T = temporal, O = occipital, and A = auditory reference

corresponding to the regions of the brain where the electrodes are placed. Convention
calls for odd numbers on the left and even numbers on the right [19].

Figure 2.1: Example of the expanded International 10-20 system
for scalp electrode placement.
11

2.1.2

SPECTRAL CONTENT OF THE EEG

An EEG signal can be broken into different frequency bands. Each band has been shown
to be associated with different brain functions. As reported in [22], the five main
frequency bands are as follows:
* The delta band (0.5 - 3.5Hz) is characteristic of deep sleep stages. An increase in the
amplitude of the delta response has been found during experiments using an oddball
paradigm (refer to Section 2.2). This suggests that the response may be linked to
signal detection and the corresponding decision [23,24].

* The theta band (3.5 - 7.5Hz) has been correlated with higher cognitive and
associative brain processes [24,25]. The event related potential (refer to Section 2.3)
components in the theta band are prolonged after target stimuli in oddball paradigm
experiments. This latency indicates a relationship with selective attention [23,24].

* The alpha band (7.5 - 12.5Hz) is sometimes divided into two subbands, alphal
(7.5 - 10Hz) and alpha2 (10 - 12.5Hz). In some cases, results have indicated that the
working memory is associated with alpha oscillations [23,26].

* The beta band (12.5 - 30Hz), like the alpha band, can also be divided into subbands,
betal (12.5 - 20Hz) and beta2 (20 - 30Hz). The beta rhythms have been found to

elicit a stronger response in recordings from the central and frontal electrodes. Beta
rhythms have also shown enhancement during states of expectancy and tension [21].
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* The gamma band (30 - 60Hz) became popular after cellular level experiments
showed a relationship with the linking of stimulus features into perceived
information. Basar-Eroglu et al., 1996, suggested that the gamma band activity is part
of the common language elements of the brain. This activity may also be associated

with mutual information transfer between subcomponents of the brain just as it is with
other oscillations such as theta, alpha, or beta [27,28].

2.2

DATA ACQUISITION PROTOCOLS

In certain protocols for EEG acquisition, the patient is exposed to a sensory stimulus in
order to elicit a particular response. These responses are known as event related or
evoked potentials. There are three common modalities, or types of stimuli, used: auditory,
visual, and somatosensory. The auditory modality uses single tones of a preset
frequencies or clicks with a broadband frequency distribution as stimuli. For the visual
type, stimuli are produced by a single light or sometimes by the reversal of a pattern such
as a checkerboard. For the somatosensory modality, stimuli are a combination of the
visual and auditory types [29].
Sequences of stimuli are arranged in paradigms to study the responses to tasks in
order to test such factors as memory, reaction time, awareness, etc. The tasks involved
could vary from simple tasks such as pressing a button to harder tasks such as the
memorization of an extensive list. The oddball paradigm, one of the most common
paradigms, has been used in experiments conducted for this study.
The traditional oddball paradigm involves two different stimuli presented in a
pseudo-random order. The oddball, or target, tone is presented randomly in a series of
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frequently occurring, or standard, tones. The standard tone is presented in 75-80% of the
trials, and the oddball stimuli in the remaining 20-25% of the trials. The oddball stimulus
is usually a different frequency than the standard, set far enough apart to be
distinguishable from the frequent stimuli [12,21]. The subjects are instructed to perform a
simple task such as pressing a button, keeping a mental count of the number of oddball
tones, etc., after hearing each oddball tone [12,21,30].
Yamaguchi et al., 2000, developed a variation of this paradigm with the use of
novel tones consisting of 60 unique environmental sounds, recorded from Disney movies
edited to be 200ms in duration. In this variation, standard stimuli occur 65%, target
stimuli occur 20%, and novel tones occur 15% of the time. Again, subjects are asked to
respond only to the oddball stimulus by performing a simple task defined at the beginning
of the experiment. This type of experiment is performed in efforts to differentiate
between different types of dementia [31,32].

2.3

EVENT RELATED POTENTIALS

The potential evoked in the EEG as a response to a stimulation is called an event related
potential (ERP) or an evoked potential [29]. ERPs are a series of positive and negative
peaks that occur in response to a specific event to which the subject is usually asked to
respond. Each element of the ERP has a name that denotes its sign, such as P for positive
or N for negative, and its latency after the stimulus is perceived by the subject. Some of
these elements are explained below and Figure 2.2 shows the labeled components of an
ERP.
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Figure 2.2: ERP signal and components
P50 is a positive peak that occurs around 50ms after the stimulus. N1 is a negative
peak occurring around 100ms after the stimulus. Golob and Starr, 2000, showed in a
study that changes in the amplitude and latency of the N1 peak may be observed during
memorization tasks [33].
P2 is a positive peak at approximately 200ms after the stimulus. P2 response is
stronger due to standard stimulus in an oddball paradigm as opposed to target stimulus,

implying that it contains a component due to sensitivity of the sensory processes other
than cognitive processes [32].
N2 is a negative peak at approximately 200ms. This response is found to be
stronger in response to target tones in the oddball paradigm, however given its close
proximity to the P3 component, it is hypothesized that the amplitude and latency of the
N2 may be affected by the P3 generation [32].
15

P3 or P300 is a positive peak occurring around 300ms. The P300 has been shown
to occur in response to oddball tones, and has also been associated with mental activity.
The P300 is measured by quantifying its amplitude and latency, where amplitude is
defined as the voltage difference between the pre-stimulus baseline and the largest peak
with latency between 250-400ms. The latency is the time measured from stimulus onset
to the point of maximum positive amplitude within the particular latency window [32,34].
The latency and amplitude of the P300 component have been shown to be related to age
and the cognitive ability of the individual [19,32]. The P300 can be attributed to a
manifestation of central nervous system activity involved with the processing of new
information when attention is engaged in updating memory. The latency of the P300 in
the discrimination task provides an indication of individual ability in mental processing
capability and speed [12].
In 1999, Katayama and Polich conducted an experiment involving 12 young
adults. EEG recordings were acquired using the oddball paradigm with both visual and
auditory modalities. The P300 was largest for the parietal and mid-line electrodes and
occurred in response to both target and non-target stimuli during both modalities [35].
A second P300 is created in experiments involving the novel tones. The target P3,
or P3b, is the traditional P300 with the strongest area of detection from the parietal
region. The novelty P3 or P3a is in response to an alarming or novel stimulus and
originates in the frontal region. The use of the novel tones is said to increase the P3b and
elicit a P3a. However, the P3a is only readily observed in about 20% of normal subjects
which, although this peak may be the most sensitive to changes in cognitive function,
tends to be limited in use [22,31,32].
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Due to the low amplitude of the ERPs compared with the ongoing EEG, averaging
several responses is a common practice to visualize the ERP. The ERPs have a similar
pattern of response which is predictable under similar conditions [21,22]. Sufficient
numbers of artifact-free trials have been shown to stabilize ERP measures in both
amplitude and latency [31].

2.4

EEG OF ALZHEIMER'S PATIENTS

Different studies have shown abnormalities in the EEG of AD patients. The hallmark of
EEG abnormalities in AD patients is slowing of the rhythms. An increase in theta and
delta activities and a decrease in beta activities are repeatedly observed [36,37,38]. The
severity of the disease is also correlated with these abnormalities [39, 40].
The P300, as mentioned in the previous sections, has been related to cognitive
processes that require attentional allocation and immediate memory processes. It has
been observed that the P300 latency is prolonged and that the amplitude is decreased in
AD patients. Sometimes this can occur so that the peak is not at all obvious as shown in
Figure 2.3 [31, 41]. The P300 directly reflects currents triggered by cortical post-synaptic
potentials and seems to be primarily generated in the temporal-parietal cortex. This
makes sense because this area shows pronounced synaptic loss in AD [42].
The P300 has been found to be affected by dementia, but there are many other
factors that affect this particular peak. Contrary to what has been stated thus far, Figure
2.4 shows a nearly nonexistent P300 for a normal subject and a prominent P300
component for an AD subject.
The factors known to affect the P300 are kept to a minimum such as no food
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intake prior to EEG, no medication of certain types taken within 48 hours of EEG, etc.
Some guidelines are put in place to keep variations in the P300 to a minimum [12, 43]. In
this study, criteria to control the factors known to affect the P300 response, such as those
listed above, were added to limit the effects on the P300. The P300 in Figure 2.4 is most
likely affected by other factors beyond those controlled in this study. Experiments
conducted in this study do not specifically analyze the P300; however the frequency
range in which the P300 and other ERP components occur are explored.
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Figure 2.3: Normal subject EEG with obvious P3 (left), AD subject
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Figure 2.4: Normal subject EEG with P3 not obvious (left), AD subject
EEG with prominent P3 (right).
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CHAPTER 3
EEG & ERPs IN ALZHEIMER'S DISEASE DIAGNOSIS
The methods described in this chapter present previous efforts investigating EEG analysis
as a potential biomarker for Alzheimer's disease. Some of the techniques that have been
explored by fellow researchers within this project's previous studies including power
spectral density analysis, ERP analysis, P300 analysis, statistical measures, and frequency
analysis are also included. These techniques are discussed to represent a basis for this
work and to present a comparison among different factors of this study and the work
being done by fellow researchers.

3.1

P300 ANALYSIS

Demiralp et al., 1999, applied a time-frequency decomposition to the event-related
potentials elicited in an auditory oddball test. The goal was to assess differences in
cognitive information processing. An analysis in the time domain revealed that cognitive
processes are reflected by various ERP components. These reflections were most
noticeable in the N1, P2, N2, and P300 ERP components. The wavelet transform allowed
the time-dependent and frequency-related information in the ERPs to be captured and
more precisely measured. A four-octave quadratic B-spline wavelet was selected as the
wavelet function and the transform was applied to the acquired auditory oddball
paradigm ERPs. The analysis showed that the frequency components in the delta, theta,
and alpha ranges reflected specific aspects of cognitive information processing [44].
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Demiralp et al., 2001, assessed how target and standard discrimination difficulty
and the degree of stimulus "novelty" affected target and non-target P300 scalp
distributions for a visual modality in a three-stimulus oddball task. A wavelet analysis
was performed on the non-target (P3a) and target (P3b) ERPs to assess how the
underlying EEG activity was affected by both the difficulty and novelty factors. When
the discrimination between target and standard stimuli was easy, amplitudes were higher
for the target P3b than the non-target P3a across all electrode sites. Both responses also
demonstrated parietal maximums. In contrast, when the target and standard stimuli
discrimination was difficult, non-target P300 (P3a) amplitudes were higher and earlier
over the frontal and central electrode sites for both levels of novelty, whereas target P300
(P3b) amplitudes were greater in parietal recordings and occurred later than the nontarget components. The wavelet analysis indicated that theta activity was related to the
more novel non-target stimuli. Delta coefficients during target stimuli were affected by
the discrimination difficulty. These results suggest that target and standard discrimination
difficulty, rather than stimulus novelty, determines P3a generation for visual stimuli.
However, the theta oscillations are affected by stimulus novelty [45].
Basar et al.,2001, analyzed the effects of the wavelet transform and digital
filtering on the underlying ERP data of the EEG. The compound ERPs are portrayed as
the superimposition of evoked rhythms in EEG frequencies ranging from the delta to
gamma bands. These frequency ranges are often referred to as the 'natural frequencies of
the brain'. A wavelet analysis was implemented on the ERPs and confirmed the results of
the combined analysis procedure obtained by using the amplitude frequency
characteristics and digital filtering. The results obtained by wavelet analysis underline
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and extend the view that alpha-, theta-, delta-, and gamma-responses are related to
psycho-physiological functions. The properties of the wavelet analysis imply that it may
be used to evaluate experiments where physiological tasks will be altered without
informing the subjects [46].
Demirapl et al., 2001, applied a comparative wavelet analysis to oddball P300
results. The results obtained confirm those obtained by using adaptive digital filtering.
The delta response dominates the P300 potential while the theta response is prolonged in
a second late window [47].
Aviyente et al., 2004, performed an analysis of event-related potentials collected
during a psychological experiment where two groups of subjects, spider phobics and
snake phobics. Both groups are shown the same set of stimuli which consist of a blank
stimulus, a neutral stimulus and a spider stimulus. The study introduces a new approach
for ERP analysis based on distance measures in time-frequency distributions. The
difference in brain activity before and after a presented stimulus is quantified using
distance measures. Three different distance measures are applied on the time-frequency
plane to discriminate between the responses of the two groups of subjects. The results
illustrate the effectiveness of using distance measures combined with time-frequency
distributions in differentiating between the two classes of subjects and the different
regions of the brain [48].

3.2

EEG AND ALZHEIMER'S

Since Hans Berger first observed pathological EEG sequences in a historically verified
AD patient [18,20], a large number of studies about the EEG of AD have been
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performed. Goodin et al., 1978, first demonstrated the slowing of P3 event-related
potentials (ERPs) with aging [49]. Since then, a number of studies have suggested that
ERPs are a useful indices for assessing age-related changes in cognitive brain functions.
Although ERP latency and its variability may be useful in describing group
differences (i.e. Alzheimer's disease patients from age-matched controls), they are not
sufficiently sensitive to classify individuals into subgroups of dementia [50]. Polich et al.,
1986, tested the ability of ERPs in distinguishing AD from other dementias and failed to
find significant differences in either P3 latency or amplitude [51]. Neshige et al., 1988,
was unable to differentiate AD patients from VD patients using P3 latency obtained from
a conventional auditory oddball paradigm [52]. However Polich et al., later found in
1990, that increased latency and decreased amplitude of P300 was associated with AD
when compared to normal ERPs [53]. For the next several years, researchers used a
variety of stimuli to increase the diagnostic sensitivity of ERPs [54,55]. It was
demonstrated that the latency, amplitude, and scalp topography of the P3 are affected by
aging processes [55,56,57]. Yamaguchi et al., 2000, proposed a modified auditory
oddball paradigm to generate a maximum parietal P3, and found that the response to
novel stimuli is affected by dementia [32].
Jeong, 2004, summarizes important findings about EEG abnormalities in AD
patients obtained from linear and nonlinear methods, and considers the clinical
neurophysiology of AD underlying the EEG abnormalities [13]. The following is an
excerpt from the article.
"Conventional visual analyzes of the EEG in AD patients have
demonstrated a slowing of the dominant posterior rhythm, an increase in
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diffuse slow activity [58,59,60,61], a reduction in alpha [62,63] and beta
activities [63,64]. There is a good correlation between the degree of the
EEG abnormality and cognitive impairment [58,59,60,61,64,65,66,67,68,
69,70]."
The above is just a sample of the topics covered in [13]. The extent of topics on EEG
analysis related to Alzheimer's disease exceeds the scope of this thesis but those topics
provided above are the foundation upon which this research is built.

3.3

EEGS, WAVELETS, AND NEURAL NETWORKS
Polikar et al., 1997, applied the Daubechies 4 wavelet to EEG data collected from

14 normal subjects and 14 subjects diagnosed with probable AD. The ERP response in
the oddball paradigm was analyzed to determine if the use of the wavelet transform was
feasible for the detection of AD with a multilayer perceptron (MLP) neural network. Half
the signals, 7 AD and 7 normal, were used for training while the rest were used for
testing the network. The generalization performance of the network was 93%. The results
confirmed that the approach is feasible for classifying ERPs, but the authors indicated
that a more diverse database with a larger variety of signals would be necessary to allow
statistically valid generalizations [30].
Petrosian et al., 1999, used a method involving recurrent neural networks (RNN)
and wavelet processing to distinguish between EEG recordings of six age-matched
subjects, 3 probable AD and 3 controls. The eye-closed continuous 9-channel EEGs were
recorded from each patient, and approximately 2 minute segments of artifact free
recordings from occipital channels were selected to train and test neural networks. The

24

Extended Kalman Filter-based algorithm was used for training RNNs. This algorithm
adapts the weights of the network in an instance-by-instance fashion. It accumulates
important information in approximate error covariance matrices, and provides
individually adjusted updates for each of the network's weights. The EEGs were encoded
with target values of -0.85 and +0.85 for control and AD EEGs, respectively. The
network training and testing procedures were implemented on both original EEGs as well
as wavelet filtered subband signals with the Daubechies 4 wavelet. The network
performed reliably when trained on a pair of AD and control recordings and tested on
four recordings [71].
Petrosian et al., 2001, also explored wavelet transform by using specifically
designed and trained recurrent neural networks (RNNs) to discriminate between EEGs of
ten mild AD patients and ten age-matched control subjects. The EEG recordings were
taken during resting state without the use of a paradigm. The Daubechies 4 wavelet was
chosen due to its good localization properties in the time and frequency domains. The
RNNs used in the study belong to a type of discrete-time recurrent MLPs. This type of
network has better temporal capabilities than that of a regular feedforward MLP, and is
capable of representing and encoding strongly hidden states. Training on three AD
subjects and three controls and testing on the remaining controls yielded performance that
was better than chance with 80% sensitivity and 100% specificity. Five out of seven of
the AD subjects were correctly classified. The authors suggest that their approach may be
extended to include more classes such as other types of dementia [72].
Yagneswaran et al., 2002, investigated signal power frequency and wavelet
characteristics for differentiating between EEGs of 9 subjects diagnosed with probable
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AD and 10 age-matched controls. The EEGs were recorded from 9 scalp electrodes
placed according to the international 10-20 system. A bandpass FIR filter using the
Hamming window was applied to each recording to segment each EEG into four
significant subbands - delta (1-4Hz), theta (4-8Hz), alpha (8-13Hz) and beta (13-22Hz).
The theta, alpha, and beta subbands were used for training and testing of a learning vector
quantization (LVQ) classifier. These subbands displayed significant group differences in
average power, relative power (RP), and slower wave ratio (SWR). The wavelet
coefficients were obtained by a decomposition of the EEG recordings with the
Daubechies 5 wavelet. The averages of the coefficients at each level were then used in
the training and testing of an LVQ classifier. Out of 37 recordings (17 from AD and 20
from controls), 18 were used for training and 19 for testing. The power frequency input
vector contained 9 spectral features (the average power, RP, and SWR of the theta, alpha
and beta subbands), while the wavelet based feature vectors had 7 features (averages of
the six detail level and the one approximation level coefficients). The network was able
to correctly classify 18 of the 19 test recordings when using the spectral features, and 17
of the 19 test recordings when using the wavelet features [15].
In 2002, de Trad performed a study using the resonant recognition model (RRM)
to predict characteristic frequencies for both beta-amyloid protein, its precursor, and
functionally important amino acids for beta-amyloid as mentioned in Chapter 1.
Amyloid plaques in the brain are a prominent and diagnostic feature of AD. One possible
approach to preventing AD is to block the production of amyloid in the brain. The RRM
is a physico-mathematical model that analyzes the interactions of protein and its target
using digital signal processing methods. Once the RRM characteristic frequency for a
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particular biological function or interaction has been determined, it is possible to identify
the individual amino acids that contribute mostly to the characteristic frequency.
Different wavelet functions (Morlet, Coiflets, Daubechies, Symlets, and Meyer) were
used and compared in de Trad's study to detect active sites of beta-amyloid and betaamyloid precursor proteins. Results linked frequencies with the proteins and predicted
high energy domains but depended on the wavelet function used. In conclusion, better
results may be obtained if a specific wavelet were designed for this application [73].
Cho et al., 2003, proposed an automatic recognition method for Alzheimer's
disease with a single channel EEG recording combined with the genetic algorithm (GA)
and artificial neural networks (ANN). Sixteen probable AD patients and sixteen agematched control patients were recruited. The EEGs were recorded from an Ag-AgCl
electrode placed at P4. The ERPs were acquired during an auditory oddball task with
standard sine-wave tones (75%) of 1 kHz and target tones (25%) of 1.5 kHz, each lasting
300ms. The subjects were instructed to count internally the number of target tones. The
EEGs and ERPs were analyzed to generate a feature pool of 118 features which included
88 power spectral measurements, 28 statistical measurements, 2 chaotic features (central
tendency and the boc-counting dimension), and 10 ERP features. The GA method
consisted of making chromosomes of 35 features from the feature pool and assigning a
fitness value to each. Genetic operations were used to create new generations of the
chromosomes to find dominant features. The combined GA/ANN was applied to find the
minimal set of dominant features from the feature pool that were the most effective in
classifying the two groups. Hence, these dominant features were then used as the training
and testing data for an ANN. 137 EEG segments from 11 AD patients and 10 normal
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subjects were used as training data. The GA/ANN approach found the 35 dominant
features including 24 spectral, 8 statistical, 1 nonlinear and 2 ERP features. 72 EEG
segments for tests were from 5 AD patients and 6 normal subjects. The recognition rate
was 81.9%. In conclusion, the selection of dominant features by the genetic algorithm
was used to optimize input for a neural network, and appears to have an impact on the
effectiveness of the network [74].
In the earlier stages of our own study, Jacques et al., 2004, used a multiresolution
wavelet analysis on ERPs followed by automated classification. The cohort consisted of
32 subjects, 14 probable AD patients and 18 cognitively normal patients. The ERPs were
collected using an oddball paradigm based on [30]. The cohort produced a total of 75
ERP recordings in which 30 were from AD subjects and 45 were from normal subjects.
Two types of wavelet functions were used, Daubechies 4 and Quadratic b-splines. The
average overall performance of the Daubechies 4 wavelet was 84.1 + 0.6%, and 82.4 +
1.0% for the b-splines. The results suggest that this method could provide a stable and
effective method for a diagnostic tool but needs further investigation [75].
Table 3.1 shows a summary of the automated methods for the diagnosis of
Alzheimer's disease from Section 3.3 and includes the author's name, the year of their
study, the size of the cohort the acquired and analyzed, the method by which they
performed their analysis, the training and testing set sized, and the resulting performance.
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Table 3.1: Summary of automated methods for AD diagnosis
Author and Year

4
--

Cohort
Size

Method

Training

Testing

Recognition
Rate

7 AD Multiresolution wavelet analysis
normal (Daubechies 4), MLPs

7 AD
normal

7 AD
7 normal

93.00%

Petrosian et al.,
1999

Wavelet analysis (Daubechies 4)
3 AD
Recurrent Neural Networks and
3 normal
Extended Kalman Filtering

2AD
2 normal

1 AD
1 normal

Reliable

Petrosian et al.,
2001

10 AD Wavelet analysis (Daubechies 4)
10 normal Recurrent Neural Networks

3 AD
3 normal

7 AD
7 normal

AD: 5/7
normal: 4/7

Polikar et al.,
1997

LVQ classifiers, power analysis,
wavelet analysis (Daubechies 5),
37 ERP recordings (17 AD, 20
19
18
normal), 2 feature vectors (one of
9 AD
Yagneswaran et al.,
random
random
9 average power, relative power,
10 normal
2002
and slower wave ratio features; the recordings recordings
other, the average of 6 detail and
1 approx. level coefficients for 7
features)

Cho et al.,
2003

Genetic algorithm, neural
networks, 118 feature pool
16 AD (88 power spectral, 28 statistical
16 normal measures, 2 chaotic measures),
chromosome of 35 dominant
features

H1AD
10 normal

Jacques et al.,
2004

Multiresolution wavelet analysis
14 AD (Daubechies 4 and quadratic
18 normal b-splines), MLPs, 75 ERP
recordings (26 AD, 49 normal)

13 AD
17 AD
25 normal 24 normal

3.4

5 AD
6 normal

9 features:
18/19
7 features:
17/19

81.90%

db4:
84.1+0.6%
b-splines:
82.4+1.0%

OTHER EEG AND ERP METHODS
Park and Cho et al., 2001, performed an ERP analysis of the amplitude and

latency of the P3 component in 4 cohorts. These cohorts consisted of 25 mild AD, 12
severe AD, 17 age-matched normal-aged controls and 7 young controls. The ERPs were
obtained using an auditory oddball paradigm. Stimuli consisted of a series of computergenerated tones with 85dB, 300ms in duration. Tones of 1kHz (75%) and 1.5kHz (25%)
were presented randomly for the 100 trials. Subjects were asked to count the number of
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target tones and report it after the session. The EEG was recorded from Ag-AgCl
electrodes placed at the F3, F4, CZ, P3, and P4 scalp locations. The N2, P3a, and P3b
components of the ERP were measured for both the standard and target stimuli. The P3a
and P3b were defined as the largest positive peak in the interval of 200-280, and 284500ms post stimulus. The N2 component was the largest negative peak in the 109-196ms
post stimulus. Correct response rates to target tones showed a significant difference
between groups. While the normal aged group (88%) and young group (100%) showed
high accuracy, the mild AD group (20%) and severe AD group (0%) had problems
counting the stimuli. Major findings in this study showed the latency in the P3
component was prolonged in AD patients, whereas the amplitude of P3 was not different
than that of the normal controls. This study suggests that the P3 components of the ERPs
could be useful in the detection of AD [76].
Abasolo et al., 2003, applied Approximate Entropy (ApEn) in the analysis of EEG
background activity of 7 patients with a clinical diagnosis of Alzheimer's disease and 7
control subjects to determine whether there are differences between the groups. The
EEGs were recorded while subjects were awake, relaxed in a quiet state with their eyes
closed. EEGs were organized in frames of 5 seconds (1280 points). The P3 electrode was
chosen for analysis at the advice of an electroencephalographer, because there are less
artifacts and the rhythmical activity is more apparent. ApEn quantifies regularity in
sequences and time series data. It assigns a non-negative number to a sequence or time
series, where larger values correspond to more instances of recognizable features or
patterns in the data. When applied to EEG data, larger values indicate higher complexity.
Results showed with a statistical difference from ANOVA tests that the ApEn was higher
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in control subject's EEGs when compared to the ApEn values of the EEGs of patients
with probable AD. This experiment suggests that the non-linear analysis of EEG data
might be useful to physicians since it shows the potential application of ApEn in
reflecting differences in the complexity of EEG data time series of patients with a
diagnosis of Alzheimer's disease and control subjects [77].
Melissant, et al., 2005, studied an automatic EEG classification technique. They
first implement a preprocessing technique for artifact-removal using independent
component analysis (ICA). An ICA-processed multichannel EEG measurement does
become more interpretable when compared to the raw data. They further proceed to show
that detection of anomalies is also better after ICA-processing. The method is evaluated
on measurements of a length of 8 seconds from two groups of patients. The first group of
28 patients show signs of the initial stages of the disease, whereas the 15 patients in the
second group show signs of the later, more progressed stages of the disease. Both
groups include a normal control group of 10 and 21, respectively. Three different
classification methods were used: Bayes classifiers, k-NN classifiers, and feed-forward
back-propagation neural networks. The results for the group with severe Alzheimer's
disease are comparable to the best results from literature (upwards of 90%). The study
shows that ICA-based reduction of artifacts improves classification results for patients in
an initial stage [78].
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CHAPTER 4
APPROACH
In our prior efforts [79-83], our approach consisted of performing a multiresolution
wavelet analysis using the Daubechies 4 wavelet on the signals of our patient cohort. The
coefficients obtained from the wavelet analysis were used as the features for the
classification algorithm. The classification algorithm then resulted in a decision or
diagnosis based on the features from the patient signal being analyzed.
This research used the same basic approach on our final cohort of 71 patients and
on a subset of the final cohort consisting of 66 patients. All 19 available electrodes have
been analyzed in this study, whereas only the PZ, CZ, or FZ electrodes had been explored
in our previous works [79-83]. Single classifiers for each electrode/stimulus/frequency
subband were trained and analyzed. The resulting performances from these classifiers
give insight to the most informative electrode/stimulus/frequency subband combinations.
Different classifier fusion techniques (specifically weighted majority vote, product rule
and sum rule) were then used in an ensemble approach to combine the classifiers trained
on the most informative electrode/stimulus/frequency subband features to increase the
generalization performance. Feature-level fusion was also analyzed by concatenating the
informative features for input into the classifiers.
The details of our approach are split between Chapters 4 and 5. Chapter 4 consists
of details about the patients, the data acquisition protocol, and the process of the
multiresolution wavelet analysis. Chapter 5 consists of the details of the classification
algorithm including the multilayer perceptron, data fusion techniques, and combination
rules. Figure 4.1 is a diagram overview of the approach of this project.
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Figure 4.1: Overview of the project
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4.1

RESEACH SUBJECTS

The data used for this research consisted of EEG data gathered at Drexel University from
patients recruited by the University of Pennsylvania. Two cohorts have been analyzed in
this research. The first set is the final cohort of this combined effort of seventy-one
patients, 34 diagnosed with probable AD and 37 cognitively normal controls. The second
cohort has excluded 5 patients from the 71 patient cohort because of suspected noisy data
with artifacts from remnants of eye movement rendering unclassifiable results. This
second cohort consists of sixty-six patients, 30 diagnosed with probable AD and 36
cognitively normal controls. Subjects were verified to be free of any evidence of other
neurological disorders by history or by exam.
Mini-mental State Exam (MMSE), a test for memory, language and praxis skills
is often used as one of the diagnostic tests during clinical evaluation. It is scored on a
scale of 0-30, with decreasing scores (particularly below 19) indicating increased
impairment. Other tests include Severe Impairment Battery (SIB), and the Clinical
Dementia Rating (CDR) Scale, all of which are part of the NINCDS-ADRDA (National
Institute of Neurological and Communicative Disorders and Stroke - Alzheimer's
Disease and Related Disorders Association) criteria for probable AD [84]. Since our
interest is in early diagnosis, the AD cohort was selected from those who has the highest
MMSE scores. Table 4.1 shows details about both cohorts.
While recruiting the probable AD and cognitively normal cohorts, the following
inclusion and exclusion criteria was used:
Inclusion criteria for cognitively normal cohort: (i) age > 60; (ii) Clinical
Dementia Rating score = 0; (iii) Mini Mental State Exam Score > 26; (iv) no indication
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of functional or cognitive decline during the two years prior to enrollment based on a
detailed interview with the subject's knowledgeable informant.
Exclusion criteria for cognitively normal cohort: (i) evidence of any central
nervous system neurological disease (e.g. stroke, multiple sclerosis, Parkinson's disease,
etc.) by history or exam; (ii) use of sedative, anxiolytic or anti-depressant medications
with 48 hours of ERP acquisition.
Inclusion criteria for AD cohort: (i) age > 60; (ii) Clinical Dementia Rating score
= 0.5; (iii) Mini Mental State Exam Score < 26; (iv) presence of functional and cognitive
decline over the previous 12 months based on a detailed interview with a knowledgeable
informant; (v) satisfaction of NINCDS-ADRDA (National Institute of Neurological and
Communicative Disorders and Stroke - Alzheimer's Disease and Related Disorders
Association) criteria for probable AD.
Exclusion criteria for AD cohort: Same as that for the cognitively normal controls.

Table 4.1: Cohort details including the number of patients, average ages and standard
deviations, and average MMSE scores and standard deviations.
Cohort 1 (71 Patients)

AD
Normal

Number of Average
Age
Patients
74.9706
34
37
76.1351

Standard
Deviation
7.0860
7.2845

Standard
Average
MMSE Score Deviation
2.9513
24.6765
1.1880
29.2432

Cohort 2 (66 Patients)
Number of Average

AD
Normal

Patients
30

Age
74.8333

36

75.9722

Standard

Deviation
7.2734
7.3192

35

Average

Standard

MMSE Score Deviation
2.9981
24.6667
1.1419
29.3056

4.2

DATA ACQUISITION

The ERP recordings were obtained from each subject using the oddball paradigm.
Subjects were comfortably seated facing a computer screen in a specially designated
room. The protocol originally described by [32] was followed with slight modifications.
Binaural audiometric thresholds were determined for each subject using a 1 kHz tone.
The evoked response stimulus was presented to both of the subject's ears using stereo
speakers with an amplitude level comfortable for their hearing. The stimulus consisted of
tone bursts 100 ms in duration. Standard tones of 1000 Hz and target (oddball) tones of
2000 Hz were presented in a random sequence with the tones occurring in 65% and 20%
of the trials, respectively. The remaining 15% of the trials consisted of novel sounds
presented randomly. These included 60 unique environmental sounds that were recorded
digitally and edited to duration of 200 ms.
A total of 1000 stimuli, including the standard (frequent) tones of 1000 Hz (n=650),
target (infrequent) tones of 2000 Hz (n=200) and novel sounds (n=150), were delivered
to each subject with an inter-stimulus interval of 1.0-1.3 seconds. The subjects were
instructed to press a button each time they heard the target tone of 2000 Hz. With
frequent breaks (approximately three minutes of rest every five minutes), the data
collection process lasted about 30 minutes per subject with each session preceded by a 1
minute practice session without the novel sounds. Each recording is 1 second in duration
with a 200ms pre-stimulus interval.
The ERPs were recorded from 19 tin electrodes embedded in an elastic cap. The
electrode impedances were kept below 20 kQ to yield a good signal. Artifacts were
identified and rejected by the EEG technician. The remaining scalp potentials were
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amplified, digitized at 256 Hz/channel (19 channels) and stored. The averaging protocol
involved averaging 30-85 recordings per patient yielding 1-3 recordings per patient. All
averages have been notched filtered at 59-61 Hz and baselined with the pre-stimulus
interval. The 1-3 recording per patients were then averaged to create an overall average
per patient (71 or 66 total) and normalized. Below in Figure 4.1 is example of the overall
average ERP for the normal and AD cohorts during the target and novel stimuli. Figure
(4.1a) is from the target recordings of the PZ electrode while Figure (4.1b) is from the
novel recordings. Appendix B contains similar figures for all electrodes during both
stimuli.
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Figure 4.2: Overall average ERP from the PZ electrode during (top) target and
(bottom) novel stimuli.
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4.3 MULTIRESOLUTION WAVELET ANALYSIS FOR FEATURE EXTRACTION
Frequency analysis is an alternative and informative method for describing time domain
signals. One advantage of the frequency domain representation over the time domain
representation is the ability to visualize the frequency content of the signal. The Fourier
Transform involves a correlation between a time signal and complex exponentials of

different frequencies. However, the FT requires that a signal be stationary as it provides a
global representation of frequencies in the signal and therefore results in the loss of time
information.
The short time Fourier transform (STFT) tries to overcome this limitation and
provides localized frequency information by windowing the complex exponential kernel
of the FT. This gives a time evolution of the frequencies of the signal by shifting the
window throughout the signal. The STFT consists of correlating the original signal with
the time-windowed and modulated complex exponentials. If the window is too narrow,
the STFT provides good time resolution and poor frequency resolution; conversely, if the
window is too wide, good frequency resolution and poor time resolution is obtained.
Ideally, low frequencies need a wide window while higher frequencies require a narrow
window in order to appropriately capture the signals behaviors. The STFT is suited for
analyzing non-stationary signals but its abilities are limited by a fixed window length
throughout its analysis. This inability to adapt with the changing frequency content of a
non-stationary signal is insufficient for our analysis [85,86].
An alternative approach to the FT and STFT, is the wavelet transform, particularly
the discrete wavelet transform. The discrete wavelet transform is obtained through a
process call multiresolution wavelet analysis. Multiresolution wavelet analysis
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determines time localizations of spectral components, providing a time-frequency
representation of the signal being analyzed. Such an analysis is particularly well-suited
for non-stationary signals, such as ERPs, whereas the Fourier and short-time Fourier
transforms lack time localization capabilities and adaptable resolutions for the
appropriate frequency content, respectively. Therefore, a multiresolution wavelet
analysis, by means of the DWT, will used in this study to extract features from the ERPs.

4.4

THE WAVELET TRANSFORM

The wavelet transform was developed as an alternative approach to overcome the fixed
resolution problem of the short time Fourier transform. The main advantage of the
wavelet transform is the varying window size which allows wide windows for low
frequencies and narrow windows for high frequencies, leading to optimal time-frequency
resolution for all frequency ranges [85,86,87].

4.4.1

THE CONTINUOUS WAVELET TRANSFORM

The continuous wavelet transform (CWT) is calculated in a similar way to that of the FT
and STFT. The signal is multiplied with a wavelet kernel function, similar to the complex
exponential kernel function in the FT. Just as the FT is calculated for different
frequencies, the wavelet transform is computed for different segments of the signal with
respect to its two parameters, scale and translation.
There are two main differences between the STFT and the CWT. First, the FTs of
the windowed signals are not taken whereas the FT is computed for every windowed
portion of the signal in the STFT. Secondly, the width of the window is changed as the
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transform is computed for every single spectral component whereas the window is a fixed
width throughout the entire calculation of the STFT [87].
A wavelet family yb,a is a set of functions created by dilations and translations of a
unique mother wavelet qy(t):

tPb,a- lal-1/2 qj (--a)

(4.1)

where a = 0, and a, b e9T are the translation and scale parameters, respectively. Thus,
the wavelet transform is a function of two variables. The constant number al-1/2 is for
energy normalization purposes so that the transformed signal will have the same energy
at every scale. Translation is a time shift and scale is a parameter inversely proportional
to frequency, where larger scales analyze global behavior and small scales analyze local
behavior, a controls the support of the wavelet function; for example, by increasing a, the
wavelet becomes narrower. b controls the position of the wavelet; for example, by
varying b, the mother wavelet is displaced in time. Figure 4.2 illustrates the effect that
changing the scale coefficient, a, has on the wavelet function. The wavelet shown is the
Morlet wavelet, which is constructed by modulating a sinusoidal function by a Gaussian
function, at scales of 0.5, 1, and 3.
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Figure 4.3: Morlet wavelet at different scales (dilations) and translations.
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The wavelet functions must satisfy two properties:
+00

-00

JW(t)dt=0

(4.2)

and
+00

SIJ p(t) dt <

(4.3)

o

-00

Equation (4.2) requires that the wavelet is an oscillatory function, meaning a "wave"
Equation (4.3) implies that the energy of in Vi(t) if of finite duration. The two properties
are easily satisfied by a large number of functions making these two requirements rather
unrestrictive.
The continuous wavelet transform of a signal is defined as the correlation between
between the signal x(t) and the wavelet qfb,a. The CWT is defined as the following:

f)x (t)

CWT(b, a))=T (b,a)=

'(

)dt

(4.4)

where ' denotes the complex conjugate. The result of Equation (4.4) indicates how
closely the wavelet function correlates with the signal at scale a. If the signal contains a
component of the frequency at the particular scale, then the wavelet basis function at that
scale will be similar to the signal at the location where that frequency occurs. These
correlations are made with different scales, a, in the wavelet function for all times
(translations), b, of a single function. The wavelet transform then gives a translation-scale
representation [85,86,87].
Once a mother wavelet is chosen, the computation begins with an initial value of
a, typically a=l. The CWT is computed for all values of a that are greater and less than
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the initial value. Note that depending on the signal, a complete transform is usually not
necessary. For all practical purposes, signals are bandlimited, and therefore, computation
for a limited interval of scales is usually adequate.
The wavelet function at scale a and translation b=0 (which is typically the
beginning of the signal x(t)) is multiplied by the signal and then integrated over all times.
The wavelet at scale a is then shifted right by an amount of b to the location t=b. This
procedure is repeated until the wavelet reaches the end of the signal. Then, a is increased
by a small value, which is controlled by the scale resolution. This procedure is repeated
for every value of a. Every computation for a given value of a fills the corresponding
single row of the translation-scale plane. When the process is completed for all desired
values of a, the CWT of the signal has been calculated [85,86].

4.4.2

THE WAVELET SERIES

Since they are continuous transforms, none of the FT, the STFT, or the CWT can be
practically computed by using computers. It is therefore necessary to discretize the
transforms. The most intuitive way of doing this for the CWT is by simply sampling the
translation-scale plane. However, in the case of the WT, the scale change can be used to
reduce the sampling rate. At higher scales (lower frequencies), the sampling rate can be
decreased, according to Nyquist's rule. This means that if the translation-scale plane
needs to be sampled with a sampling rate of Ni at scale al , the same plane can be
sampled with a sampling rate of N2 < NI, at scale

a2

, where, ai < a2 which correspond to

frequenciesfi >f2. The actual relationship between N1 and N2 is given as:
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1

N1
N,=_N,

(4.5)

This means that the sampling rate at lower frequencies can be decreased, saving
computation time and resources [85,86].
The conventional scheme for discretizing the translation-scale parameters is called
the dyadic grid sampling. The scale parameter a is discretized first on a logarithmic grid.
The translation parameter is then discretized with respect to the scale parameter,
meaning a different sampling rate is used for every scale. For this process, time remains
continuous but the translation-scale parameters are sampled by choosing aj =2j , bj,k= k2,

with j, k e Z [88]. By inserting these scale and translation parameters, the continuous
wavelets are obtained from the mother wavelet as:

,k(t)=2-j / 2

(2- j t-k)

(4.6)

For wavelet series, yj,k(t) are required to be orthonormal, biorthogonal or frame. For the

orthonormal case, shown below, the analysis and synthesis wavelets are the same.

~u-,k
x

k.(t)dt
x(t)W 'j,

(4.7)

or

x(t)=c,;Z
j

Z ¶j x Pj,k(t)

(4.8)

k

where c,is a constant that depends on the wavelet used and again 'denotes the conjugate.
If yij,k are orthogonal or biorthogonal, the transform is non-redundant [85,86].

4.4.3

THE DISCRETE WAVELET TRANSFORM

Although the wavelet series enables the computation of the CWT by computers, it is still
not a true discrete transform, but rather a sampled version of the CWT. The information it
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provides is highly redundant for the reconstruction of a signal, and therefore requires a
significant amount of computational time and resources.
The discrete wavelet transform (DWT) provides non-redundant information both
for analysis (decomposition) and synthesis (reconstruction) of the original signal, with a
significant reduction in computational time and resources. The discretization occurs in
the scaling and translation variables.
The foundations of the DWT go back to 1976 when Croiser, Esteban, and Galand
devised a technique to decompose discrete time signals [89]. Crochiere, Weber, and
Flanagan did a similar work on coding of speech signals in the same year [90]. They
named their analysis scheme as subband coding. In 1983, Burt defined a technique very
similar to subband coding and named it pyramidal coding which is also known as
multiresolution analysis [91]. Later in 1989, Vetterli and Le Gall made some
improvements to the subband coding scheme, removing the existing redundancy in the
pyramidal coding scheme [92]. These techniques, though developed by different people,
are essentially identical. The discrete wavelet transform computation involves both
multiresolution analysis and subband coding.

4.4.4 MULTIRESOLUTION ANALYSIS
Multiresolution analysis (MRA) is a hierarchical scheme. An MRA involves
approximations of functions in a sequence of nested linear vector spaces. The formal
definition of an MRA states that it consists of the nested linear vector spaces
(...c VcV cV_

c

...) such that

1. The union of subspaces is dense on the space of square integrable functions L2(R)
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2. The intersection of these subspaces is one set containing the all-zero function or
zero vector.
3. If f(t)E Vk then

f(2t)Vk- 1 and vice versa, if f(t)Vk-1 then

t

f (-)eVk,
2
4. There exists a function (scaling function) 0(t) such that { (t - k) : k integer}
constitute a basis for Vo
The following is an explanation of these properties. First to explain the term
dense in Property 1, the following example is used: Suppose X and Y are sets of real
numbers where X c Y. Xis said to be dense in Y if for every element ye Y there is

an element x EX that is as close toy as the user determines (The concept of denseness
can be found in greater detail in texts on mathematical analysis or topology).
Property 2 states that the only signal common to all vector spaces is the all-zero
signal or zero vector. Property 3 introduces dilation by stating that a factor of two dilation
of a vector belonging to a subspace at a certain level yields a vector in the next coarser
subspace. Note that this can be conversely applied; by dilating by a factor of one half, a
function in the next finer subspace can be obtained. Property 4 requires a scaling function
such that the set is linearly independent. Also any function f (t) e Vo can be expressed
as

fo(t)= 1

a(O,n)ch(t-n)

(4.09)

n=-oo

for a sequence of scalars a(O,n) where n = {..., -2, -1, 0, 1,...}.
To relate MRA to DWT, a condition is imposed upon the subspaces that states

46

V 0c V_ 1 . This condition requires that all vectors in Vo also belong to V 1. Property 4
states that 0(t) is in Vo, so it too must now be in V.1. b(t) can be expressed as linear
- n): n integer}. 0(t) becomes a scaling
{
combination of the basis for V1 by I(2t
function. With the addition of the above condition, the resulting property is called the
dilation equation, which follows a similar form of that in Equation (4.10):
00

c(n)0(2t-n)

(t)-=

(4.10)

n= -oo

where c(n) is a sequence of scalars for n = {..., -2, -1, 0, 1,...}.

Equation (4.10) is possible with use of the fact that the basis for V. 1 is given by
translates of b(2t) by integer multiples of half-unit intervals. Thus ((t)is expressed in
terms of its own dyadic dilation and translation, hence it is referred to as a dilation
equation or a two-scale difference equation.
The DWT utilizes two sets of functions, a scaling function, ((t), and a wavelet
function, yf(t). An interesting property of these functions relates back to the two-scale
difference equation in Equation (4.10). Both functions can be obtained as a weighted
sum of the scaled (dilated) and shifted versions of the scaling function itself:

0(t)=Z h[n]q(2t-n)
n

(4.11)

and
tq(t)=
n

g[n]h(2t-n)

(4.12)

Conversely, a scaling function or a wavelet function that is discretized at scalej
and translation k can be obtained by the original (prototype) function, 0(t) = 0o,o(t), or
y/(t) = Vzo,o(t) by:
j, (t)=2-j/2 (2- t-k)
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(4.13)

j /2
qPj,k(t)=2-(

(2- j t-k)

(4.14)

The wavelet function creates a vector subspace of the detail functions at level
zero. Since {((2t-n) : n integer} is the basis for V-i, the function of the subspace at this
level can then be expressed as a linear combination of

((t)and yf(t). This relation can

generally be expressed as

a(0,n)b(t-n)+ 1

f,-(t)=
n=-oo

b(0,n)it(t-n)

(4.15)

n=-ao

where a(O,n) and b(O,n) are a pair of sequences, which will ultimately be the
approximation and details coefficients.
Equation (4.15) displays the true power of the DWT. Using an MRA approach to
decompose a signal, the original signal can be obtained by adding the current levels
approximation and all the previous levels details. The DWT uses the framework of an
MRA but uses the implementation of subband coding, which uses successive high-pass
and low-pass filtering to decompose a signal into different time and frequency
localizations [85,88].

4.4.5

SUBBAND CODING
The subband coding algorithm is the filter bank implementation used by the

discrete wavelet transform (DWT). Subband coding can be thought of as the digital filter
implementation of MRA. The procedure starts by passing the signal through a half-band
digital low-pass filter with impulse response h[n]. Filtering a signal corresponds to the
convolution of the signal with the impulse response of the filter. The convolution
operation in discrete time is defined by the following:
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oO

x[n]*h[n]= E x[k].h[n-k]

(4.16)

k=- oo

After passing the signal through a half band low-pass filter, half of the samples
can be eliminated according to the Nyquist's rule, since the signal now has a highest
frequency of n/2 radians instead of n radians. Discarding every other sample will
subsample the signal by 2, and render a signal with half the number of points. Referring
to Property 3 of an MRA, the scale of the signal is now doubled. Note that low-pass
filtering only removes the high frequency information, but leaves the scale unchanged; it
is the subsampling process that changes the scale. On the other hand, resolution is related
to the amount of information in the signal, and therefore is affected by the filtering
operations. Subsampling after filtering does not affect the resolution, since removing half
of the spectral components from the signal makes half the number of samples redundant.
Therefore, half the samples can be discarded without any loss of information.
The DWT analyzes the signal at different frequency bands with different
resolutions by decomposing the signal into a coarse approximation (vector subspaces in
MRA) of the original signal and detail information. The DWT uses two sets of functions,
scaling functions and wavelet functions, which are associated with the low-pass and highpass filters of subband coding, respectively.
The decomposition of the signal into different frequency bands is obtained by
successive high-pass and low-pass filtering of the time domain signal. The original signal
x[n] is first passed through a half-band high-pass filter g[n] and a half-band low-pass
filter h[n]. As mentioned above, half of the samples can be eliminated after filtering,
hence the signal can be subsampled by 2. The results of the filtering operations constitute
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one level of decomposition. This process can be expressed mathematically as follows:

]
Yhigh-1x[n]-g[2k-n
n

(4.17)

yow,=

(4.18)

n

x[n].h[2k-n]

where yhigh[k] and ylow[k] are the outputs of the half-band high-pass and half-band lowpass filters, respectively, after subsampling by 2. Equations (4.17) and (4.18) are the
same form of the two-scale equation in Equation (4.10). This relation is what unites
MRA, subband coding, and the DWT.
Each level of decomposition reduces the time resolution by half since only half
the number of samples now characterizes the entire signal. However, the frequency
resolution is now doubled, since the frequency band of the signal now spans only half the
previous frequency band. The entire process mentioned above is the subband coding
algorithm. It can be repeated successively for as many times as desired until subsampling
is no longer possible.
At every level of decomposition, the filtering and subsampling will result in half
the number of samples (and half the time resolution) and half the frequency band spanned
(and double the frequency resolution), allowing the signal to be analyzed at different
frequency ranges with different resolutions. The outputs of the high-pass filters are the

detail coefficients and are denoted as di, i =1, 2,..., log2N, where N is the total number of
samples in the signal. The outputs of low-pass filters are the approximation coefficients,
ai, and represent the current resolution levels coarse approximation of the original signal.
The subband coding algorithm is illustrated in Figure 4.3.
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Here is an example from our analysis. The Daubechies 4 wavelet that is used in
analysis has scaling and wavelet function coefficients (each of length 8) which
correspond to the low-pass filter h[n] and high-pass filter g[n], respectively. A patient's
signal is 257 points long. The output of each level 1 filter is 264 (256+8-1) points long.
This reduces to 132 points after subsampling by 2. An approximation signal Aj(t) and a
detail signal Dj(t) can be reconstructed from the levelj approximation and detail
'

... . - _v - r.1 .r ,. . _IM

Decomposition
(Analysis)

v-?.... r1f -. r-M -T l.-l

xll]

Reconstruction
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Figure 4.4: Diagram of the subband coding (filter bank) algorithm [85]

coefficients by using substitution in Equations (4.17) and (4.18):

A,(t)=- aj[k ]-.Oj,k(t)
k

D,(t)=- d[k]'qj,k (t)
k

(4.19)
(4.20)

The original signal x(t) can be reconstructed from the approximation signal Aj(t) at any
levelj and the sum of all detail signals from levels up to and including levelj. This can be
expressed as:
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x(t)=A (t)+ E Dj(t)
=

=- a,k]-j,,k()
k

(4.21)

Z+ Zdj[k]-q[i,k(0

i=-oo k

By using the properties introduced by an MRA and the subband coding algorithm, the
DWT is implemented by using the relationship of the scale and wavelet equations
through the two-scale equation.

4.4.6

WAVELET CHOICE

The type of wavelet used for any application is usually chosen according to the similarity
of the wavelet to the signal to be analyzed. This similarity better localizes the structures
of interest within the signal and reduces the amount of noise in the analysis of the
subband structure. The wavelet chosen for this study has been used in different studies
for analyzing ERPs, the Daubechies 4 wavelet.

4.4.6a DAUBECHIES 4 WAVELET
Ingrid Daubechies invented the so-called compactly supported orthonormal wavelets,
which made discrete wavelet analysis practical. Compact support is given by the size of
the window varying throughout the signal so that the window is narrow for high
frequencies and wide for low frequencies . The result is good time resolution at high
frequencies and good frequency resolution at lower frequencies [22,85,86]. The
Daubechies family wavelets are denoted as dbN, where N is the order, and db the
"surname" of the wavelet. The first wavelet, dbl, is the Haar wavelet. Figure 4.4 shows
the wavelet functions of the next nine members of the family, namely, db2 through dblO.
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The Daubechies 4 wavelet has been used in several studies for analyzing ERPs in
general, as well as for the detection of AD [22,30]. The Daubechies mother wavelet has a
'fractal structure' and has good localizing properties in both time and frequency domains
[72].
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Figure 4.5: Daubechies family function [22].
The high-pass, h[n], and low-pass filter, g[n], coefficients for the Daubechies 4 wavelet
are given in Table 4.2, respectively and the wavelet and scale functions are shown in
Figures 4.5 and 4.6, respectively.

Table 4.2: Daubechies filter coefficients

h[n]

g[n]

-0.2304

-0.0106

0.7148

0.0329

-0.6309

0.0308

-0.0280

-0.1870

0.1870

-0.0280

0.0308

0.6309

-0.0329

0.7148

-0.0106

0.2304
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Figure 4.6: Daubechies 4 wavelet function

Figure 4.7: Daubechies 4 scaling function
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4.5

FEATURES AND CLASSIFICATION

The signals analyzed in this study consist of the preprocessed data from all 19 electrodes.
Figure 4.7 illustrates the name and location of the electrodes included. Using the DWT
and the db4 wavelet, decomposition of the signals was carried out for 7 levels resulting in
the following frequency bands: di: 64-128Hz, d2: 32-64Hz, d3 : 16-32Hz, d4: 8-16Hz, ds:
4-8Hz, d6: 2-4Hz, d7: 1-2Hz and a7: 0~1Hz. Signal power was generally higher at the
higher levels (lower frequencies), hence the 1-2Hz, 2-4Hz, and 4-8Hz subband
coefficients were analyzed from all the electrodes during both the novel and target
stimuli. The middle coefficients of each subband, corresponding to the spectral features
in the 0 - 600ms interval, were analyzed. Subbands were limited to this range to capture
any P300 components that may be elicited. Previous analyzes using these selected
features yielded diagnostic performances in the mid 60% to low 70% range [79,80,83].

Figure 4.8: The position and names of the 19 electrodes used in our experiments
55

CHAPTER 5
CLASSIFICATION
The theory involved with the classification aspects of this research is discussed in this
chapter. The main topics of each subsection of this chapter are described as follows. First
a description of the main classifier used in this study, the multilayer perceptron, and its
training algorithm, the back-propagation algorithm. The rest of the chapter discusses data
fusion and the two types of data fusion used in this study, feature-level and decision-level
fusion. In particular, ensemble of classifiers combination techniques are described along
with the decision-level fusion techniques.

5.1

PATTERN RECOGNITION TECHNIQUES

In automated classification applications, distinctive features of the signals to be analyzed
are identified and obtained. There are numerous methods available to extract features
from the gathered signals. Some examples for feature extraction include filtering, the
Fourier transform, multiresolution analysis, the wavelet transform, and statistical
measures. Next, a subset of the identified, informative features is placed in a training

data set while the remaining data is placed in the testing data set where it is not yet shown
to the classifier algorithm. The training data is presented to the classifier's training
algorithm for the purpose of setting classifier parameters such as the weights in the
multilayer perceptron. The trained classifier system is evaluated on the test data set
[93,94].
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In an advanced classification system, several classifiers can be combined together.
Classifiers trained on features from the same or different data sets for a similar problem is
known as an ensemble of classifiers or a multiple classifier system. Through data fusion
techniques, the decisions from each classifier in the ensemble can be combined to make a
final decision rather than have one classifier make a decision. The main attraction of this
method is that combining classifiers has been shown to increase generalization
performance (refer to Section 5.3 for further details).

5.2

MULTILAYER PERCEPTRONS

Multilayer feedforward networks consist of a set of sensory units (source nodes) that
constitute the input layer, one or more hidden layers of computation nodes, and an output
layer of computation nodes. The input signal propagates through the network in a forward
direction, on a layer-to-layer basis. The most commonly used example of such neural
networks are the multilayer perceptron (MLPs) type networks [93]. MLPs have been
applied successfully to solve a variety of difficult and diverse problems by training them
in a supervised manner with the highly popular error back-propagation algorithm (see
Section 5.2.1) . Error back-propagation learning consists of two passes of data through
the different layers of the network: a forward pass and a backward pass. In the forward
pass, an activity pattern (input vector) is applied to the sensory nodes of the network, and
its effect propagates through the network layer by layer. Finally a set of outputs is
produced as the actual response of the network. During the forward pass the synaptic
weights of the network are all fixed. During the backward pass, the synaptic weights are
all adjusted in accordance with an error-correction rule. Specifically, the actual response
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of the network is subtracted from a desired (target) response to produce an error signal.
This error signal is then propagated backward through the network. The synaptic weights
are adjusted to make the actual response of the network move closer to the desired
response in a statistical sense [93].
In pattern recognition involving nonlinearly separable patterns, the neurons in the
network are usually nonlinear. This nonlinearity is achieved by using a sigmoid function.
The two most commonly used forms are the anti-symmetric logistic function (which is
the sigmoid used in our experiments) and the anti-symmetric hyperbolic tangent function.
Each neuron is responsible for producing a hyperplane of its own decision space.
Through the supervised learning process, the combination of hyperplanes formed by all
neurons in the network is iteratively adjusted in order to separate patterns drawn from
different classes with the fewest classification errors on average [93].
Figure 5.1 illustrates the structure of an MLP. All nodes are fully interconnected
to the nodes of the adjacent layers by a set of weights. The weights connecting the input
nodes to the hidden layer nodes are denoted by wiy, where ij is the connection of ith input
node to thejth hidden layer node. The weights connecting the hidden layer to the output
nodes are denoted by wjk,wherejk is the connection ofjth hidden layer node to the kth
output node. The weights are determined through the back-propagation training algorithm
described in the next section [93,94]. xl through xi are the features of an input vector. yl
through y are the activation responses of the respective hidden layer nodes. or through Ok
are the responses of the respective output nodes. Lastly, di through dk are the target
outputs to which or through ok are compared to determine the classifier's accuracy.
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Figure 5.1: MLP network

5.2.1

BACK-PROPAGATION ALGORITHM

Back-propagation learning has emerged as the standard algorithm for training multilayer
perceptrons, and against which other learning algorithms are often benchmarked. The
back-propagation algorithm derives its name from the fact that the partial derivatives of
the cost function (performance measure) with respect to the free parameters (synaptic
weights and biases) of the network are determined by back-propagating the error signals
(computed by the output neurons) through the network, layer by layer. A full coverage of
the back-propagation algorithm is beyond the scope of this thesis. For more details and
explanation refer to [93,94].
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5.2.la NOTATION OF THE BACK-PROPAGATION ALGORITHM
The following is an explanation of the notation used in the summary of the backpropagation algorithm in the following section, Section 5.2.1b.
* The indices i,j, and k refer to different layers in the network. These indices refer
to the same layers as those illustrated in Figure 5.1.
* Iteration n refers to the nth training data instance being presented to the network.
* The ith element of the input vector for iteration n is xi(n).
* The kth element of the output vector for iteration n is ok(n).
* In layer 1of an MLP, 1= 0, 1, ..., L, where L is the depth of the network.
* The synaptic weight connecting the output of neuron i (the input nodes) to the
input of neuronj (the hidden layer nodes) for iteration n is given by wi(n).
Conversely, the synaptic weight connecting the output of neuronj (the hidden
layer nodes) to the input of neuron k (the output nodes) for iteration n is given by

wjk(n).
* The induced local field is the weighted sum of all synaptic input plus the bias of
neuronj at iteration n. This actually constitutes the signal being applied to the
activation function for neuronj and is denoted by vj(n).
* The activation function describes the nonlinearity associated with neuron j from
the input-output relationship. The activation function is denoted by

Qj(.).

* The output of neuronj for the nth iteration is referred to asyj(n).
* The error signal at the output of neuronj for iteration n is shown as ej(n).
* The desired response of neuron j is shown dj(n). This desired response is used to
compute ej(n).
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5.2.lb SUMMARY OF THE BACK-PROPAGATION ALGORITHM

The following is a summary of the back-propagation algorithm adapted from [93]:
* Initialization - Assume that no prior information is available. The synaptic

weights are randomly picked from a distribution whose mean is zero, and
variance is chosen to make the standard deviation of the induced local fields of
the neurons lie at the transition between the linear and saturated parts of the
sigmoid activation function. The logarithmic sigmoid was used in this research
and is shown in Figure 5.2. The logarithmic sigmoid is defined by:

p (n)=-

1

1-n

(i+e-)

Figure 5.2: The logarithmic sigmoid function.
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(5.1)

* Presentation of Training Data - An epoch of training data is presented to the
network. The sequence of forward and backward computations is then performed
for each example in the training data set.
* Forward Computation - Let the training data instance in the epoch be denoted by
(x(n),d(n)), with the input vector x for iteration n applied to the input layer of
sensory nodes and the desired response vector d for iteration n presented to the
output layer of computation nodes. The induced local fields of the network are
computed by proceeding forward through the network, layer by layer. The
induced local field vj(')(n) for neuronj in layer 1 is

Z w(n)yi-1)(n)
Vj )(n)=i=0

(5.2)

where mi is the size of layer 1and ij means from output of neuron i to the input of
neuron i. For i = 0, we have yo( "1) = 1 and woj(n)=bj()(n) is the bias applied to the
neuronj in layer 1.Assuming a sigmoid function is used for the neuron's
activation function, the output signal of neuronj in layer 1is

(n))
yJ(n)= p (v,

(5.3)

If neuronj is the output layer, set
y(L(n)-=oj(n)

(5.4)

e,(n)=dj(n)-oj(n)

(5.5)

Then, compute the error signal

* Backward Computation - The local gradients of the network, 8, are computed,
and defined by:
S(n)= e(L)(n)
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'(V(L)(n))

(5.6)

for neuronj in output layer L , and
j"((n)= (pj ' (vj()(n))

1+1(n)k
(

ik

1)

(5.7)

k

for neuronj in hidden layer 1.The prime in

'j(-)denotes differentiation with

respect to the argument. The synaptic weights in layer I are adjusted according to
the generalized delta rule:

wT)(n+1)=w )(nn)+cw (n-1)]+n6l(n)y )(n)1

(5.8)

where rqis the learning-rate parameter and a is the momentum constant.
* Iteration - The forward and backward computations in steps 3 and 4 are iterated
by presenting new epochs of training data instances to the network until the
stopping criterion is met.

Figure 5.3 illustrates a graphical summary of the signal-flow of back-propagation
learning. The flow can be interpreted as follows: The interconnecting weights, wi, are
initialized and an input vector x of length three is shown to the input nodes in this
example. The induced local field v is calculated for each neuron using Equation (5.2),
then shown to the activation function, ((-) and set as the output for each neuron, y, as in
Equation (5.3). The output from the hidden layer neurons are used to compute the next
set of induced fields and again shown to the activation function whose results are set as
the output, o. The output is compared to the desired response using Equation (5.5) and an
error signal is created. The error signal propagates back through the network to create
local gradients from Equation (5.6) and (5.7) for the respective layers I. Lastly, the
weights are adjusted according to generalized delta rule in Equation (5.8).
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Figure 5.3: Signal-flow of the back-propagation learning algorithm [93]

5.3

DATA FUSION TECHNIQUES

Fusion is the merging of similar or different elements into a union. Within the realm of
pattern recognition, fusion can be accomplished in several ways. The two approaches
described here are feature-level fusion, which involves the features before applied to any
classifier algorithms, and, decision-level or classifier fusion, which combines the
decisions of classifiers in an ensemble. The justification behind these techniques is to
obtain the most informative features (through feature-level fusion) or the most
informative decision (through classifier fusion) for a given problem.
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5.3.1

FEATURE-LEVEL FUSION

Feature-level fusion (FLF) involves the combination of different sets of features into one
feature vector. Combining features creates a new feature space that will ideally yield a
better decision boundary from the classifier. The new feature vectors are then used as the
training and testing data sets for a classifier. FLF can be achieved simply by such
methods as concatenation, averaging, or summing. The chosen method of combination is
defined by the user and varies from premise to premise. In the experiments of this thesis,
feature-level fusion was achieved by simply concatenating features and training
classifiers of the newly formed input vectors. Figure 5.4 illustrates a conceptual example
of feature-level fusion.

1 ^._

I eature vectLr 1

I

ITF71.

MLP Classifier

I

I pu

0)1
Feature Vector 2

0)2
*I

Figure 5.4: Feature-level fusion by concatenation.
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5.3.2

CLASSIFIER (DECISION-LEVEL) FUSION

Decision-level fusion is more commonly known as classifier fusion, an ensemble of
classifiers combination technique. Unlike feature-level fusion, classifier fusion is a fusion
of classifier label outputs. An ensemble based system, also known as a multiple classifier
system (MCS), combines several, preferably diverse, classifiers. The diversity in the
classifiers is typically achieved by using a different training data set for each classifier
but can also be achieved when classifiers learn different regions of the same feature
space. Each ensemble member is supposed know well a part of a feature space. Using
different feature spaces allows each classifier to generate different decision boundaries.
The reasoning and expectation is that each classifier will make different errors.
Therefore, the strategic combination of these classifiers can reduce the total error. Figure
5.5 provides a visual example of decision-level fusion.
Feature Vector 1
Classifiers

Featui
(Oj

Featui

Figure 5.5: A visualization of classifier (decision-level) fusion
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5.3.2a COMBINATION RULES
Three combination rules derived in this thesis are weighted majority vote, product rule,
and sum rule.
In weighted majority vote, the labels, and the error-based weights are needed from
each classifier in the ensemble . The decision of the ith classifier is defined as the binary
valued dgje (0,1)

, i=l,...,N andj=l,...,c where Nis the number of classifiers in an

ensemble and c is the number of classes. For a given instance x, if the ith classifier Ti
chooses classj, dij = 1, and zero otherwise. The voting weight for each classifier is
defined as

W(rTi)=-log

(5.9)

where /fris the normalized training error of classifier Ti.
For product rule and sum rule, the continuous outputs of the classifiers,
d, jE

[0,1] , which represents the degree of support given by classifier Ti to classj.

For any given classifier, these supports are normalized to add up to 1 over different
classes by the softmax transformation.
exp(di. (x))

di , (x)-= c(5.10)
Z exp(d
j=

i, j

(x))

For each rule, the final support, pj, given to classj is calculated as
N

p,(x)= Z W(Ti)dij(x),
j=l

j=l
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dij(x)e(0,1}

(5.11)

N

pj(x)=-n

Nj=l

d, (x),
j
'1

d,,(x)e[0,1]

(5.13)

for weight majority vote, sum rule, and product rule, respectively [85,86]. Denoting the
class labels as 2={(j,W2,...,,c}, and the ensemble decision for instance x as E(x),
then the ensemble decision is wm, for which the support yj(x),j=l,...,c is maximum:

E(x)=w-m\m=argmax(p (x))
J

5.4

(5.14)

OTHER COMBINATION METHODS

The following methods describe other possible combination techniques. These techniques
have been used for the early diagnosis of Alzheimer's disease in our previous studies [7983].

5.4.1

DECISION TEMPLATES

The decision template DTj for any classj is defined using the decision profiles DP(x) for
the given instance x. The decision profile is a matrix that summarizes the outputs from all
N classifiers in an ensemble for the given x. Each classifier Ti in the ensemble T= {T,...,
TN} outputs c degrees of support for each x. The outputs of the N classifiers for a
particular x are then organized into a decision profile as shown in Figure 5.5. Thejth
column with dij to dNj are the supports from classifiers Ti to TN to class w(, and the ith
row with di,1 to di,c is the support from classifier Ti(x) to classes w1 through wc.
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Figure 5.6: Decision Profile[79, 80, 95]

The decision template combiner is based upon the most typical decision profile for each
class wj. It is calculated as the average of decision profiles of all training instances of
class wj
DT

1

DP(x)

x

j XEX

(5.15)

where Xj indicates the set of class wj instances, and Nj is the cardinality of this set. For
classification of an instance x, the decision profile for x is compared to the decision
templates of all classes using a similarity measure S. The class whose decision template
provides the closest measure (the class that has the highest support) becomes the label of
x. The similarity measure that is often used is the squared Euclidean distance. Using this
measure, the ensemble support for wj is then
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P (x)= 1-

Z

Nc i=1 j=1

[DTj(i, j)-dj,j(x)]2

(5.16)

where DTj(i,j) is the (ij)th entry in the decision template. [79,80,96]

5.4.2

COMPETENCE WEIGHTING

Competence was originally intended as a classifier selection technique, where a large
number of classifiers are generated and those with the largest competencies are retained
for the final ensemble. The competence of a classifier is essentially a metric of how well
a classifier knows a particular feature space [96]. In a previous study, the feasibility of
using the competence as a weight in a combination scheme was pursued [79].
For the competence weight, a distance-based k-nn estimate was used such as the
one originally proposed by Giacinto and Roli in [97] for image classification
applications. A distance-based k-nn estimate calculates the competence of a classifier as
the weighted average of the classifier's predictions for the correct labels of the k-nearest
neighbors of a given instance x. Let Pi(l(xk)\xk) be the estimated probability of the ith
classifier Ti in correctly labeling xk, where l(Xk) denotes the true class of xk. These

probabilities are weighted by the distances between x and its k-nearest neighbors. The
competence of Ti, given x, is

SPi,(l(xk,)x,)( l/d (x,xk))
C(T, x)= I(Xk)Wj:k EW

z

l(xk)=Wj:XkE

(5.17)
(1/d(x,xk))
j

where d(x,xk) is the Euclidean distance between x and its k-nearest neighbors. Using this
definition of competence, the rules for weighted majority vote, and sum rule in Equations
(5.11), and (5.12), and were modified to use the competence as a weight in Equation
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(5.18) while product rule from Equation (5.13) was modified to Equation (5.19), as
follows:
N

C(Ttex)dt,j(x)

p,(x)=-

(5.18)

t=1
N

pj(x)=fl C(T tx)d,j(x)

(5.19)

t=1

Once again, the ensemble chooses class Wm for which the support pj(x), j =1,...,c is
maximum as in Equation (5.14).
The decision template rule was also modified by the competence weighting. Each
DP(x) entry became the support from the classifier times the competence weight of that
classifier, CWDP(x).
C(TIx)dl,l (x) ... C(Tlx)dl,,(x) ... C(Tllx)d,c(x)

CWDP(x)= C(T,lx)d, l(x) ""- C(Tx)dt, (x) " C(T,xx)dt,c(x)

(5.20)

C (TNIx)dN,1(x)"'C(TNIx)dN,,j(X)'C(TNIx)dN, (x)
The rest of the decision template algorithm remained the same as in Section 5.4.1 [79,96].
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CHAPTER 6
RESULTS
6.1 K-FOLD CROSS-VALIDATION
A cross-validation procedure was implemented to estimate the true generalization
performance of each of the classifiers and the ensemble of classifiers. Cross-validation
can be used to estimate any statistical parameter with a measure of certainty in the
original estimate [94,95]. In a K-fold cross-validation, the dataset is divided into K-blocks
as shown in Figure 6.1. The kth block is set aside for testing purposes while the network
is trained with K-1 remaining blocks. This procedure is repeated K times so that each
block is used in both the training and testing sets but never at the same time. The average
of the performance values on each of the test sets is the K-fold cross-validation
performance for the data set.
In our experiments, a leave-one-out cross-validation is implemented. In this scheme,
k is equal to the number of instances in the data set. For example, for the 71 patient
cohort, 70 patients would be used in training and 1 patient would be used for testing. This
would then be repeated 70 more times so that each instance is included in both the testing
and training sets. In this scheme, the performance for each test will either be 0 or 1 (0%
or 100%), meaning that the test instance is either incorrectly or correctly classified by the
classifier trained on the 70 other instances. The final performance for the leave-one-out
trial is then the average of these Is and Os.
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Figure 6.1: K-fold cross-validation [95]

6.2 OVERVIEW OF RESULTS
Wavelet analysis was performed on the two designated cohort data sets (one with 71
patients, the other with 66 patients) using the Daubechies 4 wavelet. The detail
coefficients from the wavelet analysis were used to train and test MLP neural networks
and combined using the fusion rules discussed in Chapter 5. Feature-level fusion was also
briefly analyzed for a subset of the detail coefficients and compared to decision-level
fusion results of MLPs trained on the same features. Performance figures are provided in
tables throughout this chapter.
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6.3 WAVELET ANALYSIS RESULTS
The number of coefficients per decomposition level and the corresponding frequency
subbands were determined. Table 6.1 outlines the number of coefficients from the
decomposition and the corresponding subbands. The coefficients for the levels d7, d6,
and d5 were used in the analysis in this work. These coefficients correspond to the 1-2Hz,
2-4Hz, and 4-8Hz subbands for a total of 32 coefficients.
Table 6.1: Number of coefficients and the corresponding frequency subbands.
a7

d7

d6

d4

d5

d3

d2

dl

nno.
o . ooff

8
8
10
14
22
38
69
132
coefficients
frequency 0-1Hz 1-2Hz 2-4Hz 4-8Hz 8-16Hz 16-32Hz 32-64Hz 64-128Hz
subbands
Figure 6.2 and Figure 6.3 show the decomposition of a signal from a normal subject
and a probable AD subject, respectively. Variations in the original signals are obvious
when compared visually. However, this is not always the case when using only visual
inspection as seen in Figure 2.3 where the AD signal shows characteristics typically
found in a normal subject's signal. Wavelet decomposition allows for a better analysis of
the frequency components of the signal. It makes the components of each frequency
subband more prominent than it otherwise would be in a purely visual analysis.
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Figure 6.2: Normal subject ERP (a) and its wavelet decomposition (b)
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Figure 6.3: AD subject ERP (a) and its wavelet decomposition (b)
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6.4 MLP RESULTS FROM ALL ELECTRODES

The following results are single classifier performances from the analysis of target and
novel stimuli from all 19 electrodes. Performances were evaluated on both the 71 patient
and 66 patient cohorts. Six feature sets were evaluated: 1-2Hz (all features), 1-2Hz
(middle-features), 2-4Hz (all features), 2-4Hz (middle features), 4-8Hz (all features) and
4-8Hz (middle features). As mentioned early, these feature sets are based on previously
established success [79-83]. The results are organized by classifier and feature set. The
average performance of five leave-one-out trials are presented along with the 95%
confidence intervals (CI) for each. Average performances of 60% and higher are
highlighted.
Table 6.2: Results for the target stimuli recordings from each electrode of the 71 patients
cohort at each feature level.
Featur

Classifier
C4
FP1
01

P8
P4
P7
F4

Level

4-8Hz(mid)
4-8Hz(all)
2-4Hz(all)
2-4Hz(mid)
1-2Hz(all)
1-2Hz(mid)
50.14 + 4.56% 56.62 + 6.47% 50.14 1.99% 49.58 + 4.52% 49.58 + 6.59% 49.58 + 4.69%
55.77 +3.83% 60.28 + 5.72%
43.94 + 4.35% 44.51 +3.63%
54.36 + 7.78% 53.52 + 3.91%
61.97 ±4.46% 59.72 + 4.02%

FZ
PZ

61.13 6.13%
60.84 + 4.18%
56.62 + 3.13%
62.53 5.88%

51.83+ 5.30%
60.84 + 2.88%
60.00 + 5.33%
52.96 + 2.00%

P3
F7
T8
CZ
F3
02
FP2
F8
C3
T7

57.46 4.35% 56.62 + 5.30%
51.27 + 2.92% 51.83 + 7.25%
57.75 + 3.91% 58.87 + 3.99%
46.48 + 6.89% 49.30 + 3.27%
42.25 + 6.89% 47.61 +4.85%
60.00 +3.18% 55.49 + 3.18%
61.97 + 5.93% 63.66 + 4.17%
56.34 + 3.91% 63.94 + 6.73%
49.30 + 6.43% 44.23 4.03%
49.58 ± 4.53% 53.80 ± 5.30%

60.28 + 1.46% 60.00 + 4.72% 46.76
48.45 + 4.56% 56.34 + 4.79% 43.38
53.52 + 4.46% 57.75 + 4.79% 44.51

63.66 +4.18%
60.56 + 4.10%
47.60 6.81%
50.14 + 6.38%
60.00 + 1.57%

61.97 + 3.27%
53.52 + 2.77%
44.22 ±4.88%
52.39 ± 6.47%
59.43 + 3.58%

6.47% 43.66 +4.63%
7.56% 43.94 + 5.01%
10.9% 37.75 + 7.25%

41.13 +5.30%
62.25 + 4.85%
51.55 + 6.37%
49.58 ± 4.53%
47.33 + 2.93%

37.75 + 3.79%
58.59 3.41%
51.55 3.83%
50.42 + 4.17%
49.86 + 4.39%

60.84 + 3.36% 63.38 + 5.67% 59.44 + 5.58% 50.14 7.27%
49.29 + 3.27% 47.60 + 4.52% 46.48 + 6.67% 51.27 + 2.65%

48.45 + 2.92% 59.44 2.28% 41.13 + 6.11% 47.04
51.27 + 2.65%
49.58 + 5.30%
46.76 + 5.30%
50.42 + 6.93%
48.45 + 3.62%
52.39 10.3%
52.68 ±3.83%
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55.77 + 3.41%
52.11 +1.27%
49.02 + 5.01%
49.86 ±5.04%
54.65 + 8.87%
59.15+ 7.00%
56.06 ± 5.16%

47.32
50.70
50.99
52.68
53.80
49.02
58.31

+ 4.39%
+ 6.18%
+ 3.99%
8.88%
+ 5.31%
+ 7.86%
±3.62%

6.84%

44.51 + 2.65%
51.27 +4.02%
50.14 + 3.62%
42.25 + 7.32%
53.80 + 4.18%
43.10 4.56%
63.66 ± 4.35%

Table 6.3: Results for the novel stimuli recordings from each electrode of the
71 patients cohort at each feature level.
Feature Level
2-4Hz(all)
2-4Hz(mid)
60.28 +5.72% 57.75+ 5.93%
60.84 +8.69% 62.25 +4.36%
50.71 + 4.94% 55.49 + 5.18%
62.54 +4.03% 64.51 +7.56%
65.92+6.35% 62.53+2.00%
64.51+ 3.99% 61.41 + 5.74%
50.14+ 3.62% 54.65 + 5.30%
52.96 + 4.56% 55.21 + 5.30%
69.01 + 1.74% 71.55 5.58%
66.76 + 7.59% 65.63+ 7.88%

Classifier
C4
FP1
01
P8
P4
P7
F4
FZ
PZ
P3

1-2Hz(all)
51.83+ 4.85%
64.79 +6.54%
53.24 + 6.47%
61.41 +4.39%
62.82+3.41%
58.59 + 7.78%
59.72 + 4.56%
45.92 + 2.65%
61.41 ± 8.62%
65.63 4.73%

1-2Hz(mid)
56.05+ 4.52%
62.53 +2.35%
55.49 + 1.57%
61.41 +5.04%
62.53 +4.03%
54.65 + 6.35%
56.90+ 5.33%
52.11 + 3.50%
65.92 + 1.46%
57.46 +3.13%

F7

54.65+ 7.46%

53.52 + 2.77% 51.83+ 5.71%

T8

60.28 +3.79%

61.69+6.35%

54.65+3.13%

54.93 +5.10%

CZ
F3

52.39 + 4.53%
48.45 + 8.35%

53.24 + 3.13%
55.49 + 0.96%

56.90 + 3.18%
54.08 + 3.18%

63.38 + 2.14% 50.42 + 3.79%
50.14 3.62% 49.30 + 5.93%

54.37 + 7.68%
41.97 3.99%

02

63.94+3.41% 64.79±+3.27%

56.90+3.17%

59.43+2.59% 45.64 +5.61%

46.20+5.00%

FP2

54.93 +4.11%
49.86 +1.99%
-

60.28 +6.10%

45.92+3.18%

45.20

57.18+- 4.39%

42.53 +6.35%

44.79 +3.79%

C3

59.72+2.34% 58.03 +2.59%
62.25 +1.92% 62.83 +3.18%
52.39 + 4.18% 56.90 + 2.65%

61.41 + 3.41%

65.07 + 5.98%

51.55

T7

51.83 4.85%

43.38 + 4.52% 48.73 + 5.19%

44.23 4.03%

51.55 5.33%

F8

4-8Hz(all)
42.82+ 5.19%
46.48 +3.91%
41.97 + 8.86%
61.41 +2.65%
51.27+5.33%
53.80+ 7.14%
50.70+ 5.10%
53.24 + 7.04%
58.59+ 4.72%
59.72 + 3.41%

4-8Hz(mid)
53.24+ 6.23%
52.40+ 5.45%
46.20 + 3.13%
55.21 6.11%
59.15 +3.71%
58.03 + 7.15%
46.84 + 5.53%
42.82 + 2.65%
68.45 + 4.39%
63.10 +4.18%

51.83+ 6.35% 41.97+ 5.85%

45.35 +6.93%

38.03+ 9.00% 53.24+4.18%

5.75%

57.18

8.17%
5.87%

43.10 4.72%

Table 6.4: Results for the target stimuli recordings from each electrode of the
66 patients cohort at each feature level.
Feature Level

Classifier
C4

1-2Hz(all)
51.82 + 6.44%

1-2Hz(mid)
54.24 + 3.36%

-4-8Hz(all)
2-4Hz(mid)
2-4Hz(all)
53.64 + 5.89% 53.64 + 5.89 % 48.48 + 5.49%

FP1
01
P8
P4
P7

58.18 + 4.72%
43.63 + 4.49%
59.40 + 3.62%
63.64 +5.48%
60.61 2.97%

63.03 ±5.08%
47.58 + 4.33%
53.03 + 3.26%
63.34 +0.84%
57.27+ 3.62%

59.40 + 6.96%
54.85 + 3.09%
53.94 + 4.33%
69.39 +9.35%
53.64 + 3.90%

F4

67.58 +5.08%

66.97+4.87% 48.18 ±11.5% 50.61

FZ
PZ
P3
F7
T8
CZ
F3
02
FP2
F8
C3
T7

56.06 + 3.26%
68.18 4.79%
65.46+4.87%
50.91 + 7.83%
59.40 + 3.62%
52.42 + 6.86%
49.09 + 4.12%
62.12+ 7.17%
66.36 + 2.06%
58.49 + 3.15%
56.06 + 5.95%
51.21 + 6.84%

56.97 + 3.90%
58.79+ 4.08%
66.67+3.26%
50.91 + 6.18%
56.06 + 3.52%
57.28 3.36%
53.64 + 2.85%
60.91+2.06%
63.64 + 2.30%
62.42 + 8.86%
52.12 + 2.53%
51.52 + 1.88%

56.36 + 4.29%
67.88+0.84%
62.73 +4.33%
46.67 + 6.16%
49.09 + 5.89%
61.21 + 3.90%
56.06 + 7.87%
48.48 +7.41%
44.54 + 1.68%i
45.15 + 3.36%
56.67 + 4.91%
55.15 + 2.15%
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57.27 + 3.62 %
56.67 + 7.24 %
59.70 + 9.83 %
70.00+5.22%
56.67 + 8.05 %

5.89%

63.33 9.72 %
70.61 4.90 %
63.33+3.09%
52.12 + 9.08 %
54.25 + 3.36 %
61.52 +2.85 %
53.64 + 4.53 %
51.21 +7.45%
50.91 ± 9.65 %
48.79 + 8.46 %
62.73 ± 7.11 %
51.82 + 8.35 %

4-8Hz(mid)
50.30 + 5.71%

49.39 + 3.90% 39.39 + 3.76%
38.18 + 7.09% 47.88 + 8.58%
43.64 + 6.97% 40.30 + 2.14%
36.06+6.70% 38.79 ±7.71%
59.09+ 6.10% 60.30 +3.62%

60.00 +2.14%

48.48 ±5.95%

54.55 +4.41%
44.54 +3.41%
53.03 +7.16%
48.49 7.17%
45.75 + 4.68%
44.24 + 1.57%
53.94 + 6.86%
46.66 +4.08%
53.64 + 8.68%
53.03 + 3.52%
46.36 + 4.91%
55.76 + 4.08%

48.18+ 4.87%
47.88 +3.42%
47.57+ 4.53%
47.88 + 5.08%
43.94 + 4.41%
46.67 +9.90%
50.61 + 6.33%
48.18 +4.29%
47.27 ± 4.29%
52.12 + 2.15%
50.61 + 6.18%
55.45 +4.12%

Table 6.5: Results for the novel stimuli recordings from each electrode of the
66 patients cohort at each feature level. ------Classifier
C4
FP1
01
P8
P4
P7
F4
FZ
PZ
P3
F7
T8
CZ
F3
02
FP2
F8
C3
T7

1-2Hz(all)
60.61+3.76%
66.36+4.29%
56.67 + 2.14%
68.18+2.30%
66.67 +4.98%
58.79 +4.87%
56.67 + 3.42%
46.06 + 2.14%
66.67 + 5.80%
65.15+1.88%
50.31 + 2.46%
56.06 ± 5.95%
55.76 +6.16%
53.64 3.15%
70.61 +6.32%
62.73 +5.42%
60.61 5.32%
54.85 ± 7.69%
50.00 +3.99%

1-2Hz(mid)
60.00 3.67%
62.12+3.99%
54.84 + 3.36%
68.49 2.06%
67.27 ±1.68%
53.64 + 5.25%
54.55 4.80%
49.70 + 4.08%
73.64 2.855
60.31+4.29%
50.61 + 2.15%
57.27 ±5.22%
60.00 2.52%
54.55 + 2.97%
65.15 +2.30%
59.70 + 6.03%
60.30 +5.55%
56.97 ±6.60%
45.15 5.70%

Feature Level
2-4Hz(mid)
2-4Hz(all)
65.46+3.09% 55.46 3.66%
60.91+5.22% 56.67 + 5.42%
50.61 +4.90% 53.03 + 4.41%
67.88 ±4.07% 71.82 +2.85%
69.39 4.87% 66.67 + 3.76%
62.12 +6.52% 60.91 +6.29%
52.73 ±4.29% 51.21 ±3.62%
52.42 3.90% 56.37 + 5.55%
67.58 + 4.33% 74.85 + 5.25%
61.52+5.08% 64.85+3.09%
58.79 + 2.79% 55.15 + 3.90%
61.52 +2.15% 58.70 ±4.90%
63.03 +3.42% 66.06 +3.15%
47.58 ± 6.86% 50.00 ± 5.95%
57.58 2.97% 56.67 + 7.48%
58.79 +5.86% 61.22 +3.15%
47.88±+5.74% 55.15 7.12%
62.43 + 7.45% 63.34 ±4.68%
44.55 ±9.37% 45.76 + 5.39%

4-8Hz(all)
60.61 ±7.60%
66.36 + 6.33%
56.67 + 5.05%
68.18 4.08%
66.67 + 4.33%
58.79 +8.96%
56.67 + 6.04%
46.06 +4.29%
66.67 + 5.15%
65.15+7.16%
50.31 + 5.08%
56.06 ± 6.01%
55.76 +3.15%
53.64 + 2.06%
70.61 + 3.99%
62.73 +2.45%
60.61 +2.15%
54.85 ± 4.53%
50.00 + 3.90%

4-8Hz(mid)
56.36 8.24%
57.27 +7.69%
46.67 +6.97%
53.94 +5.74%
62.12 ± 4.41%
58.18 +7.60%
44.54 +6.86%
45.76 +6.44%
71.52 + 5.55%
57.88+8.46%
35.15 ± 5.86%
49.09 ±5.42%
52.73 6.01%
37.57 ±4.08%
47.57 2.15%
46.97 +5.65%
41.51±6.32%
54.85 ±6.30%
53.33 + 3.36%

Table 6.2 through Table 6.5 show varying degrees of success with different
stimuli/electrode/feature set combinations. The most promising results yield
performances between the mid-60% to low 70% range and several of these results come
from the parietal (P3, P4, P7, P8, and PZ) and occipital electrodes (01 and 02). In our
previous work [79-83], only the PZ, FZ, and CZ electrodes were analyzed but the above
results show that complimentary information may rest within the recordings obtained
from other electrodes. Therefore, the next logical step is to try to improve upon these
performance figures by using advanced pattern recognition techniques. Ensembles of
classifiers trained on features from the best performing stimuli/parietal/feature set and
stimuli/parietal-occipital/feature set combinations are explored in Section 6.6. Featurelevel fusion is first used on features previously found to perform well from [79,80].
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6.5 RESULTS FROM FEATURE-LEVEL FUSION

Results from a feature-level fusion experiment for both cohorts are presented in this
section. The fusion method chosen was simple concatenation. The features evaluated
were Novel PZ (middle 1-2Hz), Target PZ (middle 2-4Hz), and Target CZ (middle
2-4Hz). As mentioned in the previous section, these stimuli/electrode/features were
previously shown to yield good performances during the analysis of the PZ, CZ, and FZ
electrodes [79-83]. For comparison purposes, individual classifiers were also trained on
each of the feature sets and combined at the decision-level.
In Table 6.6, "Fusion" means feature-level fusion. NPZ means Novel PZ, TPZ
means Target PZ, and TCZ means Target CZ. For example, "12 3 MV" means the
classifiers 1, 2, and 3 (i.e. classifier 1 is trained on the Novel PZ features, etc.) combined
by weighted majority vote. Table 6.7 shows the best 5 performances of this experiment.
Table 6.6: Results from feature-level fusion compared with classifier fusion
using the 71 patient cohort (a) and the 66 patient cohort (b).
(b)
(a)
Fusion NPZ,TPZ,TCZ
Fusion NPZ,TPZ
Fusion NPZ,TCZ
Fusion TPZ, TCZ
1) NPZ
2.) TPZ
3) TCZ
123MV
1 2 MV
13MV
23MV
1 2 3 PROD
12 PROD
13 PROD
2 3 PROD
1 2 3 SUM
12 SUM
13 SUM
2 3 SUM

66.90 1.19 %
62.25 ± 2.55 %
67.75 ± 2.25 %
70.28 ± 2.20 %
66.48 ±2.36 %
62.25 ± 3.03 %
56.76 ±2.56 %
65.07 ±1.49 %
67.89 ±2.55 %
60.84 ±2.76 %
58.73 ±2.28 %
68.59 ±2.93 %
71.13 ±2.19%
64.23 ±2.70 %
61.13 ±3.37 %
67.89 ±2.17 %
71.27 ±2.34 %
64.37 ±2.47 %
60.99 ±3.36 %

Fusion NPZ,TPZ,TCZ
Fusion NPZ,TPZ
Fusion NPZ,TCZ
Fusion TPZ, TCZ
1) NPZ
2.) TPZ
3) TCZ
12 3 MV
12 MV
13 MV
23MV
1 2 3 PROD
12 PROD
13 PROD
2 3 PROD
1 2 3 SUM
12 SUM
13 SUM
2 3 SUM
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78.48 ±1.68 %
72.42 ± 1.52 %
73.49 ± 2.62 %
75.76 1.45 %
75.30 ±1.98 %
69.40 ± 3.38 %
62.12 ± 4.57 %
73.79 ±3.61%
71.52 ±2.22 %
68.79 ±2.46 %
68.94 ±4.16 %
77.73 ± 1.45 %
80.76 ± 2.23 %
73.49 ± 2.24 %
71.52 ±3.18%
74.70 ±3.07 %
80.61 ±2.21%
73.49 ± 2.24 %
71.37 ±3.04%

Table 6.7: Best five results from feature-level fusion compared with decision-level
fusion using the 71 patient cohort (a) and the 66 patient cohort (b).

(a)
Combination
Fusion TPZ, TCZ
NPZ, TCZPROD
NPZ, TPZPROD
NPZ, TPZ, TCZPROD
NPZ, TPZPROD

Performance
76.06 ± 8.50%
74.65 ± 8.67%
74.65 ± 8.67%
73.24 ±8.82%
73.24 ± 8.82%

Sensitivity Specificity Positive Predictive Value
78.38%
75.76%
73.53%
79.41%
70.27%
71.05%
73.53%
73.53%
73.53%
71.43%
73.53%
72.97%
73.53%
72.97%
71.43%

(b)
Comlination
Fusion NPZ, TPZ, TCZ
NPZ, TPZPROD
NPZ, TPZPROD
NPZ, TPZSUM
NPZ, PZPROD

Performance Sensitivity Specificity Positive Predictive Value
83.33 ± 7.71%
80.00%
86.11%
82.76%
83.33 ± 7.71%
83.33%
83.33%
80.65%
76.67%
88.89%
85.19%
83.33 ± 7.71%
82.76%
80.00%
86.11%
83.33 7.71%
83.33%
81.25%
84.85 7.42% 86.67%

The feature-level fusion technique was more successful when used with the 66
patient cohort. The best feature-level fusion performance for the 71 patient cohort was
76.06% while the best performance for the 66 patient cohort was 83.33%. Although this
is a significant difference, the product rule combination of Novel PZ and Target PZ in the
66 patient cohort yielded a performance of almost 85%. It seems that the feature-level
fusion method is highly sensitive. This sensitivity may be from redundant or
uninformative features. With the effectiveness of this method being inconclusive, the
focus of the experiments is turned towards classifier (decision-level) fusion which is a

well-established combination method.

6.6

RESULTS FROM CLASSIFIER FUSION

Two comprehensive experiments are performed using classifier fusion. First, classifier

fusion was used to combine the ensembles of classifiers trained on features from parietal
electrodes, PZ, P3, P4, and P7. These parietal electrodes were chosen because of their
performance figures shown in Section 6.2, and their consistency for both target and novel
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stimuli. AD has been found to first show symptoms in the parietal region, thus making
the features obtained from EEG recordings in this region possible key features for the
early detection of AD.
Classifiers were trained on the following 6 feature sets for both target and novel
stimuli from the respective electrodes: P4 (middle 2-4Hz features), PZ (all 2-4Hz
features), P3 (all 2-4Hz features), P4 (all 1-2Hz features), PZ (all 1-2Hz features), and P7
(all 1-2Hz features). Tables 6.8 through 6.15 show the best 5 performance results from
five leave-one-out cross-validation trials along with the 95% confidence interval of that
trial. In each trial, fusion was achieved by the weighted majority vote, product rule, and
sum rule of various combinations of the six classifiers. All combination possibilities from
combining all 6 to combining 3 classifiers were exhausted for a total of 42 different
combinations (refer to Appendix C for full results of these combinations). The following
tables show the best electrode combinations for both stimuli, the combination rule, and
the resulting performance and CI, sensitivity, specificity, and positive predictive value.
To clarify the layout of these tables, here is an example. In Table 6.8, the first row
should be interpreted as follows: The sum rule was used to combine 4 classifiers. Each
classifier was trained on the feature sets, P4 (middle 2-4Hz), P3 (all 2-4Hz), P4 (all 12Hz), and P7 (all 1-2Hz), respectively. This ensemble achieved a performance of
74.65%, a sensitivity of 70.59%, a specificity of 72.97% and positive predictive value of
70.59%.
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74.65 + 10.37%

70.59%

72.97%

70.59%

PZ (2-4Hz),
P3(2-4Hz),
P4 (1-2Hz),
P7(1-2Hz)

SUM

73.24

10.55%

67.57%

67.57%

67.57%

P4 (2-4Hz),
PZ (2-4Hz),
P7(1-2Hz)

PRODUCT

73.24 + 10.55%

72.73%

75.68%

72.73%

PZ (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

PRODUCT

71.83 + 10.72%

71.88%

75.68%

71.88%

P3 (2-4Hz),
PZ (1-2Hz),
P7 (1-2Hz)

PRODUCT

71.83 + 10.72%

69.44%

70.27%

69.44%
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70.59%

81.08%

77.42%

P4 (2-4Hz),
P3 (2-4Hz),
P4 (1-2Hz),
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74.65 ± 10.37%

67.65%

81.08%

76.67%

P4 (2-4Hz),
PZ (1-2Hz),
P7(1-2Hz)

WEIGHTED
MAJORITY
VOTE

74.65 ± 10.37%

70.59%

78.38%

75.00%

PZ (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

SUM

74.65 ± 10.37%

70.59%

78.38%

75.00%

P4(2-4Hz),
PZ (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

PRODUCT

73.24 ± 10.55%
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81.08%

75.86%
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Table 6.10:Results of 1 classifier each from target/parietal recordings for 66 patients.

Combination
Electrodes
and
Ru

FeatureLevel

Performance

Sensitivity

Specificity

Positive
Predictive
Value

PZ (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

81.82 + 9.55%

80.00%

81.08%

80.00%

P4 (2-4Hz),
PZ (2-4Hz),
P3 (2-4Hz),

WEIGHTED
MAJORITY
VOTE

78.79 ± 10.13%

80.65%

83.78%

80.65%

78.79

10.13%

80.65%

83.78%

80.65%

PZ (1-2Hz)

P4 (2-4Hz),
PZ (2-4Hz),
P3 (2-4Hz),
PZ (1-2Hz)

SUM

P4 (2-4Hz),
PZ(2-4Hz),
PZ (1-2Hz),

WEIGHTED
MAJORITY
VOTE

78.79 ±10.13%

78.79%

81.08%

78.79%

PRODUCT

77.27 ± 10.38%

76.47%

78.38%

76.47%

P7(1-2Hz)

PZ (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

Table 6.11: Results of 3 classifiers each from target/parietal recordings for 66 patients.
Combination
Rule

Performance

Sensitivity

Specificity

Positive
Predictive
Value

P4 (2-4Hz), PZ (2-4Hz),
P3 (2-4Hz), P4 (1-2Hz),
PZ (1-2Hz)

PRODUCT

80.30 ± 9.85%

76.67%

83.33%

79.31%

P4 (2-4Hz), PZ (2-4Hz),
P3 (2-4Hz), P4 (1-2Hz),
PZ (1-2Hz)

SUM

80.30 ± 9.85%

80.00%

80.56%

77.42%

PZ (2-4Hz), P4 (24Hz),
PZ (1-2Hz),
P7(1-2Hz)

WEIGHTED
MAJORITY
VOTE

80.30 ± 9.85%

80.00%

80.56%

77.42%

P4 (2-4Hz), P4 (1-2Hz),
PZ (1-2Hz)

SUM

78.79 ± 10.13%

76.67%

80.56%

76.67%

P4 (2-4Hz), PZ (2-4Hz),
P3 (2-4Hz), PZ (1-2Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

78.79 ± 10.13%

76.67%

80.56%

76.67%

Electrodes and
Feature Level
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Table 6.12: Results of 1 classifier each from novel/parietal recordings for 71 patients.
Electrodes and

Combination

Feature Level

Rule

Performance

Sensitivity

Specificity

Predictive
Value

Positive

PZ (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

81.69 ± 9.22%

80.00%

81.08%

80.00%

P4 (2-4Hz),
PZ (2-4Hz),
P3 (2-4Hz),
PZ (1-2Hz)

WEIGHTD
MAJORITY
VOTE

78.87

9.73%

75.68%

75.68%

75.68%

P4 (2-4Hz),
PZ (2-4Hz),
P3 (2-4Hz),

SUM

78.87 ± 9.73%

80.65%

83.79%

80.65%

WEIGHTED
MAJORITY
VOTE

78.87 ± 9.73%

78.79%

81.08%

78.79%

PRODUCT

77.46 + 9.96%

76.47%

78.38%

76.47%

PZ (1-2Hz)

P4 (2-4Hz),
PZ (2-4Hz),
PZ (1-2Hz),
P7 (1-2Hz)

P4 (2-4Hz),
PZ (2-4Hz),
P3 (2-4Hz)
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Combination
Rule

Performance

Sensitivity

Specificity

Positive
Predictive
Value

PZ (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

PRODUCT

80.28 ± 9.48%

76.47%

83.78%

81.25%

PZ (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

80.28 ± 9.48%

76.47%

83.78%

81.25%

P4 (2-4Hz),
PZ (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

78.87 + 9.73%

76.47%

81.08%

78.79%

P3 (2-4Hz),
PZ (1-2Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

77.46 ± 9.96%

79.41%

75.68%

75.00%

P3 (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

77.46 ± 9.96%

73.53%

81.08%

78.13%

Electrodes and
Feature Level
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Table 6.14: Results of 1 classifier each from novel/parietal recordings for 66 patients.
Combination
Rule

Performance

Sensitivity

Specificity

Positive
Predictive
Value

P4 (2-4Hz),
PZ (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

PRODUCT

84.85 ± 8.88%

85.71%

88.89%

85.71%

P4 (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

PRODUCT

83.33 + 9.23%

88.00%

91.67%

88.00%

P4 (2-4Hz),
P3 (2-4Hz),
PZ (1-2Hz)

PRODUCT

81.82 + 9.55%

82.14%

86.11%

82.14%

P4 (2-4Hz),
PZ (2-4Hz),
P4 (1-2Hz),
PZ (1-2Hz),
P7 (1-2Hz)

PRODUCT

81.82 ± 9.55%

82.14%

86.11%

82.14%

SUM

81.82 ± 9.55%

78.57%

83.33%

78.57%

Electrodes and
Feature Level

P3 (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

Table 6.15: Results of 3 classifiers each from novel/parietal recordings for 66 patients.
Electrodes and
Feature Level

Combination

Rule

Performance

Sensitivity

Specificity

Positive
Predictive
Value

P4 (2-4Hz), PZ (2-4Hz),
P3 (2-4Hz), P4 (1-2Hz),
PZ (1-2Hz)

PRODUCT

81.82 ± 9.55%

80.00%

83.33%

80.00%

P4 (2-4Hz), P3 (2-4Hz),
P4 (1-2Hz)

SUM

81.82 ± 9.55%

80.00%

83.33%

80.00%

PZ (2-4Hz), P4 (2-4Hz),
PZ (1-2Hz),
P7(1-2Hz)

WEIGHTED
MAJORITY
VOTE

83.33 ± 9.23%

80.00%

86.11%

82.76%

P4 (2-4Hz), PZ (2-4Hz),
P4 (1-2Hz), PZ (1-2Hz)

SUM

81.82 ± 9.55%

76.67%

86.11%

82.14%

P4 (2-4Hz), P3 (2-4Hz),
P4 (1-2Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

81.82 ± 9.55%

80.00%

83.33%

80.00%
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For the first time in these results, combinations of classifiers for the 71 patient
cohort exceed 80% performance, specifically seen in Tables 6.12 and 6.13. To try to
compliment these features, a combination of both the target and novel classifiers is tried
for the 71 patient cohort. Table 6.16 represents the best 5 performances from five leaveone-out trials with these combinations and the individual trial confidence intervals (refer
to Appendix C for full results). Electrode combinations are of one classifier from each
stimuli. For example, in Table 6.16, the first entry in the "Electrodes and Feature Level"
column says P4 (2-4Hz), PZ (2-4Hz), P3 (2-4Hz), P4 (1-2Hz), and PZ (1-2Hz). This
should be interpreted as the combination Target and Novel P4 (2-4Hz), Target and Novel
PZ (2-4Hz), etc. at the specified feature levels. Note the subband features do not change
for the different stimuli.
Table 6.16: Results from each of the target and novel/parietal classifiers for 71 patients.
Specificity
Specity

Positive
Predictive
Preicve
Value

82.35%

83.78%

82.35%

8.93%

79.41%

86.49%

84.38%

SUM

81.69 + 9.22%

76.47%

86.49%

83.87%

P4 (2-4Hz),PZ (2-4Hz),
P3 (2-4Hz), P7 (1-2Hz)

PRODUCT

81.69 ± 9.22%

85.29%

78.38%

78.38%

P4 (2-4Hz), PZ (2-4Hz),
P3 (2-4Hz), PZ (1-2Hz),
P7 (1-2Hz)

SUM

81.69 + 9.22%

82.35%

81.08%

80.00%

Electrodes and
Feature Level

Combination
Rule

Sensitivity
Performance Sensiivity

P4 (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

83.10 ± 8.93%

P4 (24Hz),
P3 (24Hz),
PZ (1-2Hz),
P7 (1-2Hz)

WEIGHTED
MAJORITY
VOTE

83.10

P4 (2-4Hz),
P3 (2-4Hz),
P7 (1-2Hz)
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From the combinations of Target and Novel classifiers for the 71 patient cohort, a
performance of 83.10% is obtained through a total of 6 classifiers (Target and Novel P4
(2-4Hz), Target and Novel P3 (2-4Hz), and Target and Novel P7 (1-2Hz)). This result is
slightly higher than the 81.69% performance obtained in Table 6.12 when just 3
classifiers (Novel PZ (2-4Hz), Novel P3 (2-4Hz), and Novel P7 (1-2Hz)) were combined
through weighted majority vote. Comparatively, the target and novel combination does
show improvement in the specificity and positive predictive value.
The last experiments of this thesis involve the parietal and occipital electrode
recordings for the 71 patient cohort. The best performing feature set from each electrode
was selected. A total of 11 electrode/stimuli combinations were chosen to create the
feature sets. Those choices were: Target P4 (all 2-4Hz), Target PZ (middle 2-4Hz),
Target P3 (middle 2-4Hz), Novel P8 (middle 2-4Hz), Target 02 (all 1-2Hz), Target P7
(all 1-2Hz), Novel 02 (all 1-2Hz), Novel PZ (middle 2-4Hz), Novel P3 (middle 2-4Hz),
Novel P4 (all 1-2Hz), and Novel PZ (1-2Hz). A single classifier was trained on one of
these feature sets. All combinations of 3 classifiers (a total of 164) were exhausted and a
combination of all 11 classifiers was tried (refer to Appendix C for the full results). As in
the previous results, the best 5 resulting combinations from five leave-one-out trials are
displayed in Table 6.17 along with the combination rule, sensitivity, specificity, and
positive predictive value.. "T" stands for target and "N" stands for novel. For example in
the first row and column, TP4 (all 2-4Hz), TP7 (all 1-2Hz), and NPZ (mid 2-4Hz) means
that 3 classifiers, each trained on one of the feature sets was combined by weighted
majority vote to obtain the reported performance figures.
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Table

6.17:

Results

s.

l-- .............

...............

of

Electrodes and
Feature Level

Combination
Rule

Performance

Sensitivity

Specificity

Positive
Predictive
Value

TP4 (all 2-4Hz),
TP7 (all 1-2Hz),
NPZ (mid 2-4Hz)

WEIGHTED
MAJORITY
VOTE

83.10 + 8.93%

85.29%

81.08%

80.56%

TP4 (all 2-4Hz),
NP8 (mid 2-4Hz),
NPZ (mid 2-4Hz)

PRODUCT

81.69 ± 9.22%

79.41%

83.78%

81.82%

NP8 (mid 2-4Hz),
T02 (all 1-2Hz),
NPZ (mid 2-4Hz)

PRODUCT

81.69 + 9.22%

79.41%

83.78%

81.82%

TP4 (all 2-4Hz),
TP7 (all 1-2Hz),
NPZ (mid 2-4Hz)

SUM

80.28 ± 9.48%

76.47%

83.78%

81.25%

NP8 (mid 2-4Hz),
TP7 (all 1-2Hz),
NPZ (mid 2-4Hz)

PRODUCT

80.28 ± 9.48%

79.41%

81.08%

79.41%

I

The best performance in the above table is 83.10% and comes from the weighted
majority vote combination of 3 feature sets. In the previously mentioned results, 6
classifiers (Target and Novel P4 (2-4Hz), Target and Novel P3 (2-4Hz), and Target and
Novel P7 (1-2Hz)) were necessary to obtain 83.10% in Table 6.16. In this scenario with
combining Parietal and Occipital features, it takes half the number of classifiers
previously stated to obtain the same success.
To further, exhaust combination possibilities, 7 classifiers that yielded the best
results from the previous 11, are combined for all possible combinations of 3, 5, and 7
classifiers for a total of 56 combinations. The stimuli and features used to train this
ensemble of classifiers were: Target P4 (all 2-4Hz), Target P7 (all 1-2Hz), Novel PZ
(middle 2-4Hz), Novel P8 (middle 2-4Hz), Target 02 (alll-2Hz), Novel 02 (all 1-2Hz),
and Novel P3 (middle 2-4Hz). Once again, the best 5 combinations from five leave-oneout trials are displayed in Table 6.18.
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Table 6.18: Results of 7 classifiers from the parietal and occipital electrodes.
Electrodes and
Feature Level

Combination
Rule

Performance

Sensitivity

Specificity

Positive
Predictive
Value

NP8 (mid 2-4Hz),
TP7 (all 1-2Hz),
NPZ (mid 2-4Hz)

WEIGHTED
MAJORITY
VOTE

81.69 ± 7.71%

88.24%

75.68%

76.92%

NP8 (mid 2-4Hz),
TP7 (all 1-2Hz),
NPZ (mid 2-4Hz)

SUM

T02 (all 1-2Hz),
TP7 (all 1-2Hz),
N02 (all 1-2Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)
TP4 (all 1-2Hz),
TP7 (all 1-2Hz),
N02 (all 1-2Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)
N02 (all 1-2Hz),

NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)

I

--t
80.28 ± 7.93%

85.29%

76.32%

75.68%

i

I
SUM

78.87 ± 8.13%

I

73.53%

83.78%

i

-------

WEIGHTED
MAJORITY
VOTE

78.87 ± 8.13%

I

79.41%
-------

PRODUCT

78.87 ± 8.13%

73.53%

80.65%

77.14%

78.38%

i -~ ~
83.78%

i
80.65%

The best performance of the above 7 classifiers is 81.69% and comes from the
weighted majority vote combination of 3 feature sets, NP8 (mid 2-4Hz), TP7 (all 1-2Hz),
NPZ (mid 2-4Hz). This result is less than the 83% achieved earlier.
For the final test, feature-level fusion is revisited and combined with classifier
fusion. In the above tests, only one feature set was used from each electrode except Novel
PZ (the 1-2Hz and 2-4Hz features were used). The Target P4 electrode has consistent
performance figures for the 2-4Hz feature set (which was used in the above tests) as well
as the 1-2Hz feature set. This last experiment incorporates this other feature set of the
Target P4 electrode by using feature-level fusion and concatenating it with the 2-4Hz

feature set. A classifier was trained on the fused Target P4 features while the other
feature sets remained the same (Target P7 (all 1-2Hz), Novel PZ (middle 2-4Hz), Novel
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P8 (middle 2-4Hz), Target 02 (alll-2Hz), Novel 02 (all 1-2Hz), and Novel P3 (middle 24Hz)). Table 6.19 displays the best 5 performances of this experiment.
Table 6.19: Results of 7 classifiers including the feature-level fused Target P4
from the parietal and occipital electrodes.
Electrodes and
FeatureLevel

Combination
Rule

Performance

Sensitivity

Specificity

Positive
Positive
Predictive
Value

TP4 (all 1-2 + 2-4Hz),
TP7 (all 1-2Hz),
N02 (all 1-2Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)

WEIGHTED
MAJORITY
VOTE

84.51 ± 8.62%

79.41%

89.19%

87.10%

SUM

83.10 + 8.93%

79.41%

86.49%

84.38%

T02 (all 1-2Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)

PRODUCT

81.69 + 9.22%

79.41%

83.78%

81.82%

TP4 (all 1-2 + 2-4Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)

WEIGHTED
MAJORITY
VOTE

81.69 + 9.22%

73.53%

89.19%

86.21%

T02 (all 1-2Hz),
TP7 (all 1-2Hz),
N02 (all 1-2Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)

WEIGHTED
MAJORITY
VOTE

80.28 ± 9.48%

76.47%

83.78%

81.25%

TP4 (all 1-2 + 2-4Hz),
TP7 (all 1-2Hz),
N02 (all 1-2Hz),
NPZ (mid 2-4Hz),
NP3 (mid 2-4Hz)

The best performance of the above 7 classifiers with the feature-level fused Target
P4 was 84.51% and comes from the weighted majority vote combination of 5 electrodes,
TP4 (all 1-2 concatenated with 2-4Hz), TP7 (all 1-2Hz), N02 (all 1-2Hz), NPZ (mid 24Hz), and NP3 (mid 2-4Hz). This is the highest performance achieved by the 71 patient
cohort and matches the best performance of the 66 patient cohort. This result also reveals
that a feature-level and classifier fusion scheme may be able to achieve higher
performances than just a single feature-level or classifier fusion scheme.
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CHAPTER 7
CONCLUSIONS
7.1

SUMMARY OF ACCOMPLISHMENTS

The approach used in this study involved a multiresolution wavelet analysis of the
original time-domain ERP signals for feature extraction. Features from the resulting
1-2Hz, 2-4Hz, and 4-8Hz frequency subbands of the wavelet decomposition were used to
train MLP classifiers. Features were combined in feature-level fusion experiments and
classifiers trained on these features were combined in classifier fusion experiments. Their
performance capabilities were then tested in a leave-one-out cross validation scheme.
This study expands upon our previous studies by performing an analysis on the
recordings from all 19 available electrodes. Furthermore, recordings from both the target
and novel stimuli were analyzed. This analysis lead to the discovery of other informative
features. Of these features, the main focus was on those in the parietal and occipital
regions. AD is known to first show symptoms around the hippocampus, hence making
these surrounding regions prime candidates for informative features.
It has also been shown in this study that the novel recordings are informative, if
not more informative than the target recordings. Classifiers trained on features from the
novel recordings generally performed better than those trained on features from target
recordings. It was only when the target and novel features were combined that the best
performance of almost 85% was achieved.
In experiments prior to those performed in this study, that consisted of examining
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only the PZ, CZ, and FZ electrodes, it was thought that certain patients in our cohort were
troublesome to our algorithm. These "troublesome" patients had very poor classification
rates. The exclusion of these patients from the analysis resulted in higher performances.
However within this study, it was shown that it is not necessary to exclude those patients
and that our previous conclusions about them were incorrect. A performance equal in
success to that of using only 66 patients was achieved with all 71 patients. For this
reason, only the 71 patient cohort need be examined in continued efforts.
The metric with which we compared our performance to, was the reported overall
diagnostic accuracy of local physicians which was only 75%. Overall, our method has
achieved and surpassed this metric in performance. Comparatively, our algorithm's best
performance was almost 85%. Although this result was pleasing, the sensitivity (in Table
6.19) was only 79%, whereas it should be higher. On the other hand, the specificity and
positive predictive values were high. The positive predictive value (PPV) is the
probability that a person who has the disease yields a positive test result, so a high PPV is
very satisfactory (refer to Appendix A for formal definitions of positive predictive value,
sensitivity, and specificity).
The results achieved in this study are significant. It was shown that a
multiresolution wavelet analysis can extract meaningful features from ERP recordings.
This is true not only for the target stimuli recordings, but also for the novel stimuli
recordings. These features can then be used to train multilayer perceptron classifiers. A
combination of classifiers trained on different feature sets improved the generalization
performance and yielded the highest performance of this study. The approach used in this
study is a novel method that could be made readily available to local healthcare
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providers. It is method whose accuracy is comparable to the expertise of a
neurophysiologist and would be a valuable tool to have in addition to clinical evaluations.

7.2

SOURCES OF ERROR

The patients recruited for this study were diagnosed using clinical evaluation. As
mentioned previously, an evaluation at the local healthcare level has an estimated
accuracy of only 75%. The evaluation of the patients used in this study was performed by
an expert neurophysiologist. Their clinical evaluation is the current 'gold standard' with
an estimated positive predictive value of 90%, but currently there is no way for it to be
100% accurate. Despite this, the classification algorithms of this study were trained as if
the patient diagnoses were 100% correct. The original misdiagnoses of a test subject is a
potential source of error but less likely to occur because of the expertise of the diagnosis.
The only way to obtain a 100% accurate diagnosis is through an autopsy. Inclusion of a
postmortem analysis of the test subjects to obtain the true 'gold standard' would prevent
this error.
Other errors may lie within the classification algorithms. The free parameters for
the MLPs were based on those of our previous work. The error goal for all classifiers was
set to 0.01 and the number of hidden layer nodes was either 10 or 20 depending on the
number of features. These numbers have not been proved to be the optimal settings
despite their success in the past. The assumption of these parameters may also be a
potential source of error.
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7.3

RECOMMENDATIONS FOR FUTURE WORK

The use of all electrodes should be analyzed further. The extent of the experiments
performed in this study open the door to many possibilities. There were electrodes and
features combinations other than those of the parietal and occipital regions that performed
well. It would be logical and possibly beneficial to further pursue the value of this data.
The Daubechies 4 was the only wavelet used for analysis. Perhaps another wavelet
of a different family or even within the same family may be better suited for this type of
analysis. For example, Jacques et al. in [22] used the Daubechies 4 wavelet, but also used
a quadratic b-spline wavelet. The performance obtained in [22] when using the quadratic
b-spline wavelet was comparable to that of the Daubechies 4; hence, performing a
comparative analysis with a quadratic b-spline or another type of wavelet might be
informative.
The combination rules used in the experiments of this study were very basic.
Another combination rule such as decision templates, or competence-based classifier
selection or weighting as mentioned in Chapter 5, may render better results as more
informative features and classifiers are obtained. They have been used with some success
in the past and may be worth revisiting.
A multiresolution wavelet analysis has been the main feature extraction technique to
this point. Another more strategic feature extraction technique or feature selection
method may also be worth pursuing. The features in the 1-8Hz range have shown to be
informative. This feature range was analyzed in such a way to focus on the activity of the
P300 component. Perhaps analyzing the well-known delta and theta bands which fall in
this frequency range along with the alpha, beta, and gamma bands may be complimentary
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to our analysis. Maybe a different technique to extract these features such as bandpass
filtering may work and save computational resources. Feature selection techniques may
allow the most dominant features to be chosen. The performances obtained thus far may
be limited by the inclusion of redundant and non-informative features. A genetic
algorithm like that mentioned in [74] or an independent component analysis [78] may
extract the best features for this problem. These methods may also be a more strategic
approach than the trial and error method that has been used in this study and our previous
efforts.
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APPENDIX A
SENSITIVITY, SPECIFICITY, AND POSITIVE PREDICTIVE VALUE
_

I

Disease

II-

Present
-

-

Absent

--

Positive

Negative

Sensitivity - the probability that a symptom is present given that the person has the
disease.
A
Sensitivity -

A+C

Specificity - the probability that a symptom is not present given that the person does not
have the disease.
D
Specificity= D
B+D

Positive Predictive Value - the probability that a person has the disease given a positive
test result.
A
PPV=A
A+B
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APPENDIX B
ERP GRAPHS
The graphs included in this appendix are the overall average ERP for the probable AD
and cognitively normal cohorts from each electrode and from both target and novel
stimuli. In each figure, the top graph is from the target recordings and the bottom graph is

from the novel recordings. ERPs are often inverted when displayed. This usually makes it
easier to visualize the differences between the AD and normal signals.
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Figure B.1: Overall average ERPs from target (top) and novel (bottom) stimuli
from the C4 electrode.
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Figure B.2: Overall average ERPs from target (top) and novel (bottom) stimuli
from the FP1 electrode.
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Figure B.3: Overall average ERPs from target (top) and novel (bottom) stimuli
from the 01 electrode.
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Figure B.4: Overall average ERPs from target (top) and novel (bottom) stimuli
from the P8 electrode.
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Figure B.5: Overall average ERPs from target (top) and novel (bottom) stimuli
from the P4 electrode.
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Figure B.6: Overall average ERPs from target (top) and novel (bottom) stimuli
from the P7 electrode.
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Figure B.7: Overall average ERPs from target (top) and novel (bottom) stimuli
from the F4 electrode.
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Figure B.8: Overall average ERPs from target (top) and novel (bottom) stimuli
from the FZ electrode.
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Figure B.9: Overall average ERPs from target (top) and novel (bottom) stimuli
from the PZ electrode.
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Figure B. 10: Overall average ERPs from target (top) and novel (bottom) stimuli
from the P3 electrode.
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Figure B.11: Overall average ERPs from target (top) and novel (bottom) stimuli
from the F7 electrode.
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Figure B.12: Overall average ERPs from target (top) and novel (bottom) stimuli
from the T8 electrode.
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Figure B.13: Overall average ERPs from target (top) and novel (bottom) stimuli
from the CZ electrode.
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Figure B.14: Overall average ERPs from target (top) and novel (bottom) stimuli

from the F3 electrode.
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Figure B.15: Overall average ERPs from target (top) and novel (bottom) stimuli
from the 02 electrode.
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Figure B.16: Overall average ERPs from target (top) and novel (bottom) stimuli
from the FP2 electrode.
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Figure B.17: Overall average ERPs from target (top) and novel (bottom) stimuli
from the F8 electrode.
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Figure B.18: Overall average ERPs from target (top) and novel (bottom) stimuli
from the C3 electrode.
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Figure B.19: Overall average ERPs from target (top) and novel (bottom) stimuli
from the T7 electrode.
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APPENDIX C
EXTENDED RESULTS
The tables of results included in this appendix are the average of five leave-one-out trials
and the 95% confidence intervals from the classifier fusion experiments. The include all
combinations of the classifiers in the various experiments. Averages over 70% are bold.

116

Table C.1: Averages of 1 classifier each from the target/parietal recordings for 71 patients
(refer to Table 6.8).
Single Classifiers
1) P4 2-4Hz
61.41 ± 3.83%
2) PZ2-4Hz
62.25 ± 2.88%
3) P3 2-4Hz
61.41 ± 4.56%
4.) P4 1-2Hz
60.28 ± 4.53%
5) PZ 1-2Hz
60.28 ± 3.36%
62.25 ± 4.53%
6.) P7 1-2Hz
Combinations
1.)1 2 3 4 5 6 MV
65.35 ±3.18%
64.22 ±5.33%
PROD

Combinations
13.) 12 56 MV
64.51 ±2.28%
66.76 3.62%
PROD
65.92 ±3.79%
SUM
14.) 13 45 MV
63.10 ±5.45%
62.82 ± 2.00%
PROD
64.22 ± 4.72%
SUM
65.63 ± 4.39%
15.) 13 4 6MV
PROD
64.23 ± 6.38%
67.89 6.35%
SUM
16.) 13 5 6 MV
PROD

66.76 2.65%
65.92 ± 4.17%

66.48 ±3.13%
63.38 ±2.48%
66.48 ± 1.46%
65.35 ±1.57%
61.41 ± 6.61%
61.13 ±5.75%

SUM
2.) 123 4 5MV

65.35 ±4.21%
63.38 ±6.06%

PROD
SUM
3.) 1 2 3 4 6 MV
PROD

65.07 ± 2.28%
65.63 ± 4.56%
64.51 ±3.79%
64.79 ±4.79%

SUM
17.) 145 6MV
PROD
SUM
18.)2 34 5MV
PROD

SUM

65.35 ±2.00%

SUM

63.10 ± 5.45%

4.) 1 3 4 5 6 MV
PROD
SUM
5.) 2 3 4 5 6 MV

64.22 ±4.73%
64.51 ± 3.99%
66.76 ±5.04%
63.66 ±4.69%

PROD
SUM
6.) 124 5 6 MV

61.97 ±2.77%
66.48 ±3.13%
65.92 ±3.36%

PROD

66.48 ±2.59%

SUM

68.17 ±3.62%

7.) 1 2 3 5 6 MV
PROD
SUM
8.) 1 2 3 4 MV
PROD
SUM
9.) 1 2 3 5 MV
PROD
SUM
10.) 12 3 6 MV
PROD
SUM

63.94 ±3.41%
64.79 ±5.93%
65.92 ±3.13%
61.41 ±5.04%
65.07 ±4.53%
63.66 ±3.37%
62.82 ±4.22%
64.51 ± 5.30%
63.66 ±4.86%
63.94 ±2.93%
64.79 ±3.27%
64.23 ±5.04%

19.) 2 34 6 MV
PROD
SUM
20.) 2 4 56 MV
PROD
SUM
21.) 3 4 56 MV
PROD
SUM
22.) 23 56 MV
PROD
SUM
23.) 12 3MV

64.51 ±5.45%
63.10 ±4.85%
65.92 ± 6.47%
64.79 ±3.91%
65.64±2.00%
66.20 ±1.75%
63.66 ±1.46%
62.81 ±5.61%
64.51 ±2.28%
65.35 ±4.88%
63.94 ±3.63%
63.94 ± 2.93%
61.41 ± 3.18%

PROD

11.) 12 4 5 MV

64.79 ±4.46%

PROD

67.04 ±1.99%
68.17 ± 2.92%

SUM
24.) 12 4 MV
PROD
SUM
25.) 1 25 MV
PROD
SUM
26.) 1 26 MV
PROD
SUM
27.) 134 MV
PROD
SUM

SUM
12.) 1 24 6 MV
PROD
SUM

66.48 ±3.79%
66.20 ±4.46%
69.01 ± 2.47%
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Combinations
28.) 1 3 5 MV
PROD
SUM

62.25 ±3.36%
64.51± 5.85%
62.82 ± 3.84%

9.) 13 6MV

66.20 ±2.47%

PROD

65.07 ± 3.99%

SUM
30.) 14 5MV

66.48 ±1.46%
65.07 ±1.92%

PROD

66.20 ±2.76%

SUM

67.05 ± 0.96%

31.) 1 4 6 MV

63.10 ± 3.79%
64.79 ± 2.48%

PROD
SUM
32.) 156 MV

64.51 2.88%
63.94 ± 5.75%

33.) 2 3 4 MV

64.22 ± 3.62%
63.38 ± 5.39%
61.13 ± 5.33%

PROD
SUM
34.) 2 35 MV

62.82 5.33%
64.22 ± 5.47%
60.56 7.00%

PROD
SUM
35.) 2 3 6 MV
PROD
SUM
36.) 2 4 5 MV
PROD

62.82 ± 6.84%
61.69 ±5.45%
62.82 ± 5.74%
63.66 ± 3.99%
64.51 ±3.79%
65.63 ±5.04%
65.92 ± 3.36%

SUM
37.) 24 6MV

66.76 ±2.65%
64.51 ±4.85%

PROD

65.35 ±6.14%

SUM
38.) 25 6MV

65.07 ±3.37%
64.79 ±3.71%

64.79 5.39%

PROD

65.63 ±3.18%

61.97 ±2.77%
64.51± 1.46%
65.35 ± 2.92%
66.48 ±2.59%
63.38 ± 3.50%
65.64 ±2.00%
64.51± 3.36%
65.63 ± 4.72%
65.63 6.13%
65.35 ±4.39%
63.10 ± 1.46%
60.84 ± 6.82%
62.82 2.65%

SUM

64.51 ±3.59%

39.) 3 4 5 MV
PROD

60.56 ±4.28%
60.00 ± 6.95%
61.41 ± 7.48%

PROD

SUM

SUM
40.) 34 6 MV

60.28 ±5.30%

PROD
SUM

60.56 ± 5.93%
63.94 ± 2.00%

41.) 3 56 MV

60.28 ±4.53%

PROD
SUM
42.)4 5 6 MV
PROD
SUM

65.35 ± 6.26%
67.33 ±2.59%
64.79 ±2.14%
62.81 ± 5.47%
64.51 ± 3.13%

Table C.2: Averages of 3 classifier each from the target/parietal recordings for 71 patients
(refer to Table 6.9).
Single Classifiers
1) P4 2-4Hz
61.13 ± 2.92 %
2) PZ2-4Hz
57.46 + 3.79 %
3.) P3 2-4Hz
58.59 ± 5.04 %
4) P4 1-2Hz
62.82 ± 4.22 %
5.) PZ-2Hz
62.25 ± 2.88 %
6) P7 1-2Hz
63.10 ± 4.36 %
11.) P4 2-4Hz
63.94 ± 6.73 %
12.) PZ2-4Hz
60.28 ± 2.87 %
13.) P3 2-4Hz
63.38 ± 2.77 %
14.) P4 1-2Hz
60.84 ± 4.18 %
15.) PZ l-2Hz
63.10 ± 7.25 %
16.) P7 1-2Hz
60.84 ± 3.79 %
21.) P4 2-4Hz
61.97 ± 5.39 %
22) PZ2-4Hz
59.44 ± 4.53 %
23.) P3 2-4Hz
58.59 ± 5.88 %
24) P4 1-2Hz
60.85 ± 4.85 %
25.) PZ 1-2Hz
68.17 ± 3.62 %
26) P7 1-2Hz
63.66 ± 2.88 %

I

Combinations
1.) 123456MV
66.76 ± 4.21 %
67.33 ± 1.91 %
PROD
68.45 ± 3.17 %
SUM
2.) 1 2 3 4 5 MV
66.48 ± 3.99 %
66.76 ± 3.17 %
PROD
67.61 ± 1.74 %
SUM
3.)12346MV
69.58 ± 3.62 %
67.89 ± 1.46 %
PROD
69.01 ± 1.74 %
SUM
4.) 13 4 5 6 MV
67.32 ± 2.87 %
65.64 ± 2.65 %
PROD
68.45 ± 1.99 %
SUM
66.20 ± 1.75 %
5.) 2 3 4 5 6 MV
66.48 ± 2.59 %
PROD
66.76 ± 2.65 %
SUM
6.)12 4 5 6 MV
68.17 ± 3.17 %
69.01 ± 2.14 %
PROD
69.01 ± 2.76 %
SUM
65.63 ± 3.63 %
7.) 1 2 3 5 6 MV
69.30 ± 2.87 %
PROD
68.45 + 3.83 %
SUM
67.32 ± 2.28 %
8.) 12 3 4 MV
PROD
64.79 ± 2.77 %
64.79 ± 3.50 %
SUM
66.48 ± 2.28 %
9.) 1 2 3 5 MV
65.64 ± 1.57 %
PROD
64.79 ± 2.77 %
SUM
68.45 ± 3.62 %
10.) 1 2 3 6 MV
66.76 ± 1.99 %
PROD
69.01 ± 2.47 %
SUM

Combinations
11.) 1 2 4 5 MV 66.20 + 2.47 %
68.45 ± 1.56 %
PROD
68.17 ± 2.92 %
SUM
12.) 1 2 4 6 MV 67.89 ± 1.46 %
69.30 ± 4.17 %
PROD
69.29 ± 1.46 %
SUM
13.) 1 2 5 6 MV 65.64 2.65 %
PROD
69.01 ± 1.23 %
68.73 ± 1.91 %
SUM
14.) 13 4 5 MV 66.76 ± 4.56 %
65.07 ± 1.92 %
PROD
65.64 ± 3.41 %
SUM
15.)13 4 6 MV 69.02 ± 5.67 %
65.63 ± 3.18 %
PROD
68.45 ± 5.04 %
SUM
16.) 13 5 6 MV 69.30 ± 4.52 %
69.01 ± 2.76 %
PROD
69.01 ± 4.10 %
SUM
17.) 14 5 6 MV 67.61 ± 3.03 %
69.01 ± 2.14 %
PROD
69.29 ± 1.46 %
SUM
18.) 2 3 4 5 MV 66.20 ± 2.14 %
64.23 ± 3.63 %
PROD
65.35 ± 2.00 %
SUM
19.) 2 3 4 6 MV 67.61 ± 4.79 %
65.92 ± 2.59 %
PROD
67.33 ± 3.36 %
SUM
20.)2 4 5 6 MV 68.17 ± 2.92 %
68.17 ± 0.95 %
PROD
69.58 ± 3.62 %
SUM
21.) 3 4 5 6 MV 68.45 ± 3.83 %
65.64 ± 2.65 %
PROD
67.61 ± 2.14 %
SUM
22.)2 3 5 6 MV 66.48 ± 4.53 %
67.33 ± 4.35 %
PROD
66.20 ± 3.27 %
SUM
65.35 ± 3.18 %
23.) 12 3 MV
66.48 ± 3.13 %
PROD
66.20 ± 2.14 %
SUM
24.) 1 2 4 MV
PROD
SUM
25.) 1 2 5 MV
PROD

63.10
65.92
64.22
65.07
68.45

±
±
±
±

3.37
2.87
4.21
3.99
3.62

%
%
%
%
%

SUM
26.) 12 6 MV
PROD
SUM

66.48
65.92
66.76
68.45

± 3.79
± 5.16
± 3.41
± 2.92

%
%
%
%

118

Combinations
27.) 134MV 66.20 ± 2.76 %
64.51 ± 4.36 %
PROD
66.20 ± 2.14 %
SUM
28.) 13 5 MV 67.04 ± 4.72 %
PROD
66.48 ± 2.28 %
SUM
67.89 ± 2.87 %
29.) 136MV 68.17 ± 1.56 %
PROD
66.20 ± 1.75 %
SUM
69.58 ± 2.34 %
30.)145MV 68.17 ± 3.41 %
PROD
68.45 ± 1.56 %
SUM
68.17 ± 4.02 %
31.) 146MV 69.02 ± 5.10 %
PROD
69.86 ± 3.41 %
68.73 ± 2.28 %
SUM
32.) 15 6 MV 68.45 ± 5.88 %
PROD
71.27 ± 0.96 %
SUM
69.30 ± 2.28 %
33.) 2 3 4 MV 64.79 ± 3.91 %
64.22 ± 3.41 %
PROD
66.20 ± 4.79 %
SUM
34.) 2 3 5 MV 66.48 ± 4.35 %
64.51 ± 2.88 %
PROD
SUM
65.63 ± 2.92 %
35.) 2 3 6 MV 65.92 ± 4.53 %
PROD
66.76 ± 3.83 %
65.63 ± 3.41 %
SUM
36.) 2 4 5 MV 65.63 ± 3.18 %
PROD
64.51 ± 3.13 %
64.51 ± 3.99 %
SUM
37.) 246 MV 65.35 ± 6.25 %
69.01 ± 2.14 %
PROD
69.86 ± 3.63 %
SUM
38.) 2 5 6 MV 67.89 ± 3.13 %
PROD
70.42 ± 1.75 %
68.45 ± 3.62 %
SUM
39.) 3 4 5 MV 63.38 ± 4.79 %
63.38 ± 3.27 %
PROD
63.38 ± 3.27 %
SUM
40.) 3 4 6 MV 65.63 ± 4.21 %
65.92 ± 4.18 %
PROD
66.48 ± 3.79 %
SUM
41.) 3 5 6 MV 67.61 ± 5.67 %
PROD
66.48 ± 2.59 %
68.17 ± 3.83 %
SUM
42.) 4 5 6 MV 68.73 ± 3.99 %
66.20 ± 3.27 %
PROD
SUM
67.61 ± 1.74 %

Table C.3: Averages of 1 classifier each from the target/parietal recordings for 66 patients
(refer to Table 6.10).

1)
2)
3)
4)
5.)
6)

Single Classifiers
P4 2-4Hz
65.63 ± 4.37 %
72.68 ± 1.99 %
PZ2-4Hz
65.63 ± 8.14 %
P3 2-4Hz
61.69 ± 4.84 %
P4 1-2Hz
62.82 ± 4.87 %
PZ 1-2Hz
60.00 ± 0.96 %
P7 1-2Hz

Combinations
1.) 12 3 4 5 6 MV 72.68
70.99
PROD
73.52
SUM
2.) 12 3 4 5 MV
72.39
71.83
PROD
72.68
SUM
3.) 12 3 4 6 MV
73.52
72.11
PROD
72.68
SUM
4.)13 4 5 6 MV
72.11
69.58
PROD
72.68
SUM
71.27
5.) 2 3456MV
69.58
PROD
70.14
SUM
72.96
6.) 12 4 5 6 MV
72.11
PROD
73.24
SUM
74.08
7.)12 3 5 6 MV
72.68
PROD
72.40
SUM
72.68
8.) 12 3 4 MV
72.96
PROD
73.52
SUM
74.93
9.) 12 3 5 MV
72.96
PROD
72.96
SUM
74.08
10.) 12 3 6 MV
72.67
PROD
73.24
SUM
72.68
11.) 12 4 5 MV
72.39
PROD
73.52
SUM
70.99
12.) 12 4 6 MV
70.99
PROD
72.11
SUM

± 3.17 %
± 2.91 %
± 335 %
± 1.99 %
± 1.74 %
± 2.65 %
± 2.27 %
± 3.78 %
- 2.92 %
± 3.12 %
± 1.98 %
=. 1.56 %
± 1.99 %
± 4.37 %
± 2.27 %
22.59 %
± 1.46 %
± 2.76 %
± 3.81 %
± 3.17 %
± 4.54 %
- 3.17 %
f 2.87 %
± 2.27 %
± 5.14 %
± 4.16 %
= 5.56 %
± 4.01 %
± 4.01 %
± 4.09 %
± 2.92 %
- 3.82 %
= 434 %
± 4.01 %
± 2.64 %
± 1.46 %

Combinations
13.)1256MV 69.58 ± 6.59
72.67 ± 4.54
PROD
70.70 ± 3.97
SUM
14.) 1 3 4 5 MV 70.70 ± 2.86
69.86 ± 3.40
PROD
72.68 - 4.02
SUM
15.)1346MV 70.70 - 4.16
67.89 ± 3.97
PROD
70.70 ± 4.51
SUM
16.)1356MV 69.86 ± 6.59
69.30 + 4.67
PROD
71.55 ± 434
SUM
17.)1456MV 67.89 ± 3.97
70.14 ± 2.86
PROD
69.86 ± 1.56
SUM
18.)2 345 MV 71.27 f 3.17
69.86 ± 3.40
PROD
70.42 = 3.26
SUM
19.)2 3 4 6 MV 70.99 ± 5.17
70.14 ± 4.83
PROD
70.70 ± 3.57
SUM
20.)2 4 5 6 MV 67.89 ± 3.77
70.14 ± 4.67
PROD
69.58 ± 2.64
SUM
21.)3 4 5 6 MV 67.04 ± 5.17
68.45 ± 4.01
PROD
67.32 ± 2.86
SUM
22.) 2 3 5 6 MV 69.86 ± 6.81
71.55 ± 6.91
PROD
69.86 ± 4.54
SUM
73.52 ± 4.51
23.) 12 3 MV
73.24 ± 3.26
PROD
72.96 - 2.87
SUM
7239 ± 234
24.) 12 4 MV
71.27 ± 3.61
PROD
7239 ± 2.92
SUM
25.)12 5 MV
69.02 ± 5.91
72.68 ± 4.02
PROD
69.02 ± 4.93
SUM
68.73 ± 4.51
26.)12 6 MV
4.83
71.55
PROD
69.86 ± 3.16
SUM
68.17 ± 6.36
27.) 1 3 4 MV
67.89 ± 3.11
PROD
69.58 ± 3.82
SUM
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%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
28.)135MV 68.73 ± 4.83
71.27 ± 5.98
PROD
70.42 ± 3.48
SUM
29.) 136MV 68.45 ± 5.73
70.14 ± 4.83
PROD
70.71 ± 5.56
SUM
30.)145MV 68.45 ± 3.61
67.89 ± 0.77
PROD
68.45 ± 1.98
SUM
31.)146MV 67.89 ± 2.27
67.89 ± 6.09
PROD
67.89 ± 6.68
SUM
32.)15 6 MV 69.58 ± 2.64
69.30 ± 4.67
PROD
68.73 ± 2.27
SUM
33.) 2 3 4 MV 72.11 + 3.35
69.86 ± 3.61
PROD
71.27 ± 1.99
SUM
34.)2 3 5 MV 71.27 ± 4.19
71.55 - 4.99
PROD
69.86 ± 5.02
SUM
35.) 2 3 6 MV 69.86 ± 8.23
72.11 ± 4.99
PROD
4.51
71.55
SUM
36.)2 4 5 MV 65.64 ± 1.56
69.02 ± 3.48
PROD
67.33 ± 1.91
SUM
37.) 2 4 6 MV 70.14 ± 3.12
69.01 ± 1.23
PROD
70.70 - 3.78
SUM
38.) 2 5 6 MV 72.68 - 2.65
71.83 ± 3.70
PROD
72.96 -: 3.97
SUM
39.)3 4 5 MV 65.92 ± 3.35
66.20 ± 4.09
PROD
66.20 ± 3.69
SUM
40.)3 4 6 MV 66.20 ± 7.49
62.82 ± 4.37
PROD
66.48 ± 4.16
SUM
41.) 3 5 6 MV 65.35 ± 6.71
67.89 ± 7.23
PROD
67.32 ± 5.96
SUM
42.)456MV 65.64 ± 1.99
63.66 ± 2.27
PROD
64.51 ± 1.46
SUM

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Table C.4: Averages of 3 classifier each from the target/parietal recordings for 66 patients
(refer to Table 6.11).
Single Classifiers
66.67 ± 5.79 %
1.) P4 2-4Hz
70.00 ± 3.62 %
2.) PZ2-4Hz
61.21 ± 1.68 %
3.) P3 2-4Hz
68.79 ± 5.89 %
4) P4 1-2Hz
66.06 ± 4.33 %
5.) PZ 1-2Hz
60.30 ± 8.76 %
6.) P7 1-2Hz
64.55 ± 6.99 %
11) P4 2-4Hz
67.58 ± 2.85 %
12) PZ2-4Hz
63.03 ± 8.78 %
13.) P3 2-4Hz
66.97 ± 6.15 %
14.) P4 1-2Hz
67.27 ± 3.90 %
15.) PZ 1-2Hz
62.43 ± 4.29 %
16.) P7 1-2Hz
68.49 ± 8.96 %
21.) P4 2-4Hz
66.36 ± 4.87 %
22) PZ2-4Hz
63.64 ± 5.64 %
23.) P3 2-4Hz
67.27 ± 1.68 %
24) P4 1-2Hz
67.58 ± 3.42 %
25.) PZ 1-2Hz
64.24 ± 3.66 %
26) P7 1-2Hz
Combinations
1.) 1 2 3 4 5 6MV 73.64
75.46
PROD
74.85
SUM
73.33
2.) 1 2 3 4 5 MV
75.45
PROD
75.15
SUM
72.73
3.) 12 3 4 6 MV
75.15
PROD
75.76
SUM
73.33
4.) 13 4 5 6 MV
72.42
PROD
73.64
SUM
72.73
5.)2 3 4 5 6 MV
72.12
PROD
74.85
SUM
74.55
6.)12 4 5 6 MV
75.45
PROD
75.46
SUM
73.64
7.) 12 3 5 6 MV
73.03
PROD
75.76
SUM
71.21
8.)12 3 4 MV
71.21
PROD
72.42
SUM
69.39
9.) 12 3 5 MV
71.21
PROD
69.70
SUM
70.00
10.) 12 3 6 MV
70.61
PROD
71.51
SUM

± 3.90 %
± 3.37 %
± 2.85 %
± 5.08 %
± 5.86 %
± 5.58 %
± 3.99 %
± 2.14 %
± 3.26 %
± 4.53 %
± 1.57 %
± 2.85 %
± 4.61 %
± 2.52 %
± 2.85 %
± 2.45 %
± 1.57 %
± 2.79 %
± 5.89 %
± 1.57 %
± 2.97 %
± 2.66 %
± 2.97 %
± 4.08 %
± 3.62 %
± 4.61 %
± 2.97 %
± 3.37 %
± 1.68 %
± 3.37 %

Combinations
11.) 12 4 5 MV 74.55 ± 1.57 %
73.64 ± 1.03 %
PROD
74.85 ± 1.03 %
SUM
12.)1246MV 72.73 ± 1.88 %
73.03 ± 1.57 %
PROD
75.15 ± 1.03 %
SUM
13.)12 5 6 MV 74.55 ± 3.09 %
75.45 ± 1.57 %
PROD
74.55 ± 2.45 %
SUM
14.)13 4 5 MV 70.91 ± 3.62 %
71.52 ± 3.62 %
PROD
73.94 ± 1.57 %
SUM
15.) 13 4 6 MV 71.21 ± 5.15 %
71.82 ± 1.68 %
PROD
73.03 ± 2.45 %
SUM
16.)1356MV 70.30 ± 2.86 %
73.33 ± 3.42 %
PROD
74.24 ± 1.33 %
SUM
17.) 14 5 6 MV 73.94 + 2.45 %
73.64 + 2.15 %
PROD
73.64 ± 2.15 %
SUM
18.)2 3 4 5 MV 69.09 ± 3.15 %
72.42 ± 3.09 %
PROD
72.12 ± 3.42 %
SUM
19.) 2 3 4 6MV 70.30 ± 2.15 %
71.21 ± 1.33 %
PROD
72.42 ± 3.09 %
SUM
20.) 2 4 5 6 MV 76.36 ± 3.15 %
72.42 ± 3.62 %
PROD
76.06 ± 2.45 %
SUM
21.)3 4 5 6 MV 71.51 ± 3.36 %
71.82 ± 2.14 %
PROD
73.64 ± 1.03 %
SUM
22.) 2 3 5 6 MV 71.21 ± 3.76 %
73.64 ± 2.85 %
PROD
73.94 ± 1.57 %
SUM
68.18 ± 2.30 %
23.)12 3 MV
69.70 ± 4.80 %
PROD
68.79 ± 2.85 %
SUM
73.33 ± 2.52 %
24.) 12 4 MV
71.21 ± 2.30 %
PROD
73.94 ± 2.06 %
SUM
73.03 ± 4.49 %
25.) 12 5 MV
74.55 ± 2.45 %
PROD
74.24 ± 2.31 %
SUM
74.24 ± 3.52 %
26.) 12 6 MV
73.33 ± 1.68 %
PROD
73.94 ± 2.45 %
SUM
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Combinations
27.)134MV 70.61 ± 3.66 %
68.79 ± 1.68 %
PROD
71.52 ± 4.87 %
SUM
28.) 13 5 MV 70.91 ± 5.22 %
70.91 ± 5.22 %
PROD
70.30 ± 4.72 %
SUM
29.) 13 6 MV 70.00 ± 3.09 %
71.21 ± 2.97 %
PROD
70.91 ± 3.09 %
SUM
30.)145MV 74.24 ± 3.76 %
72.73 ± 3.99 %
PROD
73.03 ± 3.86 %
SUM
31.)146MV 71.82 ± 3.90 %
72.42 ± 3.09 %
PROD
72.42 ± 2.45 %
SUM
32.) 156MV 73.03 ± 3.09 %
73.94 ± 2.45 %
PROD
71.52 ± 4.87 %
SUM
33.) 2 3 4 MV 69.40 ± 2.79 %
71.52 ± 3.62 %
PROD
70.30 ± 3.41 %
SUM
34.)2 3 5 MV 71.21 ± 4.61 %
72.73 ± 4.80 %
PROD
70.91 ± 5.22 %
SUM
35.)236MV 68.79 ± 1.68 %
70.30 ± 2.15 %
PROD
69.09 ± 3.90 %
SUM
36.) 2 4 5 MV 72.73 ± 3.76 %
72.12 ± 2.85 %
PROD
72.73 ± 2.66 %
SUM
37.)2 4 6 MV 73.64 ± 3.41 %
72.73 ± 3.26 %
PROD
73.94 ± 1.57 %
SUM
38.)2 5 6 MV 73.33 ± 3.41 %
75.15 ± 2.52 %
PROD
74.85 ± 2.85 %
SUM
39.)3 4 5 MV 70.00 ± 2.79 %
70.30 ± 4.33 %
PROD
70.30 ± 3.66 %
SUM
40.)346MV 66.97 ± 3.09 %
69.70 ± 1.88 %
PROD
69.40 ± 3.37 %
SUM
41.)356MV 68.79 ± 4.33 %
72.73 ± 2.66 %
PROD
71.82 ± 2.85 %
SUM
42.)4 5 6 MV 72.73 ± 2.66 %
72.73 ± 2.30 %
PROD
73.94 ± 2.06 %
SUM

Table C.5: Averages of 1 classifier each from the novel/parietal recordings for 71 patients
(refer to Table 6.12).

1.)
2.)
3)
4.)
5)
6.)

Single Classifiers
P4 2-4Hz
65.63 ± 4.39 %
72.68 ± 2.00 %
PZ2-4Hz
65.63 ± 8.17 %
P3 2-4Hz
P4 1-2Hz
61.69 ± 4.85 %
62.82 ± 4.89 %
PZ 1-2Hz
P7 1-2Hz
60.00 ± 0.96 %

Combinations
1.) 123456MV 72.68
70.99
PROD
73.52
SUM
7239
2.)12 3 4 5 MV
71.83
PROD
72.68
SUM
73.52
3.)12 3 4 6 MV
72.11
PROD
72.68
SUM
4.)13 4 5 6 MV
72.11
69.58
PROD
72.68
SUM
71.27
5.) 2 3456MV
69.58
PROD
70.14
SUM
72.96
6.)12456MV
72.11
PROD
73.24
SUM
74.08
7.)12 3 5 6 MV
72.68
PROD
72.40
SUM
72.68
8.)12 3 4 MV
72.96
PROD
73.52
SUM
74.93
9.)12 3 5 MV
72.96
PROD
72.96
SUM
74.08
10.) 12 3 6 MV
72.67
PROD
73.24
SUM
72.68
11.) 12 4 5 MV
7239
PROD
73.52
SUM
70.99
12.) 12 4 6 MV
70.99
PROD
72.11
SUM

±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±

3.18
2.92
336
2.00
1.75
2.65
2.28
3.79
2.93
3.13
1.99
1.57
2.00
4.39
2.28
2.60
1.46
2.77
3.83
3.18
4.56
3.18
2.88
2.28
5.16
4.18
5.58
4.03
4.03
4.10
2.93
3.84
436
4.03
2.65
1.46

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
13.)1256MV 69.58 ±
72.67 ±
PROD
70.70 ±
SUM
14.)1345MV 70.70 ±
PROD
69.86 ±
72.68 4
SUM
15.) 1 3 4 6MV 70.70 ±
PROD
67.89 ±
70.70 ±
SUM
16.)1356MV 69.86 ±
69.30 ±
PROD
SUM
71.55 ±
17.)1456MV 67.89 ±
70.14 ±
PROD
69.86 ±
SUM
18.)2 3 4 5 MV 71.27 ±
69.86 ±
PROD
70.42 ±
SUM
19.) 2 346 MV 70.99
PROD
70.14 ±
70.70 ±
SUM
20.) 2456MV 67.89 ±
PROD
70.14 ±
SUM
69.58 ±
21.) 3456MV 67.04 ±
68.45 ±
PROD
67.32 ±
SUM
22.) 2356MV 69.86 ±
PROD
71.55 ±
69.86 ±
SUM
23.) 123MV 73.52 ±
73.24 ±
PROD
SUM
72.96 ±
24.)124MV 7239 ±
71.27 ±
PROD
7239 ±
SUM
25.)12 5 MV
69.02 ±
72.68 ±
PROD
69.02 ±
SUM
26.)12 6 MV
68.73 ±
PROD
71.55 ±
69.86 ±
SUM
27.) 13 4 MV 68.17 ±
PROD
67.89 ±
69.58 ±
SUM
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6.61
4.56
3.99
2.87
3.41
4.03
4.18
3.99
4.53
6.61
4.69
4.35
3.99
2.87
1.57
3.18
3.41
3.27
5.19
4.85
3.58
3.79
4.69
2.65
5.19
4.02
2.87
6.84
6.93
4.56
4.53
3.27
2.88
2.35
3.63
2.93
5.93
4.03
4.94
4.53
4.85
3.17
6.38
3.13
3.83

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
28.) 13 5 MV
68.73 ±
71.27 ±
PROD
70.42 ±
SUM
29.)13 6 MV 68.45 ±
70.14 ±
PROD
70.71 ±
SUM
30.) 145MV 68.45 ±
67.89 ±
PROD
68.45 ±
SUM
31.) 1 4 6 MV 67.89 ±
67.89 ±
PROD
SUM
67.89 ±
32.) 1 5 6 MV 69.58 ±
69.30 ±
PROD
68.73
SUM
33.) 2 3 4 MV 72.11
69.86 ±
PROD
71.27 ±
SUM
34.)2 3 5 MV 71.27 ±
71.55 ±
PROD
69.86 ±
SUM
35.) 2 3 6 MV 69.86 ±
PROD
72.11 ±
71.55 ±
SUM
36.)2 4 5 MV 65.64 ±
69.02 ±
PROD
67.33 ±
SUM
37.)2 4 6 MV 70.14 ±
69.01 ±
PROD
70.70 ±
SUM
38.)2 5 6 MV 72.68 ±
71.83 ±
PROD
72.96 ±
SUM
39.)3 4 5 MV 65.92 ±
66.20 ±
PROD
66.20 ±
SUM
40.)3 4 6 MV 66.20 ±
62.82 ±
PROD
66.48 ±
SUM
41.) 3 5 6 MV 65.35 ±
67.89 ±
PROD
67.32 ±
SUM
42.)4 5 6 MV 65.64 ±
63.66
PROD
64.51 ±
SUM

4.85
6.01
3.50
5.75
4.85
5.58
3.62
0.78
1.99
2.28
6.11
6.71
2.65
4.69
2.28
3.36
3.63
2.00
4.21
5.01
5.04
8.26
5.00
4.52
1.57
3.49
1.91
3.13
1.23
3.79
2.65
3.71
3.99
3.36
4.10
3.71
7.52
4.39
4.17
6.73
7.25
5.98
2.00
2.28
1.46

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Table C.6: Averages of 3 classifiers each from the novel/parietal recordings for 71

patients (refer to Table 6.13).
Single Cassifiers
65.07 ± 6.93 %
1) P4 2-4H
70.42 ± 5.93 %
2.) PZ2-4Hz
67.89 ± 228 %
3) P3 2-4Hz
64.79 ± 6.05 %
4.) P4 1-2Hz
5.) PZl-2Hz
61.13 ± 5.88 %
6.) P71-2Hz
55.49 ± 265 %
67.32 ± 287 %
11.) P42-4Hz
73.52 ± 1.92 %
12.) PZ2-4Hz
69.58 ± 5.47 %
13) P3 2-4Hz
61.41 ± 421 %
14.) P4 1-2kH
59.44 ± 228 %
15.) PZ -2Hz
56.34 ± 6.06 %
16.)P71-2Hz
63.38 ± 5.39 %
21) P4 2-41
72.40 ± 4.56 %
22) PZ2-4E
69.29 + 3.36 %
23.) P3 2-4H
24.) P4 1-2Hz
64.79 ± 3.27 %
6282 ± 403 %
25.) PZ1-2Hz
58.59 ± 421 %
26.) P7 1-2Hz
Coniinations
1.)123456MV 72.68
72.96
PROD
73.52
SUM
2.)12345MV
73.24
73.24
PROD
74.93
SUM
7239
3.)12 3 4 6 MV
72.67
PROD
73.80
SUM
71.83
4.)13456MV
70.99
PROD
72.68
SUM
71.83
5.)23456MV
70.99
PROD
71.55
SUM
71.27
6.)12456MV
72.11
PROD
71.55
SUM
70.99
7.)12356MV
72.96
PROD
72.11
SUM
72.68
8.)1234MV
72.11
PROD
72.96
SUM
72.96
9.)123 5MV
72.68
PROD
7239
SUM
72.96
10.) 12 3 6 MV
73.80
PROD
72.96
SUM

±
±
±
±

2.93 %
336 %
0.78 %
1.75 %
3.50 %
± 228 %
± 5.04 %
± 4.03 %
± 3.63 %
± 3.03 %
± 4.73 %
± 2.93 %
± 2.14 %
± 3.41 %
± 228 %
± 2.00 %
± 337 %
± 228 %
± 3.63 %
± 3.79 %
3.59 %
± 3.18 %
± 3.79 %
± 1.92 %
± 3.13 %
± 0.96 %
± 3.41 %
± 4.85 %
± 439 %
± 4.18 %

Conbinations
11.) 12 4 5 MV 73.24 ± 1.75 %
7324 ± 2.14 %
PROD
73.52 2.28 %
SUM
12)1246MV 70.42 ± 2.47 %
PROD
72.11 ± 1.92 %
SUM
71.27 ± 2.93 %
13.)12 5 6 MV 71.83 ± 2.77 %
PROD
71.83 ± 2.48 %
71.83 ± 3.27 %
SUM
14.) 13 4 5 MV 73.52 ± 3.13 %
71.83 ± 2.48 %
PROD
72.96 ± 435 %
SUM
15.)134 6 MV 71.27 ± 3.63 %
71.55 3.59 %
PROD
71.83 ± 3.50 %
SUM
5.04 %
16.) 13 5 6 MV 71.27
70.70 ± 2.28 %
PROD
72.11 ± 2.28 %
SUM
17.)1456MV 70.70 ± 1.46 %
71.83 ± 1.24 %
PROD
0.78 %
71.55
SUM
18.) 2 345MV 70.70 ± 336 %
70.14 ± 2.28 %
PROD
71.55 ± 2.28 %
SUM
2.14 %
19.) 2346MV 73.24
74.08 ± 2.65 %
PROD
73.52 3.99 %
SUM
20.)2456MV 70.14 ± 0.78 %
72.11 ± 2.88 %
PROD
70.14 ± 2.28 %
SUM
21.) 3 456MV 70.70 ± 336 %
7239 ± 3.18 %
PROD
71.83 ± 1.75 %
SUM
22)2356MV 73.52 ± 3.13 %
7437 ± 2.59 %
PROD
71.83 ± 4.11 %
SUM
73.52 ± 3.13 %
23.)12 3 MV
72.68 ± 235 %
PROD
SUM
7239 ± 2.65 %
71.83 ± 2.48 %
24.)124MV
73.24 ± 2.14 %
PROD
73.52 ± 2.88 %
SUM
25.) 12 5 MV
70.14
2.59 %
71.83 ± 2.77 %
PROD
70.99 ± 3.41 %
SUM
69.86
0.96 %
26.)126MV
70.70 ± 1.46 %
PROD
SUM
70.70 ± 1.46 %
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Combinations
27.) 134MV 71.83 ±
70.42 ±
PROD
7239 ±
SUM
8.)13 5 MV 71.27
71.55 ±
PROD

1.75
3.27
3.63
2.92
0.78

%
%
%
%
%

SUM

7127 ± 3.83 %

29.)136MV
PROD
SUM
30.)145MV
PROD
SUM
31.)146MV
PROD
SUM
32)156 MV
PROD
SUM
33.)234MV
PROD
SUM
34.)23 5MV
PROD

72.11
71.83
70.42
69.58
70.42
69.01
70.70
7239
72.11
67.32
70.42
67.89
7437
73.52
73.80
74.65
7437

SUM

72.96

35.)23 6MV
PROD
SUM
36.)245MV
PROD
SUM
37.)246MV
PROD
SUM
38.) 2 5 6 MV
PROD
SUM
39.)345MV
PROD
SUM
40.)346MV
PROD
SUM
41.)356MV
PROD
SUM
42) 4 5 6 MV

75.49
76.90
74.65
69.01
70.70
68.45
73.52
73.80
73.80
71.83
70.70
71.27
69.58
70.99
70.14
72.67
71.55
7127
71.55
70.42
68.17
67.04

PROD

70.14 ± 3.99 %

SUM

67.61 ± 4.28 %

2.88
3.91
2.76
3.41
3.03
5.39
1.92
3.63
2.88
2.87
± 2.47
± 2.28
± 4.18
336
± 4.03
± 1.24
± 2.28

±
±
±
±
±
±
±
±
±

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

3.59 %

± 4.56
± 3.41
± 2.47
+ 1.74
± 1.46
± 2.92
± 2.28
± 2.92
± 2.00
± 1.24
± 1.92
± 3.18
+ 2.34
± 3.63
± 336
± 4.89
± 3.79
± 3.83
± 6.23
± 1.24
± 1.99
± 3.18

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Table C.7: Averages of 1 classifiers each from the novel/parietal recordings for 66
patients (refer to Table 6.14).

Single Classifiers
68.18 ± 4.41 %
1.) P4 2-4Hz
69.70 ± 3.26 %
2.) PZ2-4Hz
65.15 ± 4.97 %
3.) P3 2-4Hz
66.06 ± 5.74 %
4) P4 1-2Hz
5.) PZ -2Hz
69.39 ± 1.57 %
6.) P71-2Hz
62.12 ± 6.65 %

Combinations
1.)123456MV 74.85
7636
PROD
76.67
SUM
75.15
2.)12 3 4 5 MV
76.06
PROD
75.76
SUM
73.03
3.)12346MV
75.76
PROD
75.15
SUM
73.94
4.)13 4 5 6 MV
76.97
PROD
74.55
SUM
75.76
5.) 2 3456MV
76.97
PROD
75.76
SUM
75.15
6.)12456MV
75.76
PROD
77.57
SUM
73.03
7.)123 56MV
74.54
PROD
73.94
SUM
72.12
8.)12 3 4 MV
76.06
PROD
74.24
SUM
7333
9.)1235MV
76.67
PROD
74.54
SUM
72.42
10.) 12 3 6 MV
72.73
PROD
73.94
SUM
7636
11.) 12 4 5 MV
74.85
PROD
76.06
SUM
73.94
12.) 12 4 6 MV
74.85
PROD
73.94
SUM

±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±

5.08
3.42
4.33
4.72
3.62
4.80
4.69
230
3.90
6.70
3.85
6.96
4.61
336
3.76
2.85
4.80
2.79
2.79
336
2.45
3.67
4.29
1.88
3.15
5.73
2.79
3.62
133
3.62
3.15
4.12
3.09
3.62
7.48
3.86

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
13.)12 5 6 MV 7333 ±
72.73 ±
PROD
7333 ±
SUM
14.)13 4 5 MV 72.12 ±
74.85 ±
PROD
7636 ±
SUM
15.)134 6 MV 72.12 ±
73.64 ±
PROD
75.76 ±
SUM
16.)1356MV 7333 ±
75.15 ±
PROD
75.15 ±
SUM
17.)1456MV 76.67 ±
75.45 ±
PROD
75.45 ±
SUM
18.)2 345 MV 76.06 ±
75.76 ±
PROD
76.06 ±
SUM
19.) 2 3 4 6 MV 7333 ±
75.76 ±
PROD

2.15
2.66
2.85
4.72
5.58
4.90
3.15
2.15
4.41
2.85
3.15
3.15
2.85
2.45
3.09
3.36
2.97
2.06
3.66
1.88

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

SUM

74.55 ± 4.87 %

20.) 2 4 5 6 MV
PROD
SUM
21.) 3 4 5 6 MV
PROD
SUM
22.) 2 3 5 6 MV
PROD
SUM
23.)12 3 MV
PROD
SUM
24.)124MV
PROD
SUM
25.) 125 MV
PROD
SUM
26.) 12 6 MV
PROD
SUM
27.)134MV
PROD
SUM

72.43
74.24
74.54
7636
7636
76.06
71.82
7333
72.12
72.42
73.64
72.73
7333
74.55
74.24
73.94
71.82
73.64
70.60
70.91
71.21
70.00
74.24
71.51
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±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±

2.06
1.33
0.84
5.08
4.33
4.87
2.14
4.72
3.90
3.09
2.15
2.31
2.85
4.87
5.15
2.79
4.90
2.15
3.15
4.87
6.24
5.70
2.31
5.05

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
8.) 135MV 71.21 ± 3.52 %
75.15 ± 6.04 %
?ROD
71.82 ± 2.14 %
;UM
9.)13 6 MV 72.12 ± 5.89 %
72.73 ± 230 %
PROD
72.73 ± 4.61 %
sUM
30.)14 5 MV 74.24 ± 3.52 %
73.94 ± 1.57 %
PROD
74.85 ± 2.85 %
sUM
31.)146MV 69.70 ± 2.97 %
74.24 ± 6.91 %
PROD
72.73 ± 532 %
SUM
32.) 15 6 MV 70.91 ± 2.79 %
72.73 ± 3.52 %
PROD
72.12 ± 1.68 %
SUM
33.) 2 3 4MV 7333 ± 4.53 %
7636 ± 2.85 %
PROD
7333 ± 4.72 %
SUM
34.) 2 3 5 MV 74.24 ± 3.99 %
75.15 ± 5.08 %
PROD
74.24 ± 5.15 %
SUM
35.) 2 3 6 MV 70.91 ± 4.08 %
7333 ± 3.66 %
PROD
72.12 ± 2.85 %
SUM
36.)24 5 MV 69.70 ± 3.52 %
70.91 ± 3.62 %
PROD
70.00 ± 3.85 %
SUM
37.) 2 4 6 MV 72.73 ± 3.26 %
74.24 ± 4.21 %
PROD
76.06 ± 2.06 %
SUM
38.) 2 5 6 MV 74.55 ± 6.15 %
74.24 ± 4.41 %
PROD
75.15 ± 5.08 %
SUM
39.)3 4 5 MV 71.21 ± 5.64 %
74.55 ± 3.09 %
PROD
72.12 ± 5.74 %
SUM
40.) 3 4 6 MV 72.12 ± 5.58 %
74.24 ± 5.64 %
PROD
75.45 ± 5.55 %
SUM
41.) 3 5 6 MV 70.61 ± 7.48 %
7333 ± 2.15 %
PROD
71.52 ± 5.22 %
SUM
42.)4 5 6 MV 69.70 ± 4.80 %
72.73 ± 5.15 %
PROD
71.21 ± 4.61 %
SUM

Table C.8: Averages of 3 classifiers each from the novel/parietal recordings for 66
patients (refer to Table 6.15).
Single Classifiers
67.58 ± 3.90 %
1.) P4 2-4Hz
2.) PZ2-4Hz
72.42 ± 3.62 %
64.85 ± 6.83 %
3.) P3 2-4Hz
70.00 ± 3.37 %
4.)P41-2Hz
64.85 ± 8.76 %
5.)PZl-2Hz
63.34 ± 2.06 %
6.) P71-2Hz
71.21 ± 6.65 %
11) P4 2-4Hz
71.82 ± 5.08 %
12.) PZ2-4Hz
66.36 ± 3.09 %
13) P3 2-4Hz
69.39 ± 2.46 %
14) P4 1-2Hz
65.76 ± 7.35 %
15) PZ l-2Hz
63.03 ± 7.48 %
16.) P7 1-2Hz
70.61 ± 3.42 %
21) P4 2-4Hz
70.91 ± 3.85 %
22.) PZ2-4Hz
65.76 ± 3.42 %
23.) P3 2-4Hz
70.30 ± 2.85 %
24) P4 1-2Hz
65.15 ± 4.80 %
25) PZ -2Hz
59.40 ± 7.69 %
26.) P7 1-2Hz
Combinations
1.) 123456MV 77.88
77.27
PROD
79.09
SUM
76.97
2.) 12 3 4 5 MV
76.67
PROD
78.48
SUM
76.67
3.) 12 3 4 6 MV
75.45
PROD
76.67
SUM
77.88
4.)134 5 6 MV
77.27
PROD
78.49
SUM
75.46
5.) 2 3 4 5 6 MV
75.76
PROD
77.88
SUM
78.79
6.)12 4 5 6 MV
78.48
PROD
79.39
SUM
74.85
7.)12 3 5 6MV
73.33
PROD
75.15
SUM
7636
8.)12 3 4 MV
74.85
PROD
75.76
SUM
73.94
9.)12 3 5 MV
72.42
PROD
73.33
SUM
75.45
10.) 12 3 6 MV
73.03
PROD
74.85
SUM

±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±

2.52
2.66
2.45
3.09
4.12
1.57
2.86
2.45
2.15
3.90
3.52
4.29
5.05
3.52
5.08
1.88
1.57
2.53
2.85
3.42
2.85
1.68
4.33
1.88
3.36
3.62
1.68
3.62
2.45
3.67

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

I

Combinations
11.)12 4 5 MV 74.55 ± 3.62
79.09 ± 2.45
PROD
78.79 ± 2.97
SUM
12.)1246MV 76.97 ± 2.45
76.06 ± 0.84
PROD
77.58 ± 1.57
SUM
13.)1256MV 74.24 ± 3.76
75.46 ± 4.29
PROD
SUM
75.76 ± 5.64
14.)1345MV 77.27 ± 1.33
7636 ± 3.90
PROD
78.48 ± 3.36
SUM
15.)1346MV 78.49 ± 3.37
75.15 ± 2.85
PROD
SUM
79.09 ± 1.57
16.)1356MV 74.24 ± 4.21
73.03 ± 4.29
PROD
75.45 ± 4.49
SUM
17.)1456MV 75.15 ± 5.25
76.97 ± 2.45
PROD
75.45 ± 3.09
SUM
18.)2 3 4 5 MV 7636 ± 2.15
75.45 ± 1.57
PROD
7636 ± 1.68
SUM
19.)2 3 4 6 MV 78.49 ± 0.84
76.67 ± 3.41
PROD
2.31
78.79
SUM
20.) 2 4 5 6 MV 7636 ± 6.32
76.97 ± 2.45
PROD
77.27 ± 2.30
SUM
21.) 3 4 5 6 MV 73.94 ± 4.87
76.06 ± 3.62
PROD
75.76 ± 5.15
SUM
22.) 2 3 5 6 MV 7333 ± 5.58
72.42 ± 5.22
PROD
73.94 ± 5.39
SUM
75.76 ± 3.52
23.) 12 3 MV
7333 ± 2.53
PROD
74.54 ± 2.79
SUM
24.) 124MV
76.67 ± 2.15
77.58 ± 1.57
PROD
1.33
77.27
SUM
22.79
25.) 12 5 MV
72.43
7333 ± 3.90
PROD
72.42 ± 2.06
SUM
26.) 12 6 MV
7333 ± 4.72
71.82 ± 2.14
PROD
73.94 ± 3.62
SUM
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%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
27.)134MV 76.97 ± 1.57 %
76.06 ± 2.79 %
PROD
78.79 ± 2.97 %
SUM
28.)135MV 73.03 ± 2.79 %
72.73 ± 3.76 %
PROD
73.94 ± 3.09 %
SUM
29.)136MV 73.33 ± 4.12 %
73.03 ± 2.45 %
PROD
74.85 -1.68 %
SUM
30.)14 5 MV 75.15 ± 2.14 %
74.24 ± 2.66 %
PROD
74.55 ± 2.45 %
SUM
31.)146MV 76.36 ± 3.90 %
76.67 ± 2.86 %
PROD
76.36 ± 3.15 %
SUM
32.)156MV 72.42 ± 4.08 %
72.73 ± 3.76 %
PROD
72.73 ± 4.21 %
SUM
33.) 2 3 4 MV 77.88 ± 2.85 %
76.06 ± 2.45 %
PROD
79.09 ± 1.57 %
SUM
34.) 2 3 5 MV 74.24 ± 4.61 %
73.33 ± 5.42 %
PROD
75.15 ± 3.42 %
SUM
35.) 2 3 6 MV 73.64 ± 1.03 %
73.03 ± 4.29 %
PROD
73.33 ± 2.15 %
SUM
36.) 2 4 5 MV 73.94 ± 3.62 %
73.63 ± 1.68 %
PROD
72.42 ± 3.09 %
SUM
37.) 2 4 6 MV 76.36 ± 3.90 %
78.18 ± 1.03 %
PROD
80.00 ± 0.84 %
SUM
38.) 2 5 6 MV 73.03 ± 2.45 %
74.24 ± 2.66 %
PROD
74.85 ± 2.14 %
SUM
39.) 3 4 5 MV 74.55 ± 3.62 %
74.85 ± 3.15 %
PROD
73.94 ± 1.57 %
SUM
40.) 3 4 6 MV 73.94 ± 4.87 %
75.76 ± 3.99 %
PROD
76.67 ± 3.66 %
SUM
41.) 3 56 MV 70.00 ± 4.87 %
69.39 ± 4.08 %
PROD
70.61 ± 4.53 %
SUM
42.)456MV 73.64 ± 5.25 %
73.63 ± 4.12 %
PROD
74.55 ± 5.86 %
SUM

Table C.9: Averages of 1 classifier each from the target and novel/parietal recordings for
71 patients (refer to Table 6.16).
Single Classifiers
63.66 ± 3.59 %
1.) TP4 2-4Hz
58.03 ± 3.36 %
2) TPZ2-4Hz
61.41 ± 4.21 %
3.) TP32-4Hz
59.16 ± 2.47 %
4) TP4 1-2Hz
61.13 ± 6.13 %
5) TPZ 1-2Hz
6.) TP7 1-2Hz
61.69 ± 4.85 %
63.38 ± 6.42 %
11.) NP4 2-4Hz
73.80 ± 5.87 %
12.)NPZ2-4Hz
68.17 ± 5.75 %
13) NP3 2-4Hz
14) NP4 1-2Hz
61.13 ± 6.13 %
60.56 ± 2.76 %
15) NPZ 1-2Hz
58.87 ± 5.01 %
16.) NP7 1-2Hz

Combinations
1.) 123456MV 71.83
71.55
PROD
74.08
SUM
2.)12 3 4 5 MV
70.99
72.11
PROD
71.83
SUM
73.52
3.)12346MV
72.39
PROD
72.11
SUM
71.83
4.)13 4 5 6 MV
71.27
PROD
7239
SUM
71.27
5.) 2 3456MV
71.55
PROD
73.24
SUM
71.83
6.)12 4 5 6 MV
71.55
PROD
72.96
SUM
73.24
7.)12356MV
73.52
PROD
75.77
SUM
72.68
8.)12 3 4 MV
72.67
PROD
71.83
SUM
72.96
9.)12 3 5 MV
73.80
PROD
72.40
SUM
73.80
10.) 1236MV
75.21
PROD
76.05
SUM
70.98
11.) 12 45 MV
71.55
PROD
72.39
SUM

±
±
±
±

4.46
3.99
4.02
2.92
3.36
± 4.79
3.37
± 5.19
± 4.69
± 4.79
± 3.41
± 4.56
± 6.13
4.35
± 5.09
± 2.48
± 3.79
± 3.13
5.39
± 4.85
± 5.72
1.57
± 3.62
± 4.1
± 2.6
± 5.47
± 4.03
± 3.63
± 5.47
± 6.06
± 2.93
± 3.13
3.18

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Combinations
12.)12 4 6 MV 71.27 ± 1.57
71.83 ± 1.75
'ROD
72.11 ± 2.28
)UM
13.)1256MV 72.40 ± 4.03
73.24 ± 3.50
'ROD
72.96 ± 2.88
sUM
14.)1345MV 69.86 ± 3.62
70.14 ± 2.28
PROD
71.27 ± 3.63
sUM
.5.)1346MV 72.68 ± 5.04
PROD
71.27 ± 4.03
7239 ± 2.00
SUM
16.) 13 5 6 MV 7239 ± 7.06
75.49 ± 4.56
PROD
76.06 ± 6.06
SUM
17.)1456MV 69.58 ± 4.02
71.27 ± 2.65
PROD
7239 ± 2.65
SUM
18.)2 345 MV 70.42 ± 3.50
72.40 ± 4.03
PROD
7239 4 4.56
SUM
19.)2 3 4 6 MV 7239 ± 6.95
7239 ± 4.03
PROD
72.96 ± 5.98
SUM
20.) 2 4 5 6 MV 69.58 ± 4.56
71.27 ± 2.93
PROD
73.24 ± 3.27
SUM
21.) 3 4 5 6 MV 68.45 ± 6.95
69.30 ± 3.36
PROD
71.55 ± 5.85
SUM
22.)2 3 5 6 MV 72.11 ± 5.00
PROD
72.68 ± 2.00
7436 ± 5.01
SUM
23.)12 3 MV
7437 ± 5.85
7437 ± 5.16
PROD
75.78 ± 435
SUM
24.)124MV
69.29 ± 2.59
71.55 ± 1.46
PROD
71.27 ± 2.00
SUM
69.30 ± 3.99
25.)12 5 MV
PROD
70.70 ± 2.28
71.83 ± 4.95
SUM
26.) 126MV
69.01 ± 4.79
70.99 ± 3.18
PROD
72.11 ± 3.79
SUM
70.42 ± 5.10
27.)13 4 MV
69.58 ± 2.92
PROD
70.70 ± 4.18
SUM
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%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%/
0

%

Combinations
70.14
72.96 ±
?ROD
71.55 ±
sUM
29.)136MV 75.49 ±
74.08 ±
PROD
75.49 ±
SUM
30.) 145MV 69.29 ±
69.30 ±
PROD
SUM
69.86 ±
31.)146MV 69.01 ±
PROD
70.70 ±
72.11 ±
SUM
32.)156MV 68.73 ±
PROD
72.96 ±
72.39
SUM
33.)2 3 4 MV 71.83 ±
71.83 ±
PROD
72.68 ±
SUM
34.)2 3 5 MV 71.55 ±
72.11 ±
PROD
72.11 ±
SUM
35.)2 36 MV 73.80 ±
72.11 ±
PROD
73.52 ±
SUM
36.)2 4 5 MV 70.42 ±
69.02 ±
PROD
71.26 ±
SUM
37.) 2 4 6 MV 71.55 ±
70.98 ±
PROD
72.68 ±
SUM
38.) 2 5 6 MV 67.89 ±
68.17 ±
PROD
SUM
69.86 ±
39.)34 5 MV 67.89 ±
66.48 ±
PROD
67.33 ±
SUM
40.) 3 4 6 MV 70.70 ±
69.30 ±
PROD
72.11 ±
SUM
41.) 3 5 6 MV 71.55 ±
70.98
PROD
72.39 ±
SUM
42.) 4 5 6 MV 67.04 ±
69.01 ±
PROD
69.86 ±
SUM

28.)135MV

5.30
5.44
4.69
6.95
6.84
7.68
2.28
2.28
3.62
4.46
0.78
3.13
6.93
2.28
2.35
5.10
539
3.41
5.45
3.79
4.69
5.88
5.15
4.85
3.27
3.03
4.39
5.30
2.00
3.41
6.47
2.65
3.63
4.53
2.87
3.79
4.69
5.16
5.00
4.52
2.35
6.95
1.99
5.10
0.96

%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

Table C.10: Averages of 11 classifiers for the parietal and occipital features for 71
patients (refer to Table 6.17).
Single Classifiers
1) TP4 2-4Hz
61.13 ± 6.26%
2) TPZ2-4Hz
56.90 ± 3.17%
59.15 ± 5.93%
2) TP3 2-4Hz
68.17 + 3.41%
4) NP8 2-4Hz
58.31 + 5.88%
5.) T02 1-2Hz
65.64 ± 2.00%
6.) TP7 1-2Hz
59.44 ± 3.36%
7.) N02 1-2Hz
71.55 ± 2.88%
8.) NPZ2-4Hz
66.48 ± 2.59%
9.) NP3 2-4Hz
10.) NP4 1-2Hz 62.82 ± 3.18%
11) NPZ 1-2Hz 62.82 ±5.61%

Combinations
59.43 ±4.17%
1,2,3 MV
PROD
62.25 ±2.28%
61.13 5.61%
SUM
66.48 ± 3.79%
1,2,4 MV
70.98 2.00%
PROD
66.76 ± 5.88%
SUM
63.10 ± 6.23%
1,2,5 MV
66.48±3.79%
PROD
64.22 ± 5.04%
SUM
62.82 ±4.22%
1,2,6 MV
PROD
66.76 ±5.33%
SUM
65.07 ± 4.69%
62.82 ± 4.89%
1,2,7 MV
65.07 ± 5.72%
PROD
63.38 ±6.99%
SUM
64.51 6.47%
1,2,8 MV
68.73 2.87%
PROD
65.63 ±5.74%
SUM
63.66 ±4.85%
1,2,9 MV
PROD
67.04 4.56%
66.20 ±6.42%
SUM
1,2,10 MV 62.54 4.73%
63.66 ±2.28%
PROD
63.66 ± 5.16%
SUM
1,2,11 MV 64.22 ±7.68%
65.91 ± 4.53%
PROD
66.48 ± 8.33%
SUM
68.17 2.65%
1,3,4 MV
66.76 ± 2.34%
PROD
68.73 2.28%
SUM
62.25 4.18%
1,3,5 MV
62.82±2.93%
PROD
63.10 ±3.13%
SUM
67.04 4.21%
1,3,6 MV
64.79 2.14%
PROD
68.17 2.92%
SUM
60.84 4.53%
1,3,7 MV
62.25 ± 2.28%
PROD
60.56 ±4.46%
SUM
67.04 ±4.03%
1,3,8 MV
68.17 5.04%
PROD
67.89 ± 4.85%
SUM
65.07 ±1.46%
1,3,9 MV
67.04 ± 1.99%
PROD
64.51 ±2.88%
SUM
1,3,10 MV 64.23+ 2.00%
62.25 ± 2.28%
PROD
64.51 ± 3.13%
SUM
126

Combinations
1,3,11 MV 64.51 5.45%
PROD
62.82 ± 5.33%
63.94 ± 4.22%0
SUM
66.76 ± 5.88%
1,4,5 MV
/0
7127 ± 5.18%
PROD
67.33 ± 2.59%
SUM
1,4,6 MV 70.70 ± 1.920//o
PROD
72.11 ± 4.69/ 40
SUM
70.99 ± 4.39/
65.63 ± 3.620%/0
1,4,7 MV
70.70 ±4.53%
PROD
SUM
67.32 ± 3.360°
1,4,8 MV 71.83 ± 4.62/ /o
73.80 : 5.610 /o
PROD
72.67 3.410,/o
SUM
1,4,9 MV 70.42 ± 4.79°
73.52 ± 4.690
PROD
71.83 ± 4.11° /0
SUM
1,4,10 MV 67.89 4.529%
69.29 ± 3.589%
PROD
SUM
67.89 ±3.139,
1,4,11 MV 69.30 ± 5.16%
70.42 ± 4.28 ,
PROD
69.58 ± 4.03%/o
SUM
65.07 ±6.71%/0
1,5,6 MV
66.48 ± 9.45%/0
PROD
/
67.61 ±4.46%/
SUM
0
62.82 ± 2.93%/
1,5,7 MV
65.63 ± 4.73%
PROD
63.66 ± 2.60%/o
SUM
69.58 ± 4.56%/
1,5,8 MV
73.24 + 3.71°
PROD
71.27 4.03°
SUM
67.89 ± 4.17%vo
1,5,9 MV
70.99 ± 5.04%
PROD
68.45 ± 4.02%7
SUM
1,5,10 MV 66.76 ± 4.02%7o
7o
66.76 ±3.62%
PROD
68.17 ± 1.99%
SUM
0
1,5,11 MV 65.07 ± 5.85%vo
65.07 ± 3.13%
PROD
67.61 ± 2.47%
SUM
65.92 ± 1.92%
1,6,7 MV
67.04 ± 5.47%
PROD
66.48 ± 3.13%
SUM
1,6,8 MV 73.80 7.28 ,
73.24 -4.46,
PROD
74.09 -5.889
SUM

Table C.10: Averages of 11 classifiers for the parietal and occipital features for 71
patients (refer to Table 6.17). (continued)
Combinations
Combinations
Combinations
1,6,9 MV
PROD
SUM
1,6,10 MV
PROD
SUM
1,6,11 MV
PROD
SUM
1,7,8 MV
PROD
SUM
1,7,9 MV
PROD
SUM
1,7,10 MV
PROD
SUM
1,7,11 MV
PROD
SUM
1,8,9 MV
PROD
SUM
1,8,10 MV
PROD
SUM
1,8,11 MV
PROD
SUM
1,9,10 MV
PROD
SUM
1,9,11 MV
PROD
SUM
1,10,11 MV
PROD
SUM
2,3,4 MV
PROD
SUM
2,3,5 MV
PROD
SUM
2,3,6 MV
PROD
SUM

71.55 ± 2.60%
71.55 ± 6.23%
72.96 5.44%
66.76 + 6.26%
67.04±6.01%
68.73±6.93%
67.32 ±6.82%
68.45 ± 4.56%
69.86± 2.92%
70.14 + 2.87%
70.71 ± 4.53%
70.14 ±-3.79%
68.73±4.17%
70.14 336%
69.86 ±4.03%
63.38 2.77%
66.19 ± 7.52%
64.51 3.99%
63.38 4.46%
65.07 ± 3.37%
64.51 ± 3.59%
73.80 ±2.92%
72.96 ±3.58%
72.96 ±3.13%
69.58 ± 5.88%
68.73 ± 5.72%
69.58 ± 4.72%
69.58 ±4.88%
68.73 ±3.36%
69.01 4.95%
67.89 ±6.59%
67.61 ±2.47%
69.01 ±4.94%
65.92 ±6.47%
69.58 ± 3.41%
68.17 ±3.62%
63.66 ± 3.99%
65.35 ±3.41%
65.92 ±4.18%
63.10 ±2.28%
65.92 ±3.13%
63.38 ± 3.03%
59.72 ±7.06%
63.66 ± 6.23%
63.10 ± 4.17%
61.13 ± 4.39%
65.63 ± 5.04%
66.48 ± 4.53%

2,3,7 MV
PROD
SUM
2,3,8 MV
PROD
SUM
2,3,9 MV
PROD
SUM
2,3,10 MV
PROD
SUM
2,3,11 MV
PROD
SUM
2,4,5 MV
PROD
SUM
2,4,6 MV
PROD
SUM
2,4,7 MV
PROD
SUM
2,4,8 MV
PROD
SUM
2,4,9 MV
PROD
SUM
2,4,10 MV
PROD
SUM
2,4,11 MV
PROD
SUM
2,5,6 MV
PROD
SUM
2,5,7 MV
PROD
SUM
2,5,8 MV
PROD
SUM
2,5,9 MV
PROD
SUM

60.56 2.76%
61.13 ± 3.83%
61.41 2.35%
65.91 + 5.45%
67.89± 1.91%
66.20 ±3.91%
61.97 ±5.10%
64.51 ±2.28%
62.54 ±5.19%
61.41 ±5.33%
63.10 ±3.37%
64.51 +3.13%
59.15±8.11%
62.82 ± 3.83%
61.97 ±5.10%
69.58 ±4.02%
71.83 : 5.09%
69.58 ±2.92%
72.11 ±5.85%
73.24 ± 2.77%
73.52 ± 4.69%
69.01 ±4.79%
71.27 ±533%
68.73 ±4.85%
71.83 ± 3.50%
74.09 ± 2.65%
71.83 ± 4.79%
67.32 2.87%
7239 ± 2.93%
70.42 ± 2.76%
68.17 ±1.56%
70.99 + 4.73%
70.14 ± 3.99%
70.14 ±2.59%
72.11 ± 2.60%
71.55 ± 337%
66.76 2.65%
69.30 ± 3.58%
68.73 ±4.52%
61.41 ±2.92%
63.66 ±4.17%
62.82 ± 2.65%
67.61 ±2.14%
69.01 ± 2.76%
67.89 ± 3.13%
66.48 ± 3.58%
69.86 ± 6.01%
68.45 ± 4.02%
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2,5,10 MV
PROD
SUM
2,5,11 MV
PROD
SUM
2,6,7 MV
PROD
SUM
2,6,8 MV
PROD
SUM
2,6,9 MV
PROD
SUM
2,6,10 MV
PROD
SUM
2,6,11 MV
PROD
SUM
2,7,8 MV
PROD
SUM
2,7,9 MV
PROD
SUM
2,7,10 MV
PROD
SUM
2,7,11 MV
PROD
SUM
2,8,9 MV
PROD
SUM
2,8,10 MV
PROD
SUM
2,8,11 MV
PROD
SUM
2,9,10 MV
PROD
SUM
2,9,11 MV
PROD
SUM

66.20 + 1.75%
65.07 2.28%
66.48 2.59%
65.07 + 5.72%
64.51 ±3.37%
67.04 ±2.34%
64.51 ±1.92%
69.01 ± 6.88%
67.60 ±3.49%
73.24 ± 2.14%
73.80 ±2.35%
72.96 ±3.79%
67.89± 2.28%
67.61 ± 4.94%
70.42 ± 2.76%
67.04 2.92%
69.01 5.25%
68.17 ±3.62%
68.45 1.99%
70.42 ±2.14%
69.86 2.35%
69.58 ±4.21%
68.73 ±3.13%
68.73 ±3.13%
66.48 ± 5.72%
67.04 ± 6.38%
66.48 2.59%
63.10 ±2.28%
63.94 ± 3.62%
65.07 ± 1.92%
64.51 ±4.17%
66.76 2.65%
67.32 ±3.13%
70.70 ±4.18%
72.68 ± 5.04%
71.55 ± 6.23%
68.45 ± 5.04%
65.63 2.65%
66.76 3.62%
68.45 ±5.04%
67.04 3.41%
67.61 ± 3.91%
64.51±2.88%
66.76 ± 7.88%
66.48 ± 4.85%
65.35 ± 3.63%
67.89 ± 4.52%
67.89 ± 3.58%

Table C.10: Averages of 11 classifiers for the parietal and occipital features for 71
patients (refer to Table 6.17). (continued)
Conminations
Combinations
Combinations
4,5,10 MV 68.45 + 2.65%
64.79 + 8.65%
3,6,10 MV
2,10,11 MV 61.97 + 3.91%
70.70 ± 2.59%
PROD
62.54 ±4.72%
PROD
64.51 3.37%
PROD
69.58 1.99%
SUM
66.20 5.10%
SUM
63.10 3.13%
SUM
69.30 2.28%
MV
4,5,11
6.38%
60.00
3,6,11
MV
7.62%
67.61
3,4,5 MV
71.55 ± 2.60%
PROD
61.13 5.19%
PROD
69.58 4.56%
PROD
68.45 ± 2.92%
SUM
65.35 4.72%
SUM
69.30 ± 4.85%
SUM
70.14 ± 5.15%
4,6,7 MV
70.70 ± 4.69%
3,7,8 MV
3,4,6 MV 70.99 ± 5.04%
7239 ± 4.03%
PROD
68.73 5.58%
PROD
70.70 ± 2.88%
PROD
69.58 + 6.61%
SUM
70.42 ±4.46%
SUM
70.99 4.56%
SUM
4,6,8 MV 75.49 ± 2.65%
67.89 5.85%
3,7,9 MV
67.61 4.10%
3,4,7 MV
77.75 ± 2.87%
PROD
65.07 + 5.31%
PROD
68.73 + 3.13%
PROD
78.03 1.56%
SUM
67.89 ± 5.85%
SUM
68.45 + 4.56%
SUM
70.98 ±1.57%
MV
4,6,9
5.15%
62.25
3,7,10
MV
±
4.56%
7127
3,4,8 MV
71.83 ± 2.77%
PROD
61.69 6.35%
PROD
72.96 ± 4.85%
PROD
71.55 ±3.36%
SUM
63.94 4.22%
SUM
70.99 ±3.63%
SUM
4,6,10 MV 72.11 ±4.35%
63.10 ±5.01%
3,7,11 MV
69.58 +3.41%
3,4,9 MV
71.27 ± 3.18%
PROD
62.53 4.88%
PROD
71.83 ± 1.75%
PROD
7239 4.39%
SUM
64.79 3.27%
SUM
69.30± 2.87%
SUM
4,6,11 MV 70.42 ±1.75%
66.48+ 2.28%
3,8,9 MV
3,4,10 MV 69.01 ± 3.03%
72.96 ± 2.60%
PROD
68.17 3.62%
PROD
68.45 4.39%
PROD
72.96 3.37%
SUM
67.04 ±1.99%
SUM
69.01 2.76%
SUM
4,7,8MV 71.27 ±2.65%
69.86 3.17%
3,8,10 MV
3,4,11 MV 66.76 ±4.72%
75.21 ± 2.35%
PROD
66.76 7.88%
PROD
67.89 3.36%
PROD
70.42 ± 2.47%
SUM
68.17 2.92%
SUM
66.76 ± 3.17%
SUM
4,7,9 MV 70.14 ± 4.17%
68.45 +3.41%
3,8,11 MV
61.69+ 3.37%
3,5,7 MV
71.55 ± 4.69%
PROD
68.17 ±7.68%
PROD
61.12 ±3.41%
PROD
70.14 3.36%
SUM
67.32 + 4.52%
SUM
61.97 + 3.50%
SUM
65.64 ±1.57%
MV
4,7,10
5.10%
67.61
3,9,10 MV
66.20 7.42%
3,5,8 MV
69.30 ± 4.53%
PROD
63.66 3.37%
PROD
68.73 ±6.71%
PROD
67.33 ± 0.78%
SUM
67.32 6.47%
SUM
67.89 + 7.86%
SUM
4,7,11 MV 66.48 2.87%
66.76 ±4.02%
3,9,11 MV
64.79 6.66%
3,5,9 MV
70.98 ± 2.00%
PROD
63.66 2.88%
PROD
66.48 3.13%
PROD
67.32 3.13%
SUM
67.61 ±4.79%
SUM
65.35 3.18%
SUM
4,8,9 MV 74.93 ± 2.28%
3,10,11 MV 59.44 4.85%
3,5,10 MV 63.38+ 5.39%
75.21 4.21%
PROD
61.41 ±4.03%
PROD
60.28 3.99%
PROD
7437 ±1.46%
SUM
4.10%
61.97
SUM
64.22 4.21%
SUM
71.83 ±3.50%
4,8,10MV
±1.75%
71.83
MV
4,5,6
±6.84%
62.82
3,5,11 MV
69.86 1.99%
PROD
71.55 ± 2.28%
PROD
61.69 7.96%
PROD
69.86 2.92%
SUM
69.86 ±1.57%
SUM
63.66 6.93%
SUM
4,8,11 MV 70.14 ± 3.79%
69.01 2.76%
4,5,7 MV
65.35 + 5.75%
3,6,7 MV
74.08 ± 4.73%
PROD
70.98 ± 235%
PROD
64.79 ± 5.53%
PROD
70.99 ± 4.03%
SUM
68.17 + 0.95%
SUM
65.35 + 4.03%
SUM
4,9,10 MV 69.30 4.17%
69.58 -4.02%
4,5,8 MV
3,6,8MV 70.14 ± 1.91%
70.14 ± 0.78%
PROD
74.65 ± 6.99%
PROD
68.17 + 6.73%
PROD
68.73 + 3.79%
SUM
68.73 + 2.28%
SUM
70.42 ± 2.47%
SUM
4,9,11 MV 69.58 + 3.62%
67.61+ 1.23%
4,5,9 MV
69.30 + 5.01%
3,6,9 MV
70.70 ± 3.36%
PROD
72.68 ± 2.00%
PROD
64.51+ 1.46%
PROD
69.30 ± 2.87%
SUM
68.17 + 0.95%
SUM
68.45 + 4.02%
SUM
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Table C.10: Averages of 11 classifiers for the parietal and occipital features for 71
patients (refer to Table 6.17). (continued)
Combinations
4,10,11 MV 65.64 3.41%
69.29 4.35%
PROD
67.32±2.87%
SUM
63.94 ±6.73%
5,6,7 MV
65.35 + 3.83%
PROD
65.07 ± 5.16%
SUM
71.83 ± 3.91%
5,6,8 MV
71.55 ±4.18%
PROD
70.99 ±4.56%
SUM
70.14 ± 3.79%
5,6,9 MV
70.42 ± 4.10%
PROD
70.14 ± 3.13%
SUM
67.04 4.56%
5,6,10 MV
65.63 + 3.41%
PROD
67.61 + 3.27%
SUM
66.48 + 6.23%
5,6,11 MV
67.89 ±4.69%
PROD
67.32 + 6.71%
SUM
71.55 ± 2.28%
5,7,8 MV
70.14 ± 3.36%
PROD
68.73 + 3.36%
SUM
68.45 + 3.41%
5,7,9 MV
71.55 ± 3.59%
PROD
68.45 4.72%
SUM
64.79 3.50%
5,7,10 MV
66.76 3.83%
PROD
67.32 + 3.13%
SUM
65.35 + 6.49%
5,7,11 MV
65.63 5.88%
PROD
65.35 + 3.83%
SUM
69.02 + 4.46%
5,8,9 MV
72.96 ± 337%
PROD
69.30 2.87%
SUM
5,8,10 MV 70.14 ± 4.52%
70.70 ±4.18%
PROD
70.42 ± 3.50%
SUM
5,8,11 MV 71.83 ±4.46%
70.99 ± 3.18%
PROD
69.29 2.59%
SUM
65.35 6.61%
5,9,10 MV
68.73 + 5.45%
PROD
68.17 ± 5.04%
SUM
64.51 ±1.92%
5,9,11 MV
68.73 + 6.47%
PROD
67.61 + 6.66%
SUM
5,10,11 MV 65.92 +4.18%
67.89 + 3.99%
PROD
66.48 + 3.79%
SUM

Combinations
6,7,8 MV 73.24 h 2.77%
69.01 + 3.91%
PROD
69.30 ±4.85%
SUM
6,7,9 MV 71.27 ± 3.63%
71.55 ± 228%
PROD
71.55 ±5.15%
SUM
6,7,10 MV 67.89 + 5.45%
67.60 ±6.77%
PROD
69.86 5.61%
SUM
6,7,11 MV 67.32 ± 4.85%
70.42 ± 4.46%
PROD
68.45 5.19%
SUM
6,8,9 MV 72.68 ±2.00%
73.24 ± 327%
PROD
74.09 ± 2.93%
SUM
6,8,10 MV 70.42 ± 539%
69.86 ± 3.17%
PROD
69.86 2.92%
SUM
6,8,11 MV 71.27 ±2.00%
73.52 ± 4.85%
PROD
72.40 ±3.83%
SUM
6,9,10 MV 65.92 + 3.79%
65.35 4.03%
PROD
66.76 5.88%
SUM
6,9,11 MV 67.61 3.91%
68.73 7.25%
PROD
70.14 ± 7.66%
SUM
6,10,11 MV 67.33 + 3.13%
66.48 3.13%
PROD
67.32 2.87%
SUM
7,8,9 MV 73.24 ±3.50%
73.24 ± 2.14%
PROD
71.27 ± 2.00%
SUM
7,8,10MV 71.83 ± 2.48%
68.45 3.62%
PROD
69.02 4.46%
SUM
7,8,11 MV 69.02 ±4.10%
69.30 + 5.30%
PROD
69.58 + 2.65%
SUM
7,9,10 MV 69.29 ±1.46%
68.17 1.56%
PROD
69.86 +2.65%
SUM
7,9,11 MV 67.32 2.87%
68.17 + 7.68%
PROD
67.61 ± 4.10%
SUM
7,10,11 MV 65.92 + 3.36%
65.92 ± 1.92%
PROD
66.20 + 2.76%
SUM
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Combinations
8,9,10 MV 70.70 ±2.28%
69.86 ± 3.62%
PROD
70.42 ±3.71%
SUM
8,9,11 MV 70.42 ± 2.47%
70.98 ± 235%
PROD
70.42 2.48%
SUM
8,10,11 MV 68.17 + 4.02%
67.04 ±3.83%
PROD
67.04 4.02%
SUM
9,10,11 MV 63.66 2.88%
64.51 3.58%
PROD
65.92 2.87%
SUM
73.80 1.57%
ALLMV
73.24 ± 2.77%
PROD
74.37 ± 1.46%
SUM

Table C.11: Averages of 7 classifiers for the parietal and occipital features for 71 patients
(refer to Table 6.18).
Single Classifiers
1)TP4 1-2Hz
60.00+ 1.99%
2) NP8 2-4Hz
67.32 ± 4.85%
3) T02 1-2Hz
60.56 ± 4.46%
4) TP7 1-2Hz
62.25 + 3.13%
5.) N02 1-2Hz
61.97 ± 5.80%
6.) NPZ2-4Hz 71.83 ±4.46%
7.) NP3 24Hz
67.89 + 7.36%

1,2,3 MV
PROD
SUM
1,2,4 MV
PROD
SUM
1,2,5 MV
PROD
SUM
1,2,6 MV
PROD
SUM
1,2,7 MV
PROD
SUM

1,3,4 MV
PROD
SUM
1,3,5 MV
PROD
SUM
1,3,6 MV
PROD
SUM
1,3,7 MV
PROD
SUM
1,4,5 MV
PROD
SUM
1,4,6 MV
PROD
SUM
1,4,7 MV
PROD
SUM
I_- - -

-

Coniinations
65.92 + 3.58%
69.30 ± 3.13%
66.20 3.71%
68.17 ± 5.19%
67.89 ±1.46%
68.45 ± 3.17%
65.92 ± 1.46%
69.58±1.56%
66.76 ±1.99%
69.86 + 3.62%
72.96 ± 3.99%
72.11 1.46%
67.04 4.39%
68.73 ± 3.13%
68.17 4.02%
65.35+ 3.63%
64.23± 4.03%
65.35 ± 4.03%
62.82 4.88%
63.10 2.28%
62.54 3.41%
67.89±2.59%
69.30 2.28%
67.60 ± 3.49%
65.07 ±2.88%
67.32 3.99%
64.51 3.79%
65.35 3.63%
63.94 2.65%
66.20 2.14%
70.42 ±3.27%
69.58 2.92%
71.27 ± 3.83%
69.01 5.93%
65.35 + 4.73%
69.86 5.88%
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Combinations
1,5,6 MV 69.86 ± 4.56%
PROD
69.58 ± 4.02%
SUM
70.14 ± 3.79%
1,5,7 MV 68.17 4.39%
PROD
69.01 ±5.10%
SUM
69.01 4.10%
1,6,7 MV 72.40 3.62%
PROD
72.39 533%
SUM
72.11 ±2.88%
2,3,4 MV 70.14 ± 3.13%
PROD
70.70 ±2.28%
SUM
68.45 ±4.88%
2,3,5 MV 67.61 5.10%
67.89 4.17%
PROD
SUM
66.48 ± 5.85%
2,3,6 MV 71.27 ±4.21%
PROD
73.24 3.50%
SUM
71.83 ±4.46%
2,3,7 MV 69.86+ 5.04%
69.58 ± 3.63%
PROD
SUM
69.30 ±4.85%
2,4,5 MV 68.45 5.75%
PROD
69.29 ±1.46%
SUM
68.45 ±6.61%
2,4,6MV 73.52 ±7.15%
PROD
74.09 + 2.93%
SUM
75.77 4.17%
2,4,7 MV 71.27 +4.56%
PROD
69.86 ± 3.62%
SUM
72.11 ±3.99%
2,5,6 MV 70.71 ±4.85%
PROD
7239 ±1.57%
SUM
70.14 44.53%
2,5,7 MV 67.89 5.30%
PROD
70.98 4.88%
SUM
68.73 ±3.99%
2,6,7 MV 72.11 7.15%
PROD
70.70 4.53%
SUM
71.55 ±6.47%
3,4,5 MV 61.97 +4.11%
PROD
64.79 ± 4.46%
SUM
63.94 ±4.03%

3,4,6 MV 70.99 7.68%
PROD
SUM

71.83 ±2.77%
71.83 +3.27%

Table C.11: Averages of 7 classifiers for the parietal and occipital features for 71 patients
(refer to Table 6.18). (continued)
__
Combinations
71.27 ± 6.84%
3,4,7 MV
72.40 ±6.26%
PROD
SUM
72.96 ±6.47%
69.01+ 5.67%
3,5,7 MV
PROD
70.42 ± 6.54%
SUM
68.73 + 3.36%
73.80 ± 5.04%
3,6,7 MV
7239 ± 5.04%
PROD
SUM
73.24 428%
7239 ±5.88%
4,5,6 MV
PROD
68.45 3.17%
SUM
70.14 ±7.25%
68.73 ±4.35%
4,5,7 MV
PROD
68.73 8.33%
69.01 4.10%
SUM
73.24 ±4.28%
4,6,7 MV
PROD
72.68 ±4.56%
SUM
73.80 ±3.63%
73.24 ± 4.46%
5,6,7 MV
71.27 ±7.16%
PROD
SUM
72.96 ±4.18%
1,2,3,4,5 MV 67.33 + 3.79%
PROD
69.86 2.92%
SUM
67.04 4.39%
1,2,3,4,6 MV 71.27 ±2.65%
PROD
72.96 ± 1.46%
72.11 ± 2.88%
SUM
68.73 5.30%
1,2,3,4,7 MV
PROD
70.70 2.28%
SUM
69.86 + 4.72%
69.01 + 1.23%
MV
1,2,3,5,6
72.11 1.46%
PROD
69.58 4.56%
SUM
69.01 ± 4.94%
1,2,3,5,7 MV
PROD
71.55 ± 1.46%
71.83 ± 2.77%
SUM
1,2,3,6,7 MV 70.14 ±7.25%
PROD
73.52 ± 4.85%
71.55 4.52%
SUM
69.30 3.36%
1,2,4,5,6 MV
71.83 ±3.50%
PROD
70.14 ±2.28%
SUM
1,2,4,5,7 MV 68.17 ±3.17%
71.55 ± 435%
PROD
SUM
69.58 + 3.62%

Conibnations
1,2,4,6,7 MV
PROD
SUM
1,2,5,6,7 MV
PROD
SUM
1,3,4,5,6 MV
PROD
SUM
1,3,4,5,7 MV
PROD
SUM
1,3,4,6,7 MV
PROD
SUM
1,3,5,6,7 MV
PROD
SUM
1,4,5,6,7 MV
PROD
SUM
2,3,4,5,6 MV
PROD
SUM
2,3,4,5,7 MV
PROD
SUM
2,3,4,6,7 MV
PROD
SUM
2,3,5,6,7 MV
PROD
SUM
2,4,5,6,7 MV
PROD
SUM
3,4,5,6,7 MV
PROD
SUM
AILMV
PROD
SUM
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72.40± 738%
72.96 ±4.85%
74.09 ±2.00%
67.89 ±3.99%
73.52 ±5.44%
70.99 ±3.62%
70.14 ±4.85%
70.99 3.18%
72.40 ±4.73%
69.01 ±4.63%
69.29 3.36%
68.17 ±5.61%
73.80 ±2.00%
73.80 ± 4.03%
7437 ± 5.72%
69.58 ± 5.61%
73.52 ±2.88%
70.99 ±3.63%
71.83 ±4.95%
71.27 ±533%
72.11 ±3.13%
68.73 ± 3.99%
75.21 ±1.57%
70.99 ±4.72%
68.73 ±336%
72.68 ±3.41%
71.83 ± 2.48%
74.08 ±4.56%
73.80 ± 2.93%
76.34 ± 1.46%
70.14 ± 4.85%
74.65 ± 2.76%
72.40 4.56%
71.55 ±6.93%
72.68 ± 5.18%
72.40 ± 5.75%
73.24 3.50%
72.96 :4.18%
74.65 ±3.91%
71.55 ±336%
73.80 1.57%
7239 ±2.00%

Table C.12: Averages of 7 classifiers including feature-level fused Target P4 and the
parietal and occipital features for 71 patients (refer to Table 6.19).
Single Classifiers
1.) TP4 cat
62.25 ±3.13%
2) NP8 2-4Hz
66.76 ± 3.41%
3) T02 1-2Hz
58.87 ±3.13%
4.) TP7 1-2Hz
62.25 ± 5.15%
58.87 ± 2.28%
5.) N02 1-2Hz
6.) NPZ2-4Hz
73.52 ± 4.18%
7.) NP3 2-4Hz
69.58 ± 5.61%

1,2,3 MV
PROD
SUM
1,2,4MV
PROD
SUM
1,2,5 MV
PROD
SUM
1,2,6 MV
PROD
SUM
1,2,7 MV
PROD
SUM
1,3,4 MV
PROD
SUM
1,3,5 MV
PROD
SUM
1,3,6 MV
PROD
SUM
1,3,7 MV
PROD
SUM
1,4,5 MV
PROD
SUM
1,4,6 MV
PROD
SUM
1,4,7 MV
PROD
SUM

Conirinations
67.32 ±2.87%
69.58 ±3.62%
68.17 ±3.17%
69.58 4.03%
70.14 5.45%
69.01 ±6.18%
68.17 ± 3.62%
69.30 ±2.87%
66.76 ±5.33%
73.80 ± 2.00%
75.21 6.26%
73.24 4.10%
74.08 - 3.18%
70.70 4.85%
73.52 3.13%
61.97 ± 5.25%
65.63 ±5.88%
65.92 3.36%
59.15 ± 5.93%
67.32 ±3.13%
61.41 ± 2.35%
65.07 ±2.28%
67.04 ±4.21%
67.32 ±3.36%
64.79 4.46%
71.27 2.65%
67.89 ±3.13%
65.35 ± 4.21%
67.04 ±3.41%
65.63 ±4.89%
71.27 2.35%
70.14 6.81%
7239 1.57%
73.24 ± 6.99%
74.09 ± 3.84%
7437 6.59%
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Conbinations
1,5,6 MV 73.52 ±3.79%
69.58 ±4.39%
PROD
7239 ±3.63%
SUM
1,5,7 MV 70.70 ± 4.85%
PROD
73.24 ±1.24%
SUM
71.55 2.28%
1,6,7 MV 75.78 + 4.69%
PROD
71.27 3.18%
SUM
75.21 ±4.72%
65.35 ± 4.03%
2,3,4 MV
PROD
70.42 4.46%
SUM
67.61 ±3.03%
67.04± 7.16%
2,3,5 MV
PROD
70.14 4.85%
SUM
67.32 ±4.17%
2,3,6 MV 70.42 2.14%
PROD
74.93 ±2.28%
SUM
71.55 2.28%
69.86±4.21%
2,3,7 MV
PROD
69.86 4.02%
SUM
69.86 ±3.17%
68.17 ± 4.72%
2,4,5 MV
69.58 2.65%
PROD
SUM
68.17 ±3.17%
2,4,6 MV 72.11 ±3.13%
7437 +2.88%
PROD
74.08 3.63%
SUM
2,4,7MV 72.11 ±3.79%
PROD
72.11 2.88%
SUM
7239 ±3.63%
2,5,6 MV 70.98 ± 2.00%
PROD
73.80 - 5.04%
70.70 ±3.13%
SUM
2,5,7 MV
67.61 ± 5.93%
70.99 ±5.87%
PROD
SUM
69.01 ± 5.10%
2,6,7 MV 70.98 ± 2.00%
72.96 5.45%
PROD
SUM
70.99 3.63%
62.82 5.88%
3,4,5 MV
PROD
64.22 ±4.21%
SUM
63.10 ±7.36%
68.45 ± 3.83%
3,4,6 MV
PROD
71.27 3.63%
69.01 ±3.27%
SUM

Table C.12: Averages of 7 classifiers including feature-level fused Target P4 and the
parietal and occipital features for 71 patients (refer to Table 6.19). (continued)
Combinations
3,4,7 MV
69.58 ± 7.06%
73.80 5.18%
PROD
SUM
69.86 ±4.56%
3,5,7 MV
66.48 4.53%
72.11 2.28%
PROD
SUM
68.45± 1.99%
3,6,7 MV
72.96 +336%
76.90 4.21%
PROD
74.93 ±530%
SUM
69.86 3.41%
4,5,6 MV
PROD
69.58 ± 2.34%
70.14 ±2.28%
SUM
69.86 ±6.13%
4,5,7 MV
PROD
70.14 -5.45%
70.42 +5.25%
SUM
73.52 5.00%
4,6,7 MV
73.80 4.03%
PROD
7437 ±5.01%
SUM
5,6,7 MV
74.09 ± 6.25%
71.55 ±337%
PROD
74.08 5.61%
SUM
69.58 ± 5.75%
1,2,3,4,5 MV
72.68 4.88%
PROD
69.86 ±4.56%
SUM
1,2,3,4,6 MV 71.27 5.19%
75.21 5.47%
PROD
73.52 -2.87%
SUM
1,2,3,4,7 MV 72.68 ± 439%
72.67 + 3.62%
PROD
SUM
72.68 ± 235%
1,2,3,5,6 MV 72.11 ± 1.46%
75.21 ±3.41%
PROD
72.11 ±3.13%
SUM
1,2,3,5,7 MV 71.83 + 2.77%
PROD
72.11 5.72%
72.11 ± 3.13%
SUM
1,2,3,6,7 MV 73.52 ±3.79%
74.65 ± 4.79%
PROD
74.09 ± 4.72%
SUM
1,2,4,5,6 MV 72.96 ± 1.92%
74.93 2.87%
PROD
73.24 ±4.10%
SUM
1,2,4,5,7 MV 73.80 ± 5.04%
7239 ±2.65%
PROD
72.96 4.53%
SUM

Coniinations
1,2,4,6,7 MV 74.93 ± 4.18%
74.37 1.92%
PROD
75.21 ±2.65%
SUM
75.21 ± 3.83%
1,2,5,6,7 MV
74.93 3.99%
PROD
7437 3.99%
SUM
68.17 ± 3.41%
1,3,4,5,6 MV
70.42 ±3.27%
PROD
70.70 2.59%
SUM
1,3,4,5,7 MV 70.70 +3.99%
74.37 ± 1.46%
PROD
70.70 5.15%
SUM
1,3,4,6,7 MV 72.96 ± 5.44%
74.65 4.46%
PROD
7437 ± 4.18%
SUM
1,3,5,6,7 MV 72.96 ±337%
74.93 ± 3.58%
PROD
7437 ±5.72%
SUM
1,4,5,6,7 MV 77.18 ±5.85%
74.65 ±2.76%
PROD
76.90 5.04%
SUM
69.01 ± 1.23%
2,3,4,5,6 MV
75.49 ±3.83%
PROD
72.11 ± 3.79%
SUM
2,3,4,5,7 MV 70.70 ±5.85%
71.55 ±337%
PROD
71.83 ±4.63%
SUM
2,3,4,6,7 MV 72.96 ± 1.46%
74.08 2.65%
PROD
73.24 ± 2.14%
SUM
2,3,5,6,7 MV 71.55 3.99%
74.65 ± 4.79%
PROD
72.96 ±3.59%
SUM
2,4,5,6,7 MV 72.67 ±3.83%
74.65 2.47%
PROD
73.52 336%
SUM
73.52 5.16%
3,4,5,6,7 MV
74.65 ± 3.27%
PROD
73.24 ±3.91%
SUM
73.81 ±4.56%
AILMV
7437 ± 2.28%
PROD
74.09 ±2.00%
SUM
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